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The Chemistry of Sterols
The extraction of a plant or animal tissue
with organic solvents yields an appreciable quan¬
tity of lipid material which is resistant to
saponification* Such unsaponifiable lipids may
include vitamins, ubiquinone and one or more of a
variety of organic substances belonging to a group
of crystalline alcohols known as sterols. In the
tissues of vertebrates the principal sterol is
the CS7 alcohol, cholesterol. The classical
work of Wieland, Windaus, Diels, Rosenheim and
King which is reviewed by Pieser and Pieser (1959)
led to the formulation of the structure of choles¬
terol, the fundamental carbon skeleton being the
cyclopentanoperhydrophenanthrene ring, as shown in
Pig 1* This consists of three six-membered
rings fused together with one five-membered ring.
At C i7, an iso-octane side chain is attached.
In this molecule there are several asymmetric
centres, the angular methyl group at Ci0 being
taken as the reference. Oneof these centres is
at position S, where the hydroxyl group can be
either above or below the plane of the ring.
2.
a-Substituents, which are below the plane of the
ring and therefore trans to the methyl group at
Cjo are indicated by dotted lines, and j3-substit-
uents, which are above the plane of the ring and
cis to the reference group are shown by solid
lines. Thus, cholesterol has a hydroxyl group
in the 3p-position. There is also a potential
asymmetric centre at position 5, Thus, if in
cholesterol the double bond between Cg and C6
becomes saturated, two series of compounds can
arise. Compounds with the hydrogen in the a-pos¬
ition at Qj , i.e., trans to the reference group,
belonging to the cholestane series, whereas the
series of compounds which have the hydrogen in the
p-position, cis to the reference group, is known
as the coprostane series.
The alcohol, cholestanol, derived from
cholestane, is given the systematic name of
choleetan-sp-ol. In partially unsaturated
sterols, such as cholesterol, the presence of a
double bond is indicated by the suffix "ene".
Thus, the systematic name for cholesterol is
cholest-5-en-3(3-ol. The sterochemistry and nom¬
enclature of steroids are reviewed by Klyne (1957).
3.
Occurrence of Cholesterol
In mammals cholesterol is present in all
tissues, and it v/ould seem, in all cells and
parts of cells. It is found both free and ester-
ified at the 3{3-position with various fatty acids.
For example, in liver, the predominant esterified
fatty acid is linoleic acid, a CS8 poly-unsatura-
ted, methylene-interrupted fatty acid, and then
oleic and palmitic acids. The short chain fatty
acids are not found to any great extent.
In most animals the adrenal cortex is rich
in cholesterol esters, whereas in nervous tissue,
which also contains a large amount of sterol, it
is found entirely in the free form. Tissues,
ouch as liver, kidney and lungs, are intermediate
in cholesterol content, whereas bone, muscular
tissue and cartilage are low in sterol.
Cholesterol is found in all parts of cells.
In liver, nuclei and cell debris contain 50/ of
the cell cholesterol, microsomes 25/ and mito¬
chondria and supernatant about 1G$C each (Kritch-
evsky, Langan and hitehouse, I960). Cholesterol
is solutilised in the form of lipo-protein com¬
plexes, which a spear to be an integral part of
cell membranes.
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Enzyme preparations have been obtained from
liver, pancreas and plasma which will both esteriQr
cholesterol with fatty acids, such as oleic acid,
and also hydrolyse such esters (Sperry and Brand,
1941; Deykin and Goodman, 1962 (a), 1962 (b);
Swell, Byron and Treadwell, 1950; Swell and
Treadwell, 1950),
In general, the functions of cholesterol
esterification are not well understood# It may
be of significance that brain, with the lowest
turnover rate of cholesterol of any tissue in the
body, has essentially no cholesterol in the ester-
ified form, whereas adrenal cortex, liver, and
plasma with rapid turnover rates have relatively




Cholesterol is readily oxidised in colloidal
aqueous solution when exposed to excess oxygen#
The chief products of this auto-oxidation are
cholest-5-en-3{3-o1-7-one (7-keto-cholesterol),
cholest-5-en-30-70-diol and cholest-5-en-3p-7a-diol
(70- and 7a-hydroxycholesterol, respectively), and
their dehydration products (Bergstrom and Winter-
steiner, 1941, 1942)# This shows that the
5
7-position, which is allvlic, must he a very-
reactive one* find in vitro studies on the metab¬
olism of cholesterol in tissue preparations are
made very difficult by the formation of these
products non-enzymically.
In liver cells, 99f of the sterol present is
cholesterol and its esters, and only trace amount^
of any other sterols have been found. Reports
in the literature of the isolation of large
amounts of these 7-oxygenated substances are open
to question, as they are most likely artefacts
formed during the actual extraction procedure.
Biosynthesis of Cholesterol
Although dietary cholesterol is readily
absorbed by higher animals, it is not an essential
component of their diet, and the fact that most
animals can make their sterols from smaller carbon
compounds has long been known*
The use of isotopic methods has provided
important information about the metabolic pathways
in sterol synthesis, and the studies of Bloch and
co-workers (1954), and of Cornforth and associates
(1953, 1957) have led to the elucidation of these
pathways. I'arly experiments had shown that
acetic acid is an effective precursor of cholest¬
erol# In fact, it was shown that all the 27
carbon atoms of cholesterol were derived from the
carbon atoms of acetate. Very briefly, the steps
in the formation of cholesterol from acetate have
been shown to be:-
acetate—>mevalonate—»farnesenic acid ►
squalene, which is cyclised to give lanosterol
> cholesterol
The details of cholesterol biosynthesis can be
found in a recent review by Popjak and Cornforth
(1960).
Although the liver is of major importance in
cholesterol synthesis, all other animal tissues
are capable of performing this process. As
judged by isotope data, the half-life of cholest¬
erol in the liver of the intact rat is about 6
days; in the extra-hepatic tissues the half-life
is about 32 days.
Degradation of Cholesterol
Using isotopically-labelled cholesterol it
has been shown that it can be metabolised to
various classes of compounds in the tissues of the
body. In the adrenal glands, progestins,
7.
together with oestrogens and androgens are formed
and the latter hormones in the reproductive
glands.
Cholesterol may "be metabolised to Vitamin D0.
Glover, Glover and Morton (1952) showed the
reversible formation of cholest-E: 7-diene-3p-ol
(7-dehydrochclesterol) from cholesterol in the
intestinal wall of the guinea-pig. 7-Dehydro-
cholesterol is converted in skin and in vitro
into vitamin Ds, on irradiation with ultra-violet
light. More recently, however, Mercer and
Glover (1961) suggested that 7-dehydrocholesterol
and lathosterol (cholest-7-en-3p-ol) which are
readily interconvertible in rat intestine?in vivo
and in vitro, are precursors of cholesterol
rather than metabolites. Thus, if cholesterol
is converted to vitamin Ds, this is a quantitat¬
ively small pathway. Quantitatively the most
important route of metabolism of cholesterol is
the conversion to bile acids and neutral sterols
in the liver and their subsequent excretion via
the bile to the intestine. It is not known in
v/hich cells of the liver, the breakdovm of cholest
erol occurs. The circulating cholesterol may be
removed from the blood by the Kupffer cells, as on
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feeding cholesterol to rats, it is found to aceunH
ulate in these reticulo—endothelial cells
(Friedman, Byers and Hosenman, 1954)# Interfer¬
ence with the function of the cells led to a red¬
uction in this deposition. It is normally held,
then, that the hepatic reticulo—endothelial
system plays an important role in the removal of
cholesterol from the blood and its deposition but
it is not known whether breakdown of cholesterol
occurs in the Kupffer cells also.
Formulae of the main bile acids occurring in
bile are shown in the Fig* 1. These bile acids
occur in bile as conjugates of the amino-acids
glycine and taurine, to which they are bound at
the carboxyl group by an amide linkage. The main
bile acids in rat bile are cholic acid (80; ) and
cheno-deoxycholic acid (about 20%)* Deoxycholic
acid is formed from cholic acid in the intestine
by the micro-organisms there, which remove the
7a-hydroxyl group. An active system capable of
reintroducing a 7a-hydroxyl group into deoxycholic
acid has been found in rat liver, the substrate
being taurodeoxycholie acid* (Bergstrom and Gloor,
1954, 1955; Gloor, 1954).
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When the bile acids are formed in the liver
they are rapidly excreted in the bile into the
intestinal lumen where they are reabsorbed and
re-excreted forming an entero-hepatic circulation*
Any one bile acid molecule may re-cycle fifteen
to twenty times a day.
The presence of both cholesterol and bile
acids in bile and the similar response of "oxy-
cholesterol" (breakdov.n products of cholesterol)
and some bile acids to a ferric chloride colour
reaction suggested to Lifschtttz the probably form¬
ation of bile acids from cholesterol, although the
structures of these compounds were unknown at that
time. ,rOxycholesterol" was later found to be a
mixture of the auto-oxidation products of cholest¬
erol, 7-keto-cholesterol, and 7a- and 7j3-hydroxy-
cholesterol. In the period 1920 - 1930 the
findings of a close structural similarity between
cholesterol and bile acids seemed to lend support
to Llfschtttzfs theory.
The first direct evidence that cholesterol
was degraded in the animal organism to bile acids
was not, however, produced until 20 years ago,
when Bloch, Berg and Bittenberg (1943) administered
deuterated cholesterol to a dog whose bile duct
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drained into its "bladder, thus allowing the "bile
to be collected and analysed. They found that
the cholic acid isolated from the urine was
labelled v/ith deuterium to a highly significant
degree. The finding of Bloch et al. was con¬
firmed in 1952 by Fukushimo and Gallagher, who
studied the distribution in the cholesterol mole¬
cule when labelled according to Bloch. They
found that about 50% of the deuterium was present
in the terminal side-chain isopropyl group and as
the side-chain is lost during conversion of chol¬
esterol into bile acids, they calculated that
about Q8% of the cholesterol had been converted
into cholic acid in Bloch's experiment.
If, then, cholesterol is converted into
cholic acid, five changes in its structure must
necessarily take place:-
(a) Epimerisation of the 3p-hydroxylgroup to
a hycroxyl in the a-configuration.
(b) Saturation of the double bond, to give
rise to the coprostane series with the hydrogen
at 5 in the (3-position.
(c) Addition of two hydroxy1 groups in the
7a and 12a positions.
(&) Removal of the side chain to give a car-
boxy1 group at C24r.
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If each of these changes in structure was
brought about in one enzymic step, the number of
possible intermediates could be calculated.
However, it is not likely that each step is a
single one, and so this greatly increases the
number of possible intermediates.
The sequence and detailed mechanisms of the
reactions involved in the transformation of chol¬
esterol to bile acids have not, as yet, been fully
elucidated. Several techniques have been used
to investigate the sequence of reactions, and
these are discussed in the following paragraphs.
1. Radioactive studies
(a) Chaikoff, Siperstein and Dauben, (1952)
administered intravenously, cholesterol labelled
at Cjje with Carbon1- to a rat and found that the
isotope was expired rapidly as carbon dioxide.
However, when cholesterol labelled at was
administered the label was excreted in the bile
acids and faeces. This evidence indicates that
the steroid nucleus remains intact during its
conversion from cholesterol to bile acids.
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(b) Zabin and Barker (.1953) concluded from
the distribution of the label in the cholic acid
isolated after administration of labelled acetate,
that the cholic acid side-chain was derived from
cholesterol by a direct removal of the three term*
inal carbon atoms.
2. Bile-Fistula technique
This technique has been developed and used
by the Swedish workers Bergstrom (1955) Lindstedt
(1957 (a)) Danielsson (1961 (b)). It consists of
cannulating the bile duct of rats so that bile car
be collected. Hypothetical intermediates on the
pathway from cholesterol to bile acids are pred¬
icted, synthesised chemically, labelled with tri¬
tium, and injected into the rats. The bile is
then collected and analysed for the presence of
labelled bile acids. It should be emphasised
that if the bile is completely removed from an
animal in this way, profound changes will take
place in the rate of bile acid synthesis which is
ten times faster than in normal rats (Eriksson,
1957). This is because, when the entero-hepatic
circulation is broken, no bile acids reach the
liver. Bergstrom and Banielsson (1958) studied
the bile acid production in bile fistula rats
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during continuous infusion of taurocheno&eoxy-
distal
cholic acid into the/end of the severed hile duct.
As chenodeoxycholic acid does not give rise to
cholic acid, cholic acid excretion could "be deter-*
mined. By this procedure cholic acid synthesis
ras reduced to the range existing in the intact
rat. These results therefore indicate a home-
ostatic regulation of bile acid synthesis. Thus,
the bile fistula rats used in these studies are
abnormal.
However, by using the time taken for the con-*
version of cholesterol into cholic acid as a ref¬
erence time, and finding how the time taken for
various labelled hypothetical intermediates to
form cholic acid compares with this, much useful
information has been obtained by this technipue.
There are two main possible pathways in the
sequence of reactions from cholesterol to bile
acids; either the side-chain is oxidised before
any changes take place in the steroid nucleus, or
the hydroxylations and other changes involving the
nucleus precede the oxidation of the side-chain.
IIn the former case, 3p-hydroxy- A5 -cholenic acid
would be an intermediate; in the latter case
coprostan-3a-7a,12a-triol (Set,7a,12o-trihydroxy-
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coprostane)• When these compounds were injected
into "bile-fistula rats, 5a,7a,12a-trihydroxycop-
rostane was rapidly converted into cholic acid,
v/hile 35-hydroxy- &5-cholenic acid was not
(Bergstrom, Paaho and Rumpf, 1954; Bergstrom,
1955)• This evidence indicates, then, that
hydroxylation of the nucleus takes place before
the oxidation of the side-chain is completed.
If epimerisrtion of the 3(3-hydroxyl group to
a 3a-hydroxyl and saturation of the 5-6 double
bond occur before the introduction of the 7a- and
12a-hydroxyl groups, then one of the folloiwing
compounds would be expected as an intermediate:





However, none of these compounds, when
injected into a bile-fistula rat was converted
into cholic acid (Harold, Jayko and Chaikoff,1955;
Harold, Chapman and Chaikoff, 1957; Bergstrom,
1955), Thus, hydroxylation would seem to occur
before epimerisation of the 3p-hydroxy1 group and
possibly also the saturation of the double bond.
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This assumption has been confirmed by experi¬
ments carried out by Lindstedt (1957 (b)) and
Bergstrom and Lindstedt (1956), who showed that
both 7a-hydroxycholesterol and also coproctan-Sa,
7a-diol (3a,7a-dihydroxycoprostane) are converted
into cholic and chenodeoxycholic acids in the rat,,
although not so efficiently as 5a,7a,12a-trihydro-*>
xycoprostane, 7a-hydroxycholesterol being the
least efficiently converted.
It was also found that 5a,7a-dihy<3roxycopro-
stanic acid (Bridgwater and Lindstedt, 1960) and
chenodeoxycholic acid (5a,7a-dihyd.roxycholanic
acid) did not form cholic acid in the rat (Berg¬
strom and Sjttvall, 1954). The former gave chen¬
odeoxycholic acid. Thus, the introduction of
the 12a-hydroxyl group apparently does not occur
once the side-chain has been oxidised. This is
also indicated by the fact that cholest-5-en-3p,
25-diol or cholest-5-en-3P,26-diol (25- and 26-
hydroxycholesterol) do not give rise to eholic
acid (Prederickson and Ono, 1956), but to cheno¬
deoxycholic acid (Donielsson, 1961 (a)).
As it seems that many or all of the changes
in the steroid nucleus take place before side-
chain oxidation is completed, a possible inter
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mediate is 3a,7a,12a-trihydroxycoprostanic acid,
and this has been shown by Bridgwater and Lind-
stedt (195?) to be excreted rapidly in the bile as
taurocholic acid, after intraperitoneal infection
into a bile-fistula rat.
Samuelsson (i960) has shown that the inver¬
sion of the 3p-hydnoxyl group probably proceeds
via a 3-ketone, as cholesterol with a tritium
atom in the 3a-position loses its tritium when
converted into cholic acid in rat liver. He has
also shown (Oamuelsson, 1959) that the saturation
of the double bond in the conversion of cholest¬
erol to chenodeoxycholic acid in the pig is a
stereospecific cis-addition from the p-side.
Thus, if hydroxylation at the 7-position
occurs before inversion of the 3p-hy&roxyl group,
and also if the inversion takes place via a
3-ketone group, then cholest-4-en-3-one-7a-ol is
a probable intermediate. This was suggested by
Yamasaki, Noda and Shumizu (1959) frdm their in vitro
studies (p. 24 ) and also by Danielsson (1SG1 (b)).
Danielsson (1961 (b)) showed that when labelled
cholest-4-en-3-one-7a-ol was injected into a bile-
fistula rat, it was indeed converted into both
chenodeoxycholic acid and cholic acid.
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Yamasaki, Noda and Shimizu (1959) suggested
that the further conversion of cho1es t~4-en-3-one-
7a-ol to the 3a-hydroxylated compound with satura¬
tion of the double bond at the 4:5 position to
give 3a,7a-dihydroxycoprostane might take place via
the possible intermediate coprostan-3-one-7e-ol.
Danielsson. (1961 (c)) showed that this substance
was indeed converted to both chenodeoxycholic and
cholic acids.
The possibility that the introduction of the
12a-hydroxy1 group could be one of the early steps
in the breakdown of cholesterol to bile acids is
not entirely remote on the evidence accumulated
above. Danielsson (1961 (d)) studied the meta¬
bolism of cholest-5-en-£p,12a-diol (12a-hydroxy-
cholesterol) in the bile-fistula rat. He found
that it was converted in part to cholic acid, and
pointed out that two mechanisms for the formation
of cholic acid can be visualised. Firstly, 12a-
hydroxycholesterol could be hydroxylated in the 7a-
position before the side-chain is degraded or,
secondly, the side-chain might be oxidised prior to
the introduction of the 7a-hydroxy group, possibly
with the intermediate formation of deoxycholic
acid. If the second of these possibilities were
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correct, the cholic acid formed from 12a-hydroxy-
cholesterol represents only a metabolite of deoxy-
cholic acid, as the latter is rapidly hydroxyla tec.
at the 7 position by rat liver. To establish
the direct formation of cholic acid from 12c,- hy¬
droxycholesterol, the rabbit would be a suitable
experimental animal, as in this species deoxy-
cholic acid cannot be hydroxylated by the liver
to cholic acid (Lindstedt and Sjbvall, 1957).
It seems very likely, then, that hydroxyla-
tion at the 7-position is the initial stage in the
breakdown of cholesterol to bile acids. This is
suggested in the first plaoe by the fact that the
7-position is very reactive, as is seen in auto-
oxidation, and also by the fact that the "primary"
bile acids contain a 7c-hydroxyl group. Also,
7a-hydroxycholesterol is converted to bile acids
less readily than are 3a-,7a-hyfiroxycoprostane and
3a,7a, 12a, trihyclroxycoprostane. The stereochem¬
ical course of the introduction of the 7a-hydroxyl
group has been investigated by Bergstrom, Lind¬
stedt, Samuelsson, Corey and G-regoriou (1958) with
the aid of 7a and 7f3-tritium labelled cholesterol.
The introduction of the 7a-hydroxyl group into
cholesterol during its conversion into cholic acid
"
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occurs In a stereospecific manner, the 7<x-hydroxy:.
group replacing the 7a-hydrogen. This indicates
that the hydroxylation does not take place via
7-ketocholesterol.
3. In vitro studies
Up until about 1952 only the auto-oxidation
products of cholesterol had been isolated in
in vitro work.
Meier, Siperstein and Chaikoff, (1952) were
able to achieve the oxidation of cholesterol
labelled at CS6 with C14 to C14r02 in rat liver
slices. The same reaction has been studied in
cell free preparations of mouse liver by Anfinsen
and Horning (1953) and Homing, Prederickson and
Anfinsen,(1957) who found that mouse liver mito¬
chondria in the presence of NAD*, AMP and a heat-
stable co-factor obtained from the cell supernat¬
ant can oxidise up to 15®' of the added 26-C14-
cholesterol to C140s. (it must be pointed out
that mouse liver seems much more active in produc¬
ing C02 from cholesterol than rat liver). Without
ft
The following abbreviations will be used through¬
out the textj-
NAD s= Nicotinamide adenine dinucleotide
NADH > Reduced w " ,r
NADP ss Nicotinamide adenine dinucleotide phosphate
NADPHb Reduced " ,r " r*
AMP « Adenosine monophosphate
ATP ss Adenosine triphosphate
20.
this boiled supernatant factor (SF) the production
of C14C2 from 26-C14-cholecterol was uracil less.
This SF does not seem to be any of the well-
known co-enaymes and an attempt to discox^er its
nature was made by Horning, Frederickson and
Anfinsen, (1957). The SF retained its activity
for six weeks at -15°, but the activity was com¬
pletely removed by passage through an acid-washed
charcoal column. The activity could be recovered
by elutlon with water* When £F was ashed no
activity was observed. SF behaved on positively
and negatively charged ion-exchange columns as
though it contained no strong anionic groups. On
paper chromatography a ninhydrin-positive fraction
retaining the activity was obtained, and organic
phosphate was also found to be present in this
fraction. No conclusion as to the absolute
nature of SF was arrived at by Horning, et al»
In Philadelphia, G-urin and co-workers (lynn,
Staple and Gurin, 1905; Whitehouse, Staple and
Gurin, (1909))have investigated the same reaction
using rat liver mitochondria fortified with NAD,
AMP, glutathione, nicotinamide, magnesium chloride
and citrate, and this SF obtained by boiling rat
liver supernatant. These workers have used this
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"cholesterol oxidase" system as a measure of the
breakdown of cholesterol and have studied the
effect of diet, sex, metal ions, etc., on this
reaction.
They have reported also the conversion of
26-C14r-cholesterol to 25-dehydrocholesterol, to a
steroid alcohol, and to an acid in these prepara¬
tions, and have suggested that these might be
intermediates in side-chain cleavage. They also
found that this "cholesterol oxidase" system
(Staple and Gurin, 1962) can oxidise coprostane-
5a-7a,l2a-triol 26-27C14r (i.e. Sa,7a,12a-tri-
hydroxycoprostane labelled at Css or C2? with C14r)
to coprostane-Sa,7a,12a,26-tetrol. The prepara¬
tion stimulated with co-ensyme A could also cleave
the side-chain with the production of propionyl
CoA.
Whitehouse, Staple and Gurin, (1961) studied
the distribution of SP and found that boiled
particle free extracts of human placenta, bovine
adrenal cortex, sow ovary, rat testes and spleen
had some stimulatory activity on the oxidation of
cholesterol. Boiled extracts of rat skeletal
muscle, thymus, brain, kidney, blood and intestine
were found to be either ineffective or inhibitory
22.
The boiled supernatant of liver after removal of
mitochondria was found to inhibit the oxidation
of both cholesterol and sodium octanoate, and
they suggested that this was due to calcium ions.
Frederickson (1956) investigating the pro¬
ducts formed from cholesterol labelled at 0* with
C±4r in the mouse liver system of Anfinsen and
Horning (1955) found that of the 25% of cholest¬
erol metabolised, 15% of the metabolic products
were acids not identifiable with deoxycholic or
cholic acid, 7% was 25- or 26-hydroxycholesterol
and £$ was cholesterol esters.
The oxidation of 4-Ct4:-cholesterol and 26-C1
-cholesterol has been studied by Danielsson (i960)
in mitochondrial preparations of mouse and rat
liver. Again he found that addition of SP to the
mouse mitochondria doubled the conversion of
cholesterol to more polar products. Mouse liver
mitochondria, he found, were twice as active as
rat liver mitochondria. The simultaneous occurr¬
ence of autoxidation and enzymatic oxidation of the
added labelled cholesterol was ascertained by ana¬
lyses of the labelled products formed under non-
enzymatic and "enzymatic" conditions. For non-en-
zymatic conditions he incubated the labelled choles¬
terol with SP, AMP and NAD, and for "enzymatic"
conditions he used
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mouse mitochondria + SF, AMP, and NAD. Among
autoxidatively formed products he identified
3(3,5a,6£~trihydroxycholestane, 7a-hydroxycholest-
erol, 7(3-hydroxycholesterol and 7-ketocholesterol.
Two major enzymically formed compounds (not occur--
ring in incubations under non-ensymic conditions)
both retaining the 037 side-chain as they were
both formed from 26-C14 cholesterol, were isolated
but not identified. One of these was found to be
less polar than 7a-hydroxycholesterol, but more
polar than 7-ketocholesterol. 1.8$ of the added
cholesterol was converted into this substance.
The other product had a mobility similar to that
of a neutral trihydroxy-CS7-sterol and was found
to be converted into chenodeoxycholic acid in the
bile-fistula rat. 2.5^ of the added cholesterol
was converted into this compound. (l3f of the
added cholesterol was converted into more polar
products). Danielsson pointed out that there is
no evidence that these "enzymatic"products are
formed directly from cholesterol, as they could
just as well be enzymically transformed autoxi-
dation products, probably from 7o-hydroxycholest-
erol.
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It can thus he seen that any in vitro study
of the breakdown of cholesterol is complicated "by
the possibility of auto-oxidation taking place
and it is for this reason that it is considered
to be more advantageous to study the metabolism
of the possible early intermediates in cholesterol
breakdown, in vitro, rather than cholesterol
itself.
Yamasaki et al. (1959) therefore studied the
metabolism of 7a-hydroxycholesterol, which is
probably the first intermediate in cholesterol
breakdown, in rat liver homogenates. He found
that 7a-hydroxycholesterol was converted, in the
presence of NAD, to a compound which, on the
grounds of its u.v. absorbing properties, was sug¬
gested to be eholest-4-en-5-one-7o~ol. On frac¬
tionating the liver homogenate he found the activ¬
ity for producing this substance lay in the super¬
natant left after spinning down "microsomes"
at 80,000 x g for 30 min. It is doubtful if this
procedure would give a microsome-free supernatant.
He did not, however, identify the product.
Danielsson (1961 (e)) also studied the meta¬
bolism of 7a-hydroxycholesterol, but in mouse
liver homogenates only. He separated the
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metabolites formed by chromatography and partly
identified them. The two main metabolites in
incubations fortified with HAD were cholest-4-en
3-one~7a-ol, which he identified by crystallisa¬
tion to constant specific activity with the un-
labelled authentic compound* and a compound more
polar than 7<x-hydroxycholesterol, for which the
structure cholest-4-en-3-one-7a,26-diol was sug¬
gested# This substance, when administered to a
bile-fistula rat, was metabolised to chenodeoxy-
cholic acid and to some extent to cholic acid.
Cholest-5-en~3p ,7a,26-triol, the 27-hydroxylated
derivative of 7a-hydroxycholesterol, was identi¬
fied as a minor metabolite, of 7ci-hy&roxycholest¬
erol.
Again using mouse liver homogenates, Daniel¬
se on (1961 (a)) has identified 26-hydroxycholest¬
erol as a metabolite of 4-C1^-cholesterol.
Incubations of 4-C14"-26-hydroxycholes terol with
homogenates yielded a number of different products
one of these being identified as cholest-5-en-3p,
7<x,26-triol. This substance was formed
from 7a-hydroxycholesterol also.
A summary of the sequence of events occurring:
in the breakdown of cholesterol to bile acids, as
far as it is known from the above evidence, is
given in Pigs. 3 and 4.
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liy&roxylation of steroids
The steroid ring system, as has been seen
above in the case of cholesterol, is not oxidised
to carbon dioxide and water in animals, but under*
goes enzymic reactions which degrade the side-chain
possibly through the formation of hydroxy-inter¬
mediates, and which hydroxylate, oxidise, and
reduce the nucleus. Steroids, in fact, can be
hydroxylated at every possible position. The
positions which are affected in cholesterol meta¬
bolism are at 3-, 7-, 12-, 20-, 25-, and 26-.,
- \
and. "r-— other positions are involved in
steroid, hormone hydroxylat ions.
As yet the actual mechanism of steroid hydro*
xylation is not know, but most of the enzymic
systems studied appear, when characterised, to be
"mixed function oxidases" acting with reduced
pyridine nucleotides as electron donors (Mason,
1958). (The term "mixed function oxidase" is
applied to enzymes having two interdependent cata¬
lytic activities; reduction of one atom of an
oxygen molecule coupled with specific oxygenation
or hydroxylation of the other atom).
SUMMARY OF THE METABOLISM OF THE POSSIBLE INTERMEDIATES IN
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Hydroxylat ion reactions involving the steroid
hormones have been fairly extensively studied#
Steroid 11-p-hydroxy la t ion is found to be cata¬
lysed by adrenal mitochondria, but not by liver
(Brownie and Grant, 1956; Grant and Brownie, 1956)#
Only one product is formed from deoxycortico¬
sterone by adrenal mitochondria - the 11-p-hydroxy-
lated compound, corticosterone - oxygen being
required for the reaction# It was found that
adrenal homogenates and crudely prepared mito¬
chondria could be activated by various citric acid
cycle intermediates, by ATP or NADP (Hayano,
Wiener and Lindberg, 1953; Hayano and borfman,
■
1954)# This situation was clarified by the dis¬
covery that NADPH is essential and. specific and
that the role of citric acid cycle components
appears to be that of supplying NADPK (Grant and
Brownie, 1956) by the sequence of reactions
following:-
Fumarate + H20—*Iflalate ••• ••• (1)
Malate + HAD * Oxaloacetate + NADH •• (2)
.
HADH + NADF > NAD + NADPH # • • (o)
transhydrogenase
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Tomkins, Curran and Michael (1958) found
that at least two and probably three enzymes
extractable from adrenal mitochondria acetone pow¬
der were required for the hyclroxylation of deoxy-
cortisone, and that the reaction was greatly stim¬
ulated by a heat-stable co-factor obtained from
an acetone powder of rabbit liver. The co-factor
could also be obtained from placenta, tests, and
adrenal tissue. This co-factor could not be
replaced by any of the follov?ing:- ascorbic acid,
glutathione, nicotinamide, nicotinamide-riboside,
fumarate, citrate, more NADFH, hydrogen peroxide,
"
folic acid, or the phenylalanine-hydroxylating
co-factor, (Kaufman, 1958). This tTco-hydroxylasd'
was found to be acidic in nature.
21-hydroxylation of 17a~hydroxyprogesterone
occurs in a system consisting of the combined sup¬
ernatant and microsomal fractions of bovine adren¬
als (Ryan, 1956; Ryan and Engel, 1956). Again
the reaction requires oxygen and is stimulated by
RAD and ATP. Cooper, Estabrook and Rosenthal,
(1963) found that addition of the steroid sub¬
strate resulted in increases in oxygen consumption
and NADPH oxidation, that were equivalent to the
amount of product formed. This system is similar
29,
to the liver phenylalanine hydroxylase (Mitoma
and Leeper, 1954), which has been separated into
two fractions and which is activated "by NADH. A
co-factor from rat liver is also required and is
suggested "by Kaufman (3.958) to be a pteridine
moiety, as tetrahydrofolic acid is highly active
in replacing the co-factor.
The cyclisation of squalene to lanosterol in
rat liver and concomitant introduction of a hydro-
xyl group at position 5 is again a similar type of
reaction. The oxygen of the hydroxyl group is
derived from molecular oxygen (Tchen and Bloeh,
1956) and the oxidative cyclisation is catalysed
by microsomes together with the supernatant frac¬
tion. Apparently one of the roles of the super¬
natant is to provide a reductant, as it can be
partially replaced by NADH or NADPH.
Thus, hydroxylation seems to be a complicated
type of reaction, often requiring two enzymes,
and in most cases it vyould seem that the super¬
natant fraction of the cell plays some part in the
process apart from supplying NADPH.
Hydroxylations of cholesterol have not been
studied to the same extent as have hydroxylations
of C2i steroids. However, it has been suggested
by Whitehouse et al. (1961) that the distribution
of 8F (see p. 21), the co-factor which activates
in some way the conversion of cholesterol int3>
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carbon dioxide, suggests a resemblance to the co-
hydroxylase of Tonkins (described above) in as
much as it is found in those tissues which hydro-
xylate and oxidise steroids.
Mason (1958) has suggested two types of mech¬
anism for "mixed function oxidation" reactions,
as all these steroid hydroxylations appear to be.
In one of these, type (l), he stiggests that the
hydroxylating intermediate is the enzyme-oxygen
complex E-0S, which during hydroxylation is trans¬
formed into E-0, In a second and third stage,
the electron donor reduces E-0 to E and 02", as
is shown belows-
Type (1) E + 03—» E—02




E-0 + DHg—*E. OH + DH—»E + D + Hs0
(where DHa is the
electron donor)
In the second possible type of mechanism sug¬
gested by Mason the hydroxylating intermediate is
an enzyme-peroxide complex, E0§~ or E. H80s, formed
by two-equivalent reduction of enzyme-oxygen com¬
plex.
Type (2) E.02 + DH2—>E.02Hh + D








Thus, one can imagine that hydroxylation of
steroids might take place by one of the above
mechanisms. It might be that the molecular oxy¬
gen is "activated" by formation of a peroxide,
which might then be bound to the enzyme. Lino-
leic acid, which esterifies readily with cholest¬
erol, can form a hydroperoxide, and it has been
suggested by Mawer (1962) that the linoleic acid
may play a role in 7a-hytLroxylation of cholesterol.
Her theory is outlined in Pig. 5. *
It is also possible that hydroxylation might
take place by the formation of a hydroperoxide of
the steroid. Hydroperoxides of steroids have
been synthesised chemically by photo-oxygenation
reactions. Thus, if, for example, the 7a-hydro~
peroxide of cholesterol could be formed enzymicaHy
the electron donor NADPH might reduce the peroxide
to form 7a-hydroxycholesterol.
Hydroxylation is not the only type of reaction
common to cholesterol and the Csl steroid hormones.
The reduction ofA^-S-ketones for example, is an
important reaction in hormone metabolism, as it
is generally thought that ring A unsaturation is
important for the biological activity of the
hormones, and hydrogenation of the double bond
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causes inactivation. This reduction occurs
primarily in the liver and has been studied
extensively by Tomkins, Bakemeier and Weinberg,
(1961) using cortisone as substrate. Upon reduc
tion of the 4:5 double bond, an asymmetric centre
at position 5 is produced, which means that either
of two isomers, 5a or 50, is possible, as dis¬
cussed on p. 2 • The liver enzymes which speci¬
fically catalyse the production of one or other of
the isomers can easily be separated by centrifuga-
tioru The 5-0 reductases reside in the superna¬
tant fraction of the cell, whereas the enzymes
catalysing the formation of the 5a- reduced iso¬
mers are associated with the microsomal fraction.
NADPH is required for both types of reductase*
On partial purification of the 5p-reductase activ¬
ity it was apparent that several reductases exist
in this fraction, each of which seems to be sub-
s tra te-speMfic.
Thus, in the supernatant fraction of rat
liver, cortisone is reduced to dihycrocortisone.
As the enzyme preparation usually contains 3a-re-
ductase activity also, tetrahydrocortisone is al
produced. These reactions are analogous to those
which one might predict would occur if cholest-4-




metabolism, ancl is, indeed, reduced to 3a,7o-
dihydroxyeoprostane (set. Fig, 6).
"
■
« ' 1 JOutline of the work undertaken in this Thesis
From the information obtained by the tech¬
niques in the work described above, the possible
sequence of events occurring the breakdown of
cholesterol can be built up. This is summarised
in the diagram on p, 25 ,
From the evidence, it can be seen that there
are many "gaps" in our knowledge in the proposed
sequence of events. For example:
(a) the enzymic formation of 7a-hyciroxychol-
esterol from cholesterol has never been demonstra-
ted$
(b) the metabolism of 7a-hydroxyeholesterol
has not been studied in rat liver, Danielssonfs
studies on mouse liver may not give the same
results as rat liver, and as the bile-fistula
studies have always been carried out on rats it
seems more logical to carry out in vitro work on
the rat alsoj
(c) it has been suggested by Ysmasaki that
cholest-4-en-3-one-7a-ol, a metabolite of 7a-
hydroxycholesterol in mouse liver, might be
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reduced* possibly via coprostan-3-one-7a-ol, to
give 5a,7a-dihydroxycoprostane, but there is no
in vitro evidence to support this;
(d) the conversion of 3<x,7a-dihydroxycoprostane to
3a,7a,12a-trihydroxycoprostane has not been dem¬
onstrated;
(e) the role of SP in cholesterol metabolism has
not been studied. So far it has been shown that
SP will increase the over-all conversion of
cholesterol to either carbon dioxide or to more
polar products. It has been suggested that SP
may have some effect on hydroxylation reactions,
but this has not been proved.
In this work an attempt has therefore been made:
(a) to study the hydroxylation of cholest¬
erol, giving 7a-hydroxycholesterol;
(b) to study the metabolism of 7a-hydroxy-
cholesterol in the different cell fractions of
rat liver;
(c) to study the metabolism of cholest-4—en-
3-one-7<x-ol in the different cell fractions of
rat liver and show that this substance can be con¬
verted into 5a,7a-dihydroxycoprostane;
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(d) to obtain more information on the role
of SP in cholesterol metabolism, and to discover








Normal rats of either sex were used in
these studies. These animals had been fed on
stock diet and usually wei,piled 150 - 200 g. ,
yielding livers of about 9 - 12 g.
The animals were killed by a sharp blow on
the head, and the liver was removed immediately
and dropped into a beaker which was kept ice-cold*
The liver was weighed, chopped up finely with
scissors and homogenised in four times its
volume of 0.25 M sucrose. A teflon homogeniser
was used and all operations were carried out at
0*C.
The homogenate was then separated into cell
fractions by the following procedure. Using the
MSE refrigerated centrifuge, nuclei and cell
debris were spun down at 600 x g for 10 min.
This fraction was discarded and the supernatant,
which contained mitochondria, microsomes and the
soluble fraction, was spun at 10,000 x g for
15 min. This sedimented mitochondria and proba¬
bly lysosomes. The mitochondria were washed

























































were then made up to the required volume and
homogenised very gently to ensure complete mixing.
The supernatant left after spinning down
mitochondria now contained microsomes and the
soluble (or supernatant) fraction. Microsomes
were sedimented by spinning at 100,000 x g for
60 min. on the "spinco" refrigerated ultracentri¬
fuge. The microsomes were made up to the
required volume with 0.85 M sucrose and again
homogenised gently. The soluble (or supernatant)
fraction which was a clear red solution, was used
in this form in incubations.
This cell fractionation is according to
the method of Dchneider and Hogeboom (1952).
Preparation of Boiled Supernatant Factor (SF)
(Ai.finsen and Horning, 1953)
The supernatant fraction was heated at
100°C. for 10 min. The precipitated protein was
removed by centrifugation, leaving a clear,
yellow-brown solution, which was then stored in
the deep-freeze for as long as eight weeks.
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Preparation of an Acetone Powder of Mitochondria
or Microsomes
The mitochondria or microsomes were prepared
as above. The mitochondria were then poured
very slowly, with vigorous stirring, into a large
volume (500 ml.) of acetone, which was cooled by
placing in a beaker of acetone and solid carbon
dioxide. The microsomes, being rather gelatin¬
ous, had to be stirred with the minimum volume of
sucrose before being poured into the cold acetone.
The tissue formed a precipitate* which was very
quickly removed by spinning, and pouring off the
acetone. The tissue precipitate was extracted
three or four times with ice-cold acetone, to
ensure that all water had been removed. Lastly
the precipitate was washed twice with ice-cold
ether and then dried in a vacuum desiccator. The
resulting pinkish powder could then be stored in
this state in the deep-freeze and mixed with
buffer when reqtiired for incubation.
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2. EXPERIMENTAL CONDITIONS
" ' r ■" 1 Jl "
Incubations of the substrates used in this
study with the cell fractions of rat liver were
carried out in stoppered flasks with a capacity
of about 50 ml. but with relatively large, flat
bases to present as great a surface area as pos¬
sible to the gas phase, which in most eases was
air, but on some occasions nitrogen or oxygen.
The flasks were incubated in the Y/ater bath at
37°C. with shaking, for one hour, unless other¬
wise stated.
The incubation mixture used was the following:
200 jjtg* substrate (for example, 7a-hydroxy-
cholesterolj 0.5 g mole) in 0.1 ml.
methanol
0.5 ml. 0.2 M nicotinamide (100 p moles)
0.5 ml. 0.2 M magnesium sulphate (10 p moles)
0.5 ml. 0.02 M phosphate buffer, pB 7.4
1 ml. 0.01 M NAD (10 g moles)
3.0 ml. tissue (equivalent to 1 g. wet weight
of liver)
As small amounts of tissue were used it was
possible to set up 8 or 9 incubations on the cell
fractions from any one rat liver so that each rat
acted as its own control. A boiled tissue con¬
trol was usually included in any set of incubations.
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3. AILXYSIS OF IKCUBATIOM FIXTURES
The Investigation of the metabolism in vitro
of cholesterol and possible intermediates in the
breakdown of cholesterol to bile acids, was
carried out by incubating the substrate to be
studied as described, with the different cell
fractions of rat liver. The substrate and meta¬
bolites produced from it during the incubation
were extracted from the tissue together with a
quantity of interfering lipid material. The
lipid extract was therefore partially purified by
a crude chromatographic column technique which
separated the constituents of the extract into
three groups. The final separation of substrate
and metabolites was carried out by thin layer
chromatography giving a method whereby the amount
of substrate disappearing (i.e. metabolised) dur¬
ing the incubation and the amount of products
formed, could be estimated.
a) Lipid Extraction
The best type of extraction was found to be
one in which two layers of solvent were formed;
one layer, which was organic, contained most of
the lipids, and the other aqueous layer, contained
all the water-soluble substances from the tissue
and incubation mixture.
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The reaction occurring in the incubation
mixture was stopped by adding 12.5 ml. methanol.
The tissue and methanol were then transferred
quantitatively to a Quickfit tube, where the mix¬
ture was shaken vigoroutsly. The protein was
centrifuged clown and the methanolic supernatant
decanted into a further Quickfit tube. The pro¬
tein was then re-extracted with 25 ml. of chloro¬
form, and after spinning, the chloroform was added
to the methanol, giving a two-phase solution.
GO?' saturated ammonium sulphate was added to the
aqueous layer to make it more ionic and thus draw
the steroids into the chloroform layer. After
shaking, the mixture was centrifuged and the
aqueous layer discarded. The chloroform layer
was taken to dryness, in vacuo, together with a
further ethyl acetate extract of this tissue pro¬
tein* This extraction procedure is outlined in
the diagram.
7a-hydroxycholesterol was used to check the
recoveries from boiled tissue. This typical
substrate was chosen, partly because much of the
work in this thesis is concerned with its meta¬
bolism and partly because it can be estimated
readily by the LifecMtz colour reaction, which is
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described in the Appendix (p. 309 ). Using the
above extraction procedure, together with the
column method to be described, 97% of the 7a-hy-
droxycholesterol added to boiled tissue could be
recovered. With every set of incubations a
boiled tissue incubation was included. This
acted as a control and indicated whether the
extraction method was working satisfactorily.
The recoveries of 7ci-hydroxycholesterol from these
controls, have been collected from all experiments
performed on the metabolism of this substance and
the average recovery is found to be 96% + 3%.
This chloroform:methanol extraction procedure
is a modified one, developed after it was found
that recoveries of substrate using the method
of Yamasaki et al. (1959) were very low indeed.
The method of Yamasaki is described in the follow¬
ing paragraph.
To each incubation mixture was added 40 ml.
of ether:alcohol (3:1) and the mixture was trans¬
ferred to a stoppered tiibe, shaken, and boiled.
The precipitated protein was spun down and the
supernatant was taken to dryness in vacuo. This
was a difficult procedure as the extract contained
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a great deal of water which had originally been
in the incubation mixture. The residue, which
contained all the water-soluble substances such
as magnesium sulphate, etc. , was then "dissolved"
in 30 ml. of ether. "Dissolved" is, of course,
not the correct term because much of the residue
was insoluble in ether.
When this method was checked for 10C$ reco¬
very of 7a-hydroxycholesterol as a typical sub¬
strate from boiled tissue it was found to be com-
pletely unsatisfactory, only about 50% of the
added 7a-hydroxycholesterol appearing in the ether
solution which was columned in order to estimate
this substance, at the end of the extraction. In
order to find out what had happened to the 7o—hy¬
droxycholesterol an experiment was set up in which
7a-hyaroxycholesterol was added to the various con¬
stituents comprising the incubation mixture separ¬
ately (Table 2 )• The mixtures were then
treated as in the method described above, the
ether extracts of the dry residues being taken to
dryness end the 7a-hydroxycholesterol recovered
was estimated by the Lifschhtz reaction (see p.309).
As can be seen from the Table, 10Q& recovery of





































































no sucrose was present. When sucrose was present
the 7a-hydroxycholesterol was found to remain in
the flask with the ether-insoluble residue. This
was rather disquieting as sucrose is the best med¬
ium in which to prepare cell fractions. It may
be that sucrose forms some sort of complex with
7a-hydroxycholesterol which is insoluble in ether.
This difficulty was overcome, however, by employ¬
ing the two phase extraction procedure described
previously.
b) Separation of Lipid Extract into its
Constituents
Because of the amount of interfering lipid
also extracted from the tissue by this procedure,
it is not possible to estimate substrates directly
in the lipid extract. For example, 7a-hydroxy-
cholesterol recovered from an incubation mixture
cannot be estimated directly because of interfer¬
ence in the Lifschiits colour reaction by sub¬
stances such as vitamin A ester.
A crude column chromatography method (Yarna-
saki et. al. 1959) was therefore used to separate
the constituents of the lipid extract into three
fractions. This was a very rapid method and was
easily adapted to routine estimations on as many
as ten different extracts.
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The dry residues of the lipid extracts were
dissolved in 10 ml. dry ether and put on to 2 g.
alumina columns (Savory and Moore), prepared in
ether. The columns, of dimensions 4" x were
held in a row, vertically attached to a hoard, so
that ten columns could he dealt with in turn.
The columns were eluted with a further 10 ml. of
ether, 25 ml. ether:alcohol (9:1) and 25 ml.
alcohol. As shown in Tahle 3 , vitamin A esterg
cholesterol esters and 7a-hydroxycholesterol
esters were eluted in the ether cut, 7a-hydroxy-
cholesterol and substances of similar polarity in
the ether:alcohol cut and polar substances in the
alcohol cut.
i) Using 7a-hyc1roxycholesterol as a typical sub¬
strate, its recovery from the 2 g. alumina column
was checked. Amounts of 7a-hydroxycholesterol
varying from 12 pg. to 300 pg. were taken to dry¬
ness and put on to 2 g. alumina columns in 10 ml.
ether. The columns were eluted with a further
10 ml. ether, and 25 ml. ether:alcohol (9:1).
The latter cuts were taken to dryness and the 7a-
hydroxycholesterol recovered was estimated by the
Lifschtttz reaction. The results are given in
Table 4 and it can be seen that 10C$ recovery



























































































5.6 ml* Incubation Mixture
Reaction stopped with 15 ml. Methanol
Protein ppt.






















in 10 ml. ether.










Substances of similar stances
polarity
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Thus, substrates or metabolites, such as 7a-
hy&roxycholesterol, recovered either from "boiled!'
or "active" tissue, could be estimated free from
interfering substances, by taking one half of the
ether:alcohol cut to dryness and carrying out a
Lifschhtz colour reaction or some suitable colour
test, on the residue# The other half of the cut
could then be used for identification of the con¬
stituents of this cut#
It was found, however, that 7a-hydroxy-
cholesterol was about the only compound which
could be estimated directly in the ether:alcohol
cut because of the specificity of the Lifschfttz
reaction# As will be seen, it is impossible to
estimate ultra-violet absorbing substances
directly#
ii) Attempt to estimate directly ultra-violet
absorbing products
As one of the possible intermediates in the
breakdown of cholesterol is cholest-4-en-3-one-7a-
ol (see Introduction, p# 16), which is an a,p-un¬
saturated ketone with an absorption peak in the
u.v# at 242 rap# it was decided to study the u.v#
absorption spectrum of the ether:alcohol cuts off
the alumina columns to discover if any 242 mg#-
52.
absorbing material had been formed in incubations
with 7a-hydroxycholesterol. The cuts were taken
to dryness in vacuo and the residue dissolved in
ethanol. The absorption spectrum of the solution
was then plotted, using the Optica Recording Spec¬
trophotometer, from 200 mg. - 300 mp. In order
to balance the machine it was necessary to dilute
the solution considerably. The solution then
gave one peak at 216 mg. and two peaks at 258 mg.
and 262 mg. This spectrum, however, was found to
be due to nicotinamide which had been added to the
original incubation mixture and had been brought
through the extraction procedure. Thus nicotina-
mide completely obliterates any other u.v. absorb¬
ing substances that may be present in the cut, and
obviously, in order to identify u.v. absorbing pro¬
ducts either the nicotinamide must be remo%>-ed or a
different technique must be adopted.
Attempt to remove nicotinamide
The residues from the ether:alcohol cuts
were dissolved in 20 ml. chloroform and the chloro¬
form extracts were washed three times with acid
ammonium sulphate to aid the extraction of the
nicotinamide into the aqueous layer, leaving the
steroids in the chloroform layer. The chloroform
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layers were taken to dryness and the absorption
spectra of the ethanolie solutions plotted. This
procedure had removed the nicotinamide, but the
spectra were still very complicated and it did
not seem possible to use this technique for ident¬
ifying u.v. absorbing metabolites.
On paper chromatography of these residues
(see p. 55 ) it was found that the acid-washing
procedure had given rise to many products which
had been absent before the procedure. For
example, substances which gave a blue colour with
phosphotungstic acid and which had mobilities
similar to esters and di-esters of 7a-hyclroxy-
cholesterol were formed. It was thought that the
acid treatment had converted nicotinamide into
nicotinic acid which had esterified with 7a-hydro-
xycholesterol both at the 3 and 7 positions.
In order to identify and estimate metabolites
other than 7a-hydroxycholesterol it is therefore
necessary to separate the constituents of the
ether:alcohol cuts further, as no direct estima¬
tion is possibly*
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c) Further Separation of Metabolites
i) Attempt to separate metabolites by various
column chromatography systems
Many types of columrs were tried in an
effort to separate completely the metabolites
likely to be formed in incubations with 7a-hydro-
xycholesterol or other substrates for estimation
and identification#
Attempts were made to separate the consti¬
tuents of a standard mixture containing the foll¬
owing substances which were thought to be possible
metabolites:
7a-hydroxycholesterol 200 pg#








Columns of alumina, silicic acid (methanol
and ether washed), activated silicic acid and
silica gel G were tried, using a variety of sol¬
vents# However, complete separation of these
components was never achieved although partial
separation v/as easily obtained# When the above
mixture was added to boiled tissue and the lipids
extracted as in a normal incubation experiment,
the separation of the constituents became even
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more difficult, probably due to the other lipids
extracted during this procedure,
ii) Paper chromatop;raphy
Further separation of metabolites can be
achieved however by concentrating the cuts off the
columns and running them on paper chromatograms.
Paper chromatography is not very suitable for such
non-polar substances as steroids and in order for
than to run at all the paper must be impregnated
with paraffin. The solvent system used was
chloroformimethanol paraffin (50:40:10), and after
24 hr. equilibration in the tank, the run was
started, taking about 7 hr. The papers were then
removed from the tank, viewed under ultra-violet
light to detect u.v. absorbing substances, and
then sprayed with a 10^ ethanolic solution of
phosphotungstic acid. On heating above a hot¬
plate spots developed and a list of the colours
produced by various steroids ?;ith this reagent is
given in Table 39 , (see Appendix, p. 310).
As the paper chromatography technique is so
slow and does not give reproducible results, thin
layer chromatography v/as tried.
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iii) Thin layer chromatography
This technicrue, reviewed by Demole (1961),
involves spreading a thin layer of a mixture of
silicic acid and calcium sulphate, which acts as a
binder, on a glass plate# The plate is dried in
an oven at 100° and left there for 20 min. to
activate the silicic acid# The substances to be
separated are spo ted on to the plate with a cap¬
illary in the usual way. The plate is then
placed in a tank or jar, in the bottom of which is
the solvent# Ascending chromatography then takes
place, a run taking about 40 min# or an hour# To
detect substances, the same reagent is used as in
paper chromatography# Phosphotungstic acid is a
fairly specific reagent and in order to show up
phosphotungstic acid - negative substances, the
plate is sprayed again with a lOf ethanolic solu¬
tion of phosphomolybdic acid which is non-specific,
giving "blue-coloured spots on a yellow background,
but very sensitive (1-2 p.g# )•
This method has one disadvantage in that u#v#
absorbing substances cannot be detected# To
solve this problem, quartz plates were obtained and
thin layer chromatography was carried out on these*
However, the silicic acid layer absorbed or
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scattered the light, so that the difference
between the background and the substance was not
very great.
It was then decided to add an inorganic phos¬
phor to the silicic acid - thephosphor had to be
inorganic as an organic phosphor would have moved
up the plate with the solvent. The phosphor
used was zinc silicate, activated with manganese.
Under the light from a mercury lamp (maximum
emission at 254 mp.) the plate fluoresced a vivid
green and u.v. absorbing substances showed up as
dark spots (i.e. substances which absorb between
240 and 280 mp) when viewed from the "glass" side#
The spots could be marked on the back of the
plate with a grease crayon (Boyd and Hut ton, 1963).
The photograph shows some of the results obtained* (Fig. 15).
It was found that substances which cannot be
separated on paper chromatography can easily be
separated on thin layer chromatography. The
phosphor on fluorescent plates acts as an interna:,
indicator, as u.v. absorbing substances can be
located easily without using any destructive
spraying method, and also a guide is given to the
position of non-u.v. absorbing substances. In
view of these two facts the final separation of
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of metabolites from incubation mixtures can be
achieved on these plates# Metabolites can be
scraped off the plates, eluted, and estimated
both by radioactive measurements and by chemical
means# This fluorescent thin layer plate tech¬
nique could be developed further by using mono¬
chromatic ultra-violet light to illuminate the
plates# Thus, by varying the wavelength of the
incident light, it should be possible to identify
material which absorbs at any particular wave¬
length on the plate# This would then not only be
a means of identifying the position of u#v# absor¬
bing substance on the plate, but by finding out
the exact wavelength at which it absorbed, in¬
formation on its molecular structure would be
obtained#
A monochromator was obtained, but not yet,
a strong enough light source, such as a xenon
source and, therefore, no experiments have been
carried out on this aspect.
As an alternative phosphor to sine silicate,
Rhodamine G was tried. This phosphor has the
disadvantage that it is soluble in alcohol and
therefore for elution purposes, chloroform has to
be employed# The dye is also very slightly
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soluble in this solvent. Rbodamine G has the
advantage, however, that non-u.v. absorbing sub¬
stances can be detected under the u.v. light, as
orange fluorescent spots on a yellow-pinit fluore¬
scent background. This is not very sensitive
and non-u.v. absorbing material has to be present
in amounts of 20 - 50 gg. before it can be
detected. This phosphor was therefore only
occasionally used.
Separation of metabolites on fluorescent thin-
layer plates
The cuts from the 2 g alumina columns were
concentrated in round-bottomed flasks in vacuo.
They were then transferred to fluorescent plates,
rinsing the flasks three or four times with about
0.5 ml. chloroform and transferring the rinsings
to the plates as well. In this way about 95$> of
the contents of the flask could be put on the
plates, but the "dregs" (i.e., the h% or so left
in the flasks) were always estimated either by
counting, or, if the substrate was 7<x-hydroxy-
cholesterol, by doing a Lifschlitz reaction in the
flask. The plates were then run in the following
solvent systems:
EXAMPLE SHOWING THE METHOD OF SEGMENTING A THIN LAYER PLATE
AND COUNTING THE SEGMENTS
B-*TRIOL. F=7- KETOCHOLESTEROL.
CK POLAR* U.V. ABSORBING GeCHOLEST-4-EN-3-ONE-7«<-OL.






a) for separating the constituents of the ether
cuts- Benzene:dioxane (19:l)
b) for separating the constituents of the ether:
i
alcohol cut:- benzene:ethyl acetate:acetone
(10:5:3); the some solvent system, i.e. (b) was
usea for the alcohol cut.
When the run was completed, the plates ?/ere
removed from the jars, dried, and then viewed
under the u.v. light from the mercury lamp. Any
u.v. absorbing spots were marked with grease
crayon on the glass side of the plate. The
plates were then divided into sections, usually
about six, as shown in the diagram,(9)) j
Elution of substances from plates
I
Various solvents were tried, to elute a
standard amount of substance from thin layer
plates, including ether, ethyl acetate, chloro¬
form, ether:alcohol (5:1) (2:1). The best
recoveries were obtained with 10 ml. ether:alcohol
(1:1). The silicic acid section from a plate
was scraped off the plate into a conical centri¬
fuge tube with a spatula, through a sawn-off
filter funnel (Fig. 9). The silicic acid was
washed into the tube with 10 ml. ether:alcohol
and the silicic acid was thoroughly stirred up
RECOVERY OF 7«< HYDROXYCHOLESTEROL
FROM THIN LAYER PLATES.


































with a thin glass rod. The silicic acid was spun
down, the supernatant decanted into a Qulckfit
tube and taken to dryness in vacuo. The residue
could then be treated in several ways:-
(a) u.v. absorbing substances
The residue was dissolved in 3 ml. methanol
and its absorption spectrum plotted on the u.v.
recording spectrophotometer. After this proced¬
ure the methanol could again be taken to dryness,
and, if radioactive, the residue could be dissolved
in 10 ml. scintillator and counted on the Packard
Tri-Carb Scintillation Counter.
(b) Non u.v. absorbing substances
The residue could be used for chemical esti¬
mation. For example, 7o.-hydroxycholesteroi could
be estimated by the Lifschhtz reaction, or copro-
stane-5a-7a-diol by its sulphuric acid chromogen.
(c) Radioactive measurements
The residue could be counted directly as
described in (a). Thust-
1. In this way metabolites, isolated from an
incubation could be estimated either chemically,
or by radioactive measurements.
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2. A complete radioactive analysis of the incuba¬
tion mixture extract could be carried out by
running each concentrated cut from the alumina
columns on a plate and then segmenting the plate
into sections, eluting and counting each section
separately, (Fig. 9).
This procedure thus provides a powerful
method of investigation, and its advantages are
summarised below.
Advantages of the method
(a) Using this semi-micro method has the advantage:
that small amounts of substrate (100 - 200 hg. )
can be incubated with tissue and the products and
original substrate recovered quantitatively.
(b) As the amounts of tissue used are small, it is
possible to carry out as many as eight incubations
on one cell fraction of any one rat liver. Thus,
each rat acts as its ovm control.
(c) The time taken to perform a series of incuba¬
tions is only about two days, from the time of
killing the rat to obtaining results*
64*
SUMMARY OP EXPER IMENTAL PROCEDURE
RECOVERIES INCUBATION FIXTURE
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STUDY OP THE INITIAL
HYDHOXYLATION OP CHOLESTEROL
65.
STUDY OF THF INITIAL HYDROXYLATION
OF CHOI,STEROL
A. Studying the initial hydroxylation at the 7a-
position of cholesterol, if this is indeed the
initial step, poses a very difficult problem.
Because of the formation of autoxidation products,
one of which is 7a-hyaroxycholesteroX itself
(Bergstrom and V. intersteiner, 1941) it is diffi¬
cult to show conclusively that the 7a-hydroxy-
cholesterol formed has been produced enzymically.
Other auto-oxidation products formed from cholest¬
erol are 7-ketocholesterol, 7f3-hydroxycholesterol
and cholestane-3f5 ,5a,6£-triol. Also any more
polar products formed might arise from the auto-
oxidation products, enzymically, and not directly
from cholesterol. Furthermore, there is a large
cholesterol pool in the liver end as no intermed¬
iates of cholesterol breakdown have ever been
isolated endogenously from liver, it must be
assumed that the initial hyclroxylation is a rate-
limiting stage. As there is so much endogenous
cholesterol present in liver, it is necessary to
use radioactive cholesterol in any incubations
carried out to demonstrate the metabolism of
cholesterol.
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An experiment was therefore set up to com¬
pare the products formed from Ci4; labelled chol¬
esterol (23 c/m/pg.) when incubated with the
different cell fractions of rat liver. Active
mitochondria, microsomes and supernatant were set
up with C14:-cholesterol (430 pg. = £890 c/m.)
added as substrate, in methanol. Boiled mito¬
chondria, microsomes and supernatant were set up
as controls. No NAD was added to any incubation.
The incubation flasks were incubated for 2 hr. and
then the lipids v/ere extracted and columned as
described (p. 50 ). The ether:alcohol cuts from
the alumina columns were concentrated and run on
thin-layer chromatography plates. After viewing
the plates under the u.v. lamp, the plates were
marked off into six segments, each of which was
eluted with ether: alcohol (1:1). The eluates
v/ere taken to dryness and counted.
Prom looking at the plates, before se^nenting
under the -a.v. lamp it was seen that 7-ketochol-
esterol, an auto-oxidation product,had been formed
in active and boiled mitochondria, active and
boiled microsomes and boiled supernatant. Seg¬
menting the plates and counting the sections (p.70)
showed that the counts in the segments containing
67.
7-ketocholesterol coincided with the information
gained by viewing the plates in u.v. light. Thus*
no difference could be seen in the counts between
active and boiled mitochondria; the counts in
active microsomes were slightly more (20 c/m) than
in boiled microsomes* and the boiled supernatant
showed more counts than the active supernatant
which had not shown any 7-ketocholesterol. The
possible metabolite 26-hydroxycholesterol (Daniel-
sson, I960) runs in the benzene:ethyl acetate:ace¬
tone system with almost the same mobility as 7-
ketocholesterol and thus, if any had been produced,
it would have appeared in the 7-ketocholesterol
segments. It would seem, then, that none has
been formed, except perhaps in active microsomes
which v/ould account for the count being higher by
20 c/m than in the boiled microsome section.
The counts in the segments which should con¬
tain 7a-hydroxycholesterol showed that none seemed
to have been formed enzymically, as the counts
obtained from boiled mitochondria and boiled super¬
natant were actually higher than these obtained
from active tissue. In microsomes the counts were
nearly the some in both "active" and "boiled" seg¬
ments.
68.
A further autoxidation product of cholesterol
is cholestane-3p-5o,~6f!-triol (Danielsson, I960).
This substance would probably have a mobility
causing it to run in segment (1). Prom the counts
in these segments it ?/ould seem that this substance
might have been formed in boiled microsomes. The
•
counts in the active mitochondria segment are
slightly higher than those in the boiled mitochon¬
dria, and this right be caused by the formation
enzymlcally of a more polar substance such as the
neutral trihycroxysterol found by Danielsson.
The fact that 7a-hytfroxycholesterol counts were
lower in active mitochondria than in boiled might
indicate that the 7o,-hycroxycholesterol formed
either by autoxidation or perhaps enzymically, has
been further metabolised in the mitochondria. It
is possible that it might have been converted to a
more polar product (see in the fourth section of
this thesis where the metabolism of 7a-hydroxy-
cholesterol in mitochondria is discussed).
The results show that most autoxidation of
cholesterol takes place in the microsomal fraction.
This has been noticed many times in incubations in
connection with the me r holism of other substrates.
For example, in incubations with microsomes and
69.
7a-hydroxycholesterol much more 7-ketocholesterol
and Tp-hydroxycholesterol are formed than in an
equivalent incubation with the other cell fractions.
The ether cuts off the alumina columns were
run on thin layer plates in the bensene:dioxane
system. The plates were then divided into two
segments, one containing cholesterol and the other
containing cholesterol esters. The segments were
eluted and counted. Prom the results it can be
seen that no esterification seems to have taken
place.
It can be concluded then that hardly any, if
any, enzymic metabolism of the added cholesterol
has taken place. Autoxidation products have been
formed, particularly in the microsomal fraction.
In this experiment, the reason for failure to form
any metabolic products may be due to several factors.
(a) The cholesterol added was probably not suffic¬
iently labelled to show up any metabolic process.
(b) No additions, such as NAD, ATP, or citric acid
cycle intermediates were present.
(c) The incubation time may not have been long
enough for the labelled cholesterol to equilibrate
with the large cholesterol pool.



































































































B. A$ has been discussed in the Introduction
(p. 31 )$ it is possible that hydroxyl&tion could
take place with the intermediate formation of a
hydroperoxide of the steroid. Thus, the initial
hydroxylation of cholesterol at the 7a-position
might occur through the 7a-hydroperoxide of chol¬
esterol (choles t-5-en-30-ol-7a-hydroperoxide) as
an intermediate. This substance might then be
readily reduced by EADPH to yield 7a-hydroxy-
cholesterol.
The 7a-hydroperoxide of cholesterol has been
prepared by a photo-oxygenation method, by
Mr. Haqui (see Appendix, p.305). This substance
on thin layer chromatography in the benzene;ethyl
acetate:acetone system runs with an value of
0.58. On spraying with phosphotungstic acid it
gives a purple colour, and when sprayed with a sol¬
ution of potassium iodide in acetic acid it app
as a yellow spot, due to liberated iodine.
Some very preliminary experiments were car¬
ried out using the 7c.-hydrop< roxiue of cholesterol
as substrate.
(i) Four incubations were set up, using
150 pg. of the hydroperoxide in 0.1 ml. methanol.
Two incubations contained a solution of an acetone
72.
powder of mitochondria in buffer, one with NADPH-
generating system added, and the other without it#
The other two incubations contained buffer, and
one contained NADPH-genera ting system# The NADPH-
generating system was that used on p#188(viz. , 0.1
ml# NADP (0#G048 M), 0#1 ml# glucose-6-phosphate
(0.035 M), 0#05 ml# glucose-6-phosphate dehydroge¬
nase, where 0#1 ml, is equivalent to 1 xnnit, where
1 unit reduces lpmole NADP to NADPH)# After incu¬
bating for 1 hr. the lipids were extracted as usual
and the lipid extract was concentrated and run on
thin layer plates# A column procedure was not
necessary. The plates were viewed under the u.v.
light and then sprayed with phosphotungstic acid.
The results are shown in the Table,
Incubation 7-keto- 7a-hydroxy-
150 }ig# substrate cholesterol cholesterol
added to each formed formed




powder; NADPH ++ +++
(d) Buffer ++ ++
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As can be seen, 7-ketocholesterol, an autoxi-
dation product, was formed in all cases approxi¬
mately to the same extent. 7a-hydroxycholesterol
was also formed in all cases, even when the hydro-
peroxide was incubated with buffer alone. By eye,
it was judged that more 7a-hydroxycholesterol had
been formed in the incubations involving the ace¬
tone powder. In incubations (a) and (d) which
did not contain acetone powder, about one-third of
the hydroperoxide added was seen to be unchanged,
whereas in incubations (b) and (c) no hydroperoxide
was recovered at all.
This experiment was repeated quantitatively.
The incubations were set up as before, extracted,
and run on plates. The 7-ketocholesterol formed
in each case was marked after inspection under the
u.v. lamp and eluted with ether:alcohol (1:1).
The eluate was taken to dryness and the absorption
spectrum of the ethanolic solution was plotted.
A peak at 238 mp. was obtained in each case and
from each reading at 238 mp. the amount of 7-keto-
cholesterol formed was calculated. The portion
of thin layer plate containing 7a-hydroxycholest-
erol was also eluted in each case, and the 7a-hydr-
oxycholesterol formed was estimatedby the
74.



































As can be seen, the amount of 7-ketocholest¬
erol formed is approximately the same in each
case, although the amount formed in incubations
involving the acetone powder is slightly higher.
The amount of 7a-hydroxycholesterol formed, on the
other hand, in (b) and (c) is about twice that
formed in the incubations without acetone powder.
Adding NADFH-generating system seems to make no
difference to the products formed.
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These experiments show that the 7a-hydroper-
oxide of cholesterol is not a very stable compound
under the conditions employed in an incubation
as even incubating it at 57° with buffer leads to
the formation of both auto-oxidation products,
7-ketocholesterol and 7a-hydroxycholesterol.
Also, it is shown that acetone powder of mito¬
chondria has an effect on the production of 7a-
hy&ro.iyeholesterol* As about the same amount of
7-ketocholesterol is formed with acetone powder
as without, it appears that the increased produ¬
ction of 7a-hydroxycholesterol may be enzymic. A
control incubation containing boiled acetone pow¬
der would have to be included to settle the que¬
stion of whether the 7ahydroxycholesterol was
being formed enzymically.
(ii) As the 7a-hydroperoxide of cholesterol
is so unstable it seemed likely that it ?;ould
also form autoxidation products when subjected to
the procedure required for extraction and separa¬
tion of metabolites following an incubation with
native mitochondria or microsomes, etc.
76#
■
An experiment was set up to find the effect
of incubating the hydroperoxide with 3 ml. boiled
and therefore, inactive, homogenate of rat liver.
200 p.g. of the hydroperoxide were incubated with
boiled tissue* buffer, nicotinamide and magnesium
sulnhate as in a normal incubation. The lipid...
was extracted and the extract run on a 2 g alumina
column* At the same time a further 200 pg. of
hydroperoxide v/ere put on to a similar alumina
column. The ether:alcohol cuts from each column
were concentrated and run on thin layer plates#
On examination of the plates under the u.v. light
and after spraying, it was found that in both
eases 7-ketocholesterol, 7p-hydroxycholesterol,
and 7a-hydroxycholesterol were formes..
Thus, even passing the hydroperoxide dbwn a 2 g.
alumina column causes it to be converted to these
three products. Very little hydroperoxide rema¬
ined unchanged during this procedure.
As a column method is convenient to remove
much interfering material from a lipid extract
obtained from an incubation with native tissue, it
was decided to find out whether a silicic acid
column method would still give rise to the auto-
oxidation of the hydroperoxide.
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(iii) A 2 g. silicic acid column was therefore
set up and a mixture of cholesterol (200 pg. ) ,
7<x-hydroxycholesterol (200 pg), and 7a-hydropero-
xide of cholesterol (200 pg.) was put on to the
column in a mixture of 15% ether: 85% petrol
ether (60° - 80®). The column was then eluted
as shown, the cuts concentrated and run on thin
layer plates to identify the constituents. The
results are given in the Table.
Cut No. Solvent Vol. Constituents
in ml.
1 15% ether: 85% pet- 10
rol ether
2 20% ether: 80% pet¬
rol ether 10 Cholesterol
3 25% ether: 75% pet¬
rol ether 10 Cholesterol
4 50% ether: 50% pet¬




5 100% ether 10 7a-hydro-
^ peroxide






As can be seen, 7-ketocholesterol is formed
from 7a-hydroperoxide (7a-hyoroxycholesterol and
cholesterol are guite stable on silicic acid)
even on silicic aeicU However, only traces of
7-ketocholesterol were formed, and it was there¬
fore decided to use this column method to remove
interfering material from lipid extracts of an
acetone powder of mitochondria.
(iv) Two incubations were set up each contai
ning 100 gg. 7a-hydroperoxide and a buffer solu¬
tion of an acetone pow&er of mitochondria. The
buffer solution added to one incubation had prev-
iously been boiled and it was therefore enzymicaHy
inactive. The other incubation contained active
■
mitochondrial powder. After incubation and extr¬
action, the dry residues were put on to 2 g. sil-
icic acid columns in 15% ether: 85% petrol ether.
The columns were eluted with 10 ml. of this sol¬
vent, followed by 10 ml. of 25%o ether: 75%. petrcO.
ether. Further cuts of 30 ml. ether:methanol
(9:1) were taken. These latter cuts were taken
to dryness and run on thin layer plates.
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It was found that 7-ketocholesterol had been
formed in both incubations, but, by eye, the
amount was judged to be about the same in both
cases. The portions of the plates containing
7a-hydroxycholesterol were eluted and the eluates
taken to dryness. A Lifschtttz reaction was car¬
ried out on each eluate and it was found that the
amount of 7a-hydroxyeholesterol formed in the
incubation with active acetone powder was double
that formed in the boiled control incubation,
i.e. 20 pg. 7a~hydroxycholesterol was formed in
the "active" incubation and 9 gg. in the "boiled"
one. Thus, it would seem that some enzymic acti¬
vity is present in an acetone powder of mitochon¬
dria which will convert the 7a-hy<3roperoxide of
cholesterol into 7a-hydroxycholesterol. 7-keto-
cholesterol appears to be formed non-ensymically.
C. Experiments with Macrophages. As has been
pointed out, the problem of autoxidatiOn makes
the study of the initial stages in the breakdown
of cholesterol very difficult. As the autoxida-
tion seems to be marked by the presence of large
amounts of tissue, the microsomal fraction being
particularly bad, it was wondered whether working
80#
with reticule—endothelial cells would he a
"cleaner" procedure and less prone to autoxida¬
tion# It may* in fact, he the case that choles¬
terol degradation occurs in the liver in the Kup-
ffer cells, which are reticulo —endothelial cells.
The Kupffer cells are probably involved in the
uptake of cholesterol from the blood# It would
therefore be of interest to study cholesterol
breakdown in preparations of macrophages, which
are also phagocytic cells#
Very little is known about the metabolism
of cholesterol in macrophages, but Schonheimer and
Yuasa (1929) and Tompkins (194-6) have found that
cholesterol introduced into the subcutaneous tis¬
sues is partly converted to cholesterol esters,
presumably by the macrophages present there#
More recently Day and French (1959) have shown
that when cholesterol suspensions are ingested
by reticulo—endothelial cells in the lymph nodes
of the rat, the content of cholesterol esters
increases in the nodes# Day (i960) also showed
that both synthetic and hydrolytlc cholesterol
esterase activity is present in isolated rabbit
macrophages# Homogenates of these cells esteri-
fied the cholesterol at pH 6#0 and hycirolysed the
esters at pH 7#3#
81.
'
Day (1961) compared the oxidation by rabbit
macrophages of cholesterol-26-C*4 to C±40s with
the oxidation of C14-labelled fatty acids (sodium
palmitate-l-C14) and C14-labelled triglycerides#
He found appreciable oxidation of fatty acids and
triglycerides brought about by macrophages, but
under the same conditions no oxidation of the
cholesterol side-chain could be demonstrated# He
found that the cholesterol was phagocytosed and
thus the failure to oxidise it cannot be explained
by a failxire in its uptake.
It is possible, however, that the macrophages
can bring about the earlier stages in degradation
of cholesterol, such as the hydroxylation at pos¬
ition 7, whereas the splitting off of the side-
chain to form bile acids may be a very complicated
process for which macrophages are not equipped#
(a) Procedure for obtaining rat macrophages
.
Macrophages \ ere grown by the following pro¬
cedure by Br# A#E# Stuart, Pathology Department,
University of Edinburgh. "199" tissue culture
medium containing heparin was indebted intra-
peritoneally into 5 rats to wash out the macro¬
phages accumulated in the peritoneal cavity.
82,
The peritoneal fluid was then taken off after 5min.
&usually amounted to about 26 ml# from 5 rats. A
count of the number of cells in the fluid was
thai made and normally this was about 5 x 10®
cells per ml., which is regarded as a reasonably
high value. The required number of cells
(16 x 10® cells/bottle) were then grown in "baby
bottles" containing 8% rat serum in "199" tissue
culture medium. "Baby bottles" are used because
they have eight flat surfaces, and if placed side¬
ways on one of these surfaces, the cells grow/ as
a layer on the surface of the bottle. If the
cells were seen to be growing satisfactorily in a
good monolayer after 48 hr., Ci4-labelled choles¬
terol in rat serum was added as a substrate.
The bottles were then incubated for varying times
at 37°.
(b) Extraction and separation procedure
After incubating the macrophages with Ciif—
cholesterol for the required time, methanol v/as
added to the bottle to kill the cells and stop
any enzymic reactions. Carrier cholesterol and
7a-hydroxyclio1 es tero 1 were added. The methanolic
solution was centrifuged to remove the denatured
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protein and the supernatant was decanted off.
The protein was re-extracted with chloroform and
the chloroform extract was added to the methanolic
supernatant. After shaking and centrifuging the
aqueous methanolic layer was discarded. The
chloroform layer was taken to dryness and as the
extract was "clean" and free from interfering
substances, no column method was required. The
extracts were run directly on thin layer plates,
one half being run on one side of the plate and
the other half on the other side. After the run,
the plates were viewed under the u.v. light and
any u.v. absorbing substances were marked. One
half of the plate v/as then sprayed with phospho-
tungstie acid, the other half of the plate being
shielded with a sheet of glass. The unsprayed
half of the plate was then segmented as shown,
the segments eluted with ether:alcohol (1:1) and
the eluates taken to dryness ana counted.
(c) Experiments with C^-cholesterol and macrophages
Rat serum was obtained from rats which had
been injected with C14:-labelled mevalonate - a
precursor of cholesterol. C14r-labelled cholest¬
erol and cholesterol esters thus appeared in the
84
blood as lipoprotein complexes# Cholesterol
and cholesterol esters are therefore being pre¬
sented to the macrophages solubilised in an ideal
way#
Experiments were set up in which C14-choles¬
terol (and esters) were incubated with macrophages
for varying times before the reactions were
stopped. The results were obtained as described
above, and are set out in the Tables^ (7-10).
As can be seen, the results varied consider¬
ably from experiment to experiment and from time
to time. In other words there seemed to be no
Increased formation of more polar products as
time increased. In some cases no metabolism of
cholesterol appeared to have occurred at all,
whereas in other cases mors polar products were
definitely produced.
(i) Experiment 1
Two 24 hr. duplicate incubations were set up
and the results are shown. In the second incub¬
ation radioactivity in the 7a-hydroxycholesterol
segment was seen, being three times that occurring
in the cholesterol segment. No«7-ketocholesterol
was seen on the plate before segmenting and the


























































































































































































formation of a substance of similar polarity,
such as 26-hydroxyeholesterol. In the first
incubation a high count (six times that seen in
the cholesterol segment) was found in the origin
segment. This indicates that either polar pro¬
ducts hod been formed or that 7a-hydroxycholesterol
had run in this segment. In this experiment,
one half of the plate was not sprayed, as has
been described, and therefore the c/m are higher
than those obtained in other experiments vtfiere
only one half of the extract was counted, the
other half being sprayed for identification of
the constituents. In this 24 hr. experiment,
then, considerable metabolism of cholesterol or
cholesterol esters seems to have oocnred.
(ii) Experiment 2
In this experiment a zero hour incubation
was included as a control. Not much metabolism
of cholesterol or its esters seems to have
occurred in any incubation. In the 6 hr. incub¬
ation, the radioactivity in the 7a-hycroxycholes¬
terol segment indicates that some had been formed.
Esterifieation seems to have occurred in the 21 hr.
incubation, and hydrolysis of esters in the other
87.
incubations. The formation of 7-ketocholesterol
increases with time. Thus the incubations in
this experiment are rather inactive.
(iii) Experiment 3
In this experiment duplicate incubations
were carried out. To one incubation extract
carrier cholesterol and 7a-hyaroxycholesterol
were added* lio carrier was added to the dupli¬
cate extract. Thus# on spraying one half of the
plate on which the "no carrier" incubation had
been rim it was possible to see whether any 7a-
hydroxyeholcsterol had been formed. If any was
seen to be formed a + sign is placed on the Table
after the c/m in that sentient.
In the 12 hr. incubation, 7a-hyc1roxycholes-
terol was seen on the "no carrier" plate and
the radioactivity in the corresponding segment
indicates that it was produced from cholesterol
or its esters. The duplicate 12 hr. ""carrier
added" incubation also shows a high count in this
segment. 7a,-hycroxyeholesterol was seen also
in the 36 hr. " no carrier" incubation. In all
Incubations except the zero hour control incuba¬
tions, the radioactivity in the origin segments
88.
is fairly high, indicating the formation of more
polar products than 7a-hydroxycholesterol. 7-
ketocholesterol was not seen in any of the incubv
ations and esterification seems to have occurred
in most incubations.
In this experiment, then, the 12 hr. incu¬
bation appears to have been quite active at met¬
abolising cholesterol. The time of incubation
does not seem to be important in the formation
of products from cholesterol.
(iv) Experiment 4
In the 6 hr. and 15 hr. "no carrier" incub¬
ations in this experiment, 7a-hyd.roxycholesterol
was seen to be present and the radioactivity,
especially in the 15 hr. incubations, indicates
that it was produced from cholesterol or its
esters. However, 7-ketocholesterol was also
seen to be formed and was labelled, and therefore
the 7a-hydroxyeholesterol may have been formed by
autoxidation. Polar products would seem to be
formed in the 15 hr. and 23 hr. incubations. On
the sprayed half of the plates from 15 hr. "no
carrier", 15 hr. "carrier" and 23 hr. "carrier"































































































































were seen to "be present. Therefore the remainder
of the extracts not put on to plates, except for
the control extract, were pooled and run in the
benzene:dioxane system. Again one half of the
plate was sprayed and the other half segmented and
counted. The segments containing 7a-hycroxy-
cholestercl and its esters contained about one-
■
fifth and one-tenth, respectively, of the radio¬
activity occurring in the cholesterol segment.
As a check C.5 ml. of the serum used as a
substrate for these incubations was extracted, run
on a plate, and one half sprayed ana the other half
segmented and counted. A trace of 7a-hydrcxy-
cholester-ol was seen to be present, but it gave a
negligible count.
Thus, it would seem that metabolism of chol¬
esterol or its esters has occurred, particularly
in the 15 hr. incubations to give 7o-hydroxycholes**
terol, 7o-hyt2roxycholesterol esters, and more polar
products.
(v) Experiments 5 and C
In these experiments again, in some incuba¬










































































































However*, in the 36 hr. Incubation, 7ct-hydroxy-
cholesterol and more polar products are formed,
the radioactivity in the 7a~hydroxycholesterol seg¬
ment being about one-half of that in the cholest¬
erol segment. After 4-6 hr. much 7-ketocholesterol
appears to be produced. In the 24 hr. incubation
more polar products are formed.
(vi) Experiment 7
Although Day (1961) has found that no oxida¬
tion of the side-chain of cholesterol can be car¬
ried out by rabbit macrophages, it was thought to
be of interest to discover whether the more polar
products obtained in some incubations in previous
experiments could be bile acids.
Six incubations were prepared, and one of
these was stopped at zero time. The other five
bottles were incubated for 24 hr., the contents
were pooled and extracted as usual with methanol.
One-tenth of the methanol extract v/as treated as
usual and was run on a thin layer plate, half of
which was sprayed and the other half segmented and
counted. The other nine-tenths was extracted as
follows to discover whether any bile acids had
been formed. The protein was spun down and the
93»
methanol extract taken to dryness in vacuo. The
residue was dissolved in sodium "bicarbonate and
poured into a nickel crucible. 5 N sodium hydro¬
xide was added and the mixture was hydrolysed
under pressure for 3 hr. The mixture was then
acidified with concentrated hydrochloric acid and,
extracted four times with chloroform: ethanol (9:1).
The chloroform layer was taken to dryness in
vacuo and acetic acid and celite were added to
the residue. A column of celite prepared in 7($
acetic acid and 100$ petrol ether was made, and
the celite, on which the extracted material had
been adsorbed, was placed on top of the column.
The column was eluted as shown in Table 10
one half of each cut being taken for counting and
the other half for thin layer chromatography.
In Table 10 it can be seen from the plates
that more polar products have been formed, which
are radioactive. In the origin segment, 26 c/m
are found, and it must "be remembered that this
only represents about one-twentieth of the total
24 hr. incubation. Radioactivity was eluted in
cut 1 of the bile acid column. This would be
due to cholesterol and cholesterol esters. Some





























































































































Incubation of C14r-cholesterol (and esters)
with macrophages* Photographs of thin layer
plates obtained by running cuts from the ""bile
acid column".
1. Standard chenodeoxycholic acid
2. Cut 6
3. Standard deoxycholic acid
4. Cut 9
5. Standard cholic acid
6. Cut 12
95-
acid cnt, cut 6, in the trihydroxy-acid cut, cut
12, and in cut 9. Cut 6 was run on thin layer
chromatography in trimethyl pentane (10):ethyl
acetate (10): and acetic acid (2), together with
standard chenodeoxycholic acid and deoxycholic
acid. Cut 6 was found to contain a substance
which ran with the same mobility as chenodeoxy¬
cholic acid (Pig. 11). Cut 9 and cut 12 were
run with cholic acid in the same system and cut
12 contained a substance with the same polarity
as cholic acid, whereas cut 9 contained a sub¬
stance with a mobility slightly less than that of
cholic acid, but more polar than chenodeox.ych.olic
or deoxyeholic acids.
Thus, it would seem that the cholesterol or
the esters added to the macrophages in this exper¬
iment has indeed been converted into bile acids.
It is possible that bile acids, also labelled,
could have been present in the original serum,
but the sero hour incubation showed no radio¬
activity in the section of the plate in which
bile acids would have run (i.e. the origin seg¬
ment).
96.
3UM&ABY OP SPCTM III
A. A preliminary experiment was carried out on
the metabolism of Ci4r-labelled cholesterol in the
different cell fractions of rat liver, using a
boiled tissue incubation as a control for each
incubation. It was shown that very little, if
any, emsyrnic metabolism occurred, whereas auto-
oxidation products were formed.
B. Preliminary experiments, using cholest-5-en-
33-ol-7a-hydroperoxide as a substrate were carried
out. This substance was found to be rather
unstable, however, forming both 7a-hydroxycholes¬
terol and 7-ketocholesterol when incubated with
buffer alone. The hydroperoxide is unstable,
also, when eluted from an alumina column and to
a lesser extent from a silicic acid column.
However, by using control incubations, it was
shown that an active acetone powder of mitochon¬
dria could convert the 7a-hydroperoxide ox* chole
sterol to 7a-hy«2roxycholesterol.
97.
C. Experiments were curried out in which C14~
labelled cholesterol and cholesterol esters in
rat serum were incubated witfc growing rat macro¬
phages. After varying time intervals the pro¬
ducts of these Incubations were examined* It
was found that cholesterol or its esters had been
metabolised in some incubations to 7a-hybroxy-
cholesterol and more polar products. The more
polar products were Identified as bile acids.
Other Incubations seemed quite inactive,
autoxidation products only being formed.
SECTION IV
METABOLISM OP 7a-HYDR0XYCHOLESTEROL
IN RAT LIVER CELL FRACTIONS
98.
METABOLISM OF 7a-HYDR0XYCHOLESTEROL
7a-hydroxycholesterol, both labelled with
tritium and unlabelled, was incubated with the
different cell fractions of rat liver using the
methods described above. The metabolism of this
substrate in each cell fraction will be discussed
separately.
1. MICROSOMES and SUPERNATANT
This is the fraction left after removal of
the mitochondria by spinning at 10,000 x g for
15 min. and was studied initially before separat¬
ing the fraction further into microsomes and
supernatant.
(a) Using the incubation mixture and methods
of extraction and estimation described, the disa¬
ppearance of 7<x-hydroxycholesterol from incubation®
with microsomes and supernatant was measured in
fifteen experiments. In each case the disappea¬
rance of 7a-hydroxycholesterol from "active" tis¬
sue was compared with that from boiled tissue and
for these fifteen experiments was found to be
3QT- + 6f'. Using tritiated 7a-hydroxycholesterol
as substrate and estimating its disappearance
Graph of NAD concentration plotted against
7a -hydroxycholesterol disappearing




after incubation by eluting the substrate from a
fluorescent thin layer plate confirmed this
approximate figure.
(b) This disappearance of 7a-hydroxycholest¬
erol from an incubation mixture was used as a
measure of its metabolism (i.e., enzymic activity).
Experiments were carried out with eight incubations
each containing a different amount of NAD -varying
from 0,5 n mole to 10 p moles in the incubation
mixture in experiment (l) (see Table 11 ), and
from 5 p moles to 20 p moles in experiment (2).
Boiled tissue controls \f/ere included. As can he-
seen from Table 11 and the corresponding graphs
(Fig. 12) the amount of 7a-hydroxycholesterol dis¬
appearing per hr. increases as the NAD concentra¬
tion increases up to a concentration of about 10
p. moles NAD/6 ml. incubation mixture. NAD con¬
centrations of 15 p moles and 20 p moles per 6 ml.
gave no further increase in 7a-hydroxhcholesterol
disappearance. From these experiments it can be
concluded that the disappearance of 7a-hydroxy-
cholesterol from incubations with microsomes and
supernatant is dependent on the concentration of
NAD present up to a certain limiting value, where
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Figure 13
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This would indicate that possibly 7a-hydroxy-
cholesterol is being metabolised in this cell
fraction to a product containing two hydrogen
atoms less than 7a-hydroxycholesterol. Another
explanation is that a complicated series of reac¬
tions is taking place, and cnly one of these may
require NAD as co-factor.
(c) Experiments were carried out in which
incubations were set up containing varying amounts
of the substrate 7a-hyaroxycholesterol. The
amount of substrate added varied from 47.5 jig. to
475 gg. and each amount was added ir 0.5 ml.
methanol. The disappearance of substrate per
hr. was measured and plotted against the substrate
added (Fig. 13 Table 12). As can be seen as
the substrate concentration increased the amount
of 7a-hydroxychclesterol disappearing per hr.
also increased, giving a curve increasing sharply
initially and then flattening off. A graph of
the reciprocal of the substrate concentration
(l/(s)) against the reciprocal of the initial
velocity of reaction (l/v) i.e., the disappearance
of 7a-hy&roxycholesterol per hr.<)was drawn and
found to be a straight line giving a value for
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Graph of substrate concentration plotted
against substrate disappearing
Substrate added in 0. 1 ml. methanol
80-,








/ ^Incubation of 7a-
// hydroxycholesterol
, // with 'microsomes







c 50 100 150 200




In order to show that such large amounts of
methanol as 0*5 ml* had no effect on the enzymic
activity two experiments using microsomes and
supernatant from one rat were carried out, (TahJ3). In
one, substrate varying from 50 fig* to SCO pg* in
0*1 ml* methanol was added to the incubation mix¬
tures and the disappearance of substrate compared
with that in the second experiment where each
amount of substrate was added in 0.5 ml. methanol.
Plotting the disappearance of 7a-hydroxycholesterol
against substrate concentration in each experiment
gave curves (Pig. 14) which hardly differed and
it must he concluded that the enzyme or enzymes
are unaffected by the 0*5 ml* methanol (nearly
lOfo of the total incubation mixture)*
2. MICROSOMES
a) An attempt was made to measure the dis¬
appearance of 7a-hycroxyeho1estero.l from incubat¬
ions with this fraction by direct estimation of
the 7a-hyfiroxycholesterol in the ether:alcohol cut
as described on p. 51* This was found to be
impossible, however, due to the fact that the Lif-
schtttz colour obtained was not a typical one but
tended to be brownish instead of blue-green*
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As the estimation of 7e-hydroxycholesterol in
lipid extracts from the microsomes and supernatant
fraction was perfectly satisfactory, it must be
assumed that some interfering substance exists in
microsomes alone, which, as it does not occur in
microsomes and supernatant must either be meta¬
bolised or removed in some way when supernatant
is added to the microsomes. Therefore the only
way in which 7a.-hydroxycholesterol could be esti¬
mated after incubation with microsomes v/as to run
the concentrated ether:alcohol cut from the alumina
column on the thin layer plate to separate it from
interfering substances and then to elute it as
described on p. 60 • In this way it was found
that when 7a-hydroxycholestorol was incubated with
microsomes and NAD (10 g moles) approximately 30%
of it disappeared. When no NAD was added the
disappearance was only about 4>s.
(b) Isolation of metabolites
Using the technique of thin layer chromato¬
graphy on fluorescent plates described on p.56
and comparing the ether:alcohol cuts from the alu¬
mina columns from an incubation involving boiled
tissue with one involving active tissue, showed
1 4 3
Pig* 15
Photographs of fluorescent plates, illuminated by
u.v* light*
Plates obtained from incubations of micro¬
somes with 7a-hydroxycholesterol, v/ith varying
NAD concentration
1* No NAD added
2* 5 [i moles NAD
3* 10 ji moles NAD





Ultraviolet absorption spectra of cholest-4-en-3-one-7a-ol
and the product obtained from incubations with 7a-hydroxy-
cholesterol
42.5 (jig. pure cholest-4-
en- 3-one- 7a -ol










that in the presence of active tissue and NAD, a
u. v. absorbing substance was formed, (Pig* 15).
When labelled 7a-hydroxycholesterol was used as
substrate, this metabolite was also found to be
labelled, indicating that it must have been pro¬
duced from 7a-hydroxycholesterol* It seemed pos¬
sible that the metabolite might be cholest-4-en-
S-one-7a-ol, and the metabolite actually had the
same Rp value in the benzene:ethyl aeetate:acetone
(10:5:5) system as an authentic sample of cholest-
4-en-3-onc5-7a-ol:t ) (i, e. , 0.66), and also in the
benzene:dioxane (lS:l) system (i.e., 0.10).
When the metabolite was isolated from a thin
layer plate, it was found to have the same absorp¬
tion spectrum as cholest-4-en-5-one-7a-ol (Fig. 16)
having a peak at 842 mg., indicating the presence
of an a, p-unsaturated ketone. The substance also
gave a pink colour with phosphotungfetic acid when
sprayed on a plate, as does cholest-4-en-3-one-7a-
ol (see specificity of phosphotungstic acid test,
Appendix, p. gio )•
When the substance produced from an incuba¬
tion with labelled substrate was mixed with
unlabelled cholest-4-en-3-one-7a-ol and co-chromat-
ography was carried out in the benzene:ethyl
tThe preparation of this substance is described in
the Appendix, p. 304 .
107.
acetate:acetone system and in the benzene:dioxane
system the substance produced from 7a-hydroxy-
cholesterol did not separate in either system
from cholest-4-en-3-one-7a-ol. When the plates
were segmented into five sections, eluted, and
counted, the radioactivity was found to be con¬
centrated in this one u.v. absorbing spot.
Labelled metabolite was isolated from several
incubations, pooled, and mixed with 5 mg» unlab-
elled cholest-4-en-3-one-7a-o1, The mixture was
crystallised three times from methanol until con¬
stant specific activity was achieved. A sample
from each crystallisation was taken, its absorp¬
tion at 242 mi-i. read, and then counted to obtain
the specific activity of the sample (Table 14 )•
An infra-red spectrum of the final sample was
plotted, and this compared well with an infra-red
spectrum of authentic cholest-4-en-3-one-7a-ol.
The cumulative evidence produced here indic¬
ates then, that in microsomes 7a-hydroxycholesterol





Cholest-4-en-5-one-7aol formed by incubation
of 7a-hydroxycholesterol (labelled) with
enzyme and NAD, crystallised to constant

















sample 66 71 65
c/m present in










Using the fluorescent thin layer chromato¬
graphy plates as a means of identifying metabolites
produced from 7c,,-hydroxycholesterol, no evidence
has been found from an examination of any of the
cuts of the alumina columns to suggest that any
product other than cholest-4-en-3-one-7a-ol is
formed. For example, no further u.v. absorbing
substances which are formed only in "active"
incubations have ever been seen. 7-ketocholes-
terol is indeed formed in all incubations with
active or boiled tissue, but as the came amount,
approximately, is formed in every case (estimated
by absorption at 258 mp. or by radioactive measure¬
ments) it must be concluded that 7-ketocholesterol
is formed from 7a-hydroxycholesterol only by auto-
oxidation. 7p-hyaroxycholesterol is also seen to
be formed auto-oxidatively.
Spraying plates obtained from incubations
with active tissue with phosphotungstic acid or
with phosphomolybdic acid showed up no additional
substances which did not occur on plates obtained
from boiled control incubations. When the plates
obtained from incubations with active and boiled
tissue were segmented, eluted and counted, it was
seen that the only radioactive substances formed
110.
in the active incubations were cholest-4-en-3~one~
7a-ol end 7-ketocholesterol, whereas in the boiled,
control incubations the latter substance alone was
produced.
When no NAD was added to incubations with
microsomes and 7a-hyciroxycholesterol, only a trace
of cholest-4~§n-3-one-7a-ol could be detected, and
no other products were found. As has been
mentioned on p.105 the disappearance of 7a-hydroxy-
cholesterol amounted only to about 4$.
(c) It is now possible to estimate not only
the disappearance of 7a-hj'-aroxycholesterol from
an incubation but also the appearance of cholest-
4—en-3-one-7a-o1 under various conditions. It
was measured, as described above (p. 60 ) by
marking its position on the fluorescent thin layer
plate, scraping off this area, and extracting the
silicic acid with ether:alcohol* This extract
was taken to dryness, dissolved in methanol, and
the absorption of the solution read at 242 mg.
(i) Effect of varying the NAD concentration
A series of incubations was set up, each con¬
taining the same amount of substrate, but the NAD
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In each incubation both the amount of cholest-4-
en-5-one-7a-ol formed and also the amount of 7a-
hydroxycholesterol disappearing was estimated.
Prom the Tables below and Fig. 17, it can be seen
that, up to about 10 g moles of NAD in the incuba¬
tion mixture, the amount of cholest-4-en-3-one-
7a-ol increased proportionately with the disappea¬
rance of 7c,-hydroxycholesterol. At 20 p moles of
NAD no further increase in the amount of eholest-
4-en-3-one-7a-ol formed was observed, and the dis¬





Variation in NAD concentration






















It can therefore he concluded that 7u-hydroxy-
cholesterol is converted into cholest-4-en-3-one-
7o-ol in microsomes and that this conversion is
dependent upon NAD as co-factor. At levels of
about 10 g moles of added NAD the enzyme must he
saturated, and at this level about 30% of the
added 7a-hydroxyeholesterol has been converted to
this product. Again it must be assizmed that
large amounts of added NAD are required because of
the other NAD-requiring reactions occurring in
microsomes.
A further experiment showed that NADP could
replace NAD as co-factor.
-
(ii) Effect of varying the substrate concentration
Six incubations ?/ere set up, each containing
microsomes and 10 g moles NAD and a different
amount of substrate, ranging from 60 gg. to 600 gg,
each amount being added in 0.25 ml. methanol.
The ether-alcohol cuts obtained from these
incubations were run on fluorescent thin layer
plates and the cholest-4-en-3-one-7a-ol formed in
each case was elutefi and estimated by its absorp¬
tion at 242 mg. The 7a-hydroxycholesterol recov¬
ered in each case was also eluted and estimated by























































































Graph of substrate concentration plotted against substrate
disappearing per hour
60-












/ Incubation of 7q-hydroxy-
9 / cholesterol with microsomes
10-
i i < i i , i
100 200 300 400 500 600




Graph of g" against —













Table 15 and the graphs of the results (Pig.18
are shown opposite. The amount of cholest-4-en-
3-one-7ci-ol formed was plotted against substrate
concentration and then a graph was drawn of the
reciprocal of the substrate concentration against
the reciprocal of the initial reaction velocity
(i.e., the amount of cholest—i-en-5-one-7c,-ol
formed per hr). The amount of 7a-hydroxyeholes-
terol disappearing per hr. was also plotted
against substrate concentration.
Prom the graph it can be seen that the amount
of choles t-4-en-3-one-7a-ol increases as the sub¬
strate concentration increases giving a curve
typical of an enzymic reaction. The graph of ~
against^ was found to be a straight line giving
a K value for the reaction of 5.13 x lo""4 M.
m
'
The disappearance of 7a.-hydroxycholesterol was
also shown to increase with substrate concentration.
(iii) Effect of cyanide on the oxidation of 7a-
hydroxycholesterol to cholest-4-en-3-one-7a-
01. ■■■!■■- I
Pour incubations were set up, with labelled
7a-hydroxycholesterol with the compositions
(a) microsomes + 10 p moles NAD
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Fig. 19
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Fig. 20
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(c) microsomes + 10 (i moles NAD + 20 p. moles
potassium cyanide
(a) microsomes + 10 ji. moles NAD + 60 g moles
potassium cyanide.
In each incubation the cholest-4-en-3-»one-7a»
ol produced was isolated on fluorescent thin layer
plates, eluted and estimated by the absorption at
242 mp. and also by radioactive methods. The
amount of eho1es t-4-en-5-one-7c-o1 produced was
plotted against the amount of cyanide in the incu¬




(b) 10 )i moles KCN
(c) 20 g moles KCN
(c) 60 |j. moles KCN
(140 pg. substrate added =








The results show that, contrary to expectation
the amount of cholest-4-en-3-one-7a-ol produced
increases as the cyanide concentration in the




inhibit the reaction but actually ""activates" the
enzyme or enzymes. At a concentration of 60 g
moles of cyanide the amount of cholest-4-en-3-one-
7a-ol produced is nearly double that formed when
no cyanide is present.
The behaviour of the cyanide could be explained
if it is inhibiting the other NAD-requiring reac¬
tions occurring in the microsomes, thus leaving
more HAD available to act as co-factor in tbe
oxidation of 7o.-hydroxycholesterol to cholest-4-
en-3-one-7c,-ol.
(iv) Effect of changes in pH on the oxidation of
7a-hydroxycholesterol to cholest-4—en-3-one-7a-ol
Five incubations were set up each with micro¬
somes, 10 |u moles RAD and 7a-hydroxycholesterol.
The pH was varied from 6.0 to 8.1 by the steps
6.0, 6.4, 7.0, 7.4 and 8.1 by incubating \7ith
phosphate buffer of the appropriate pH. The
cholest-4-en-5-one-7a-ol produced in each case was
isolated from the thin layer plates, and estimated
by its absorption at 242 mg.
The amount of cholest-4~en-3-one-7a-ol formed
was plotted against pH, and the graph shown in
















The results indicate that the microsomal
enzyme has its highest activity when incubated in
a medium of pH between 7.0 and 7.4, i.e. the pH
optimum of the enzyme is between 7.0 and 7.4.
(v) Effect of succinate on the microsomal oxida¬
tion of 7a-hyaroxycholesterol to cholest-4—
en-5-dne-7a-ol~
In later experiments, using the mitochondrial
fraction of rat liver, it was found that succinate
had an effect on the metabolism of 7a-hydroxy-
cholesterol, presumably by reducing the added NAD
to NADU (p. 144). It was therefore decided to
incubate succinate with microsomes, 10 p moles NAD
and labelled 7a-hydroxycholesterol to discover if
succinate had the same effect in microsomes as it
has in mitochondrial incubations.
Incubations were set up as shown in Table 16
land the cholest-4-en-3-one-7a-ol formed in each
118.
case was isolated and estimated both by determin¬
ing its absorption at 242 rag. and by radioactive
means. The results shown in the Table indicate
that succinate has no marked effect.on the produc¬
tion of cholest-4-en-3-one-7a-ol. The incubation
in which 72 p. moles of succinate were used did,





a) Microsomes + NAD 5060
b) Micro semes + NAD + 36 g
moles succinate 5240
c) Microsomes + NAD + 72 p
moles succinate 4500
cholest-4—en-3-one-7a~ol, but the difference
between the three results is hardly significant.
In mitochondria, on the other hand, the presence
of even 7.2 n moles of succinate with 10 \x moles
of NAD gave rise to about one-thirtieth of the
cholest-4-en-3-one-7a-ol produced by mitochondria
with NAD and no succinate. Thus, if succinate
hasai effect on the production of cholest-4-en-3-
one-7a-oiin mie*,osomes it is a very small one indeed
compared to the effect occurring in incubations
with mitochondria.
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(vi) Incubations of 7a-hydroxycholesterol with an
acetone powder of microsomes
An acetone powder of microsomes was prepared
as described on p# 39 • The powder was dissolved
in buffer solution and incubated with 7a-hydroxy-
eholesterol and NAD# By viewing the fluorescent
thin layer plates it was seen that cholest-4-en-
3-one-7o—ol had been formed# The amount of this
substance formed increased as the amount of ace¬
tone powder was increased, the cholest-4-eiv-3-one-
7a-ol being estimated by radioactive measurements#
Thus it seems that the oxidation reaction
occurring in microsomes when cholest-4-en-3-one-
7a-ol is formed from 7a-hydroxycholester ol is not
affected when the microsomes are treated in this
way#
3. SUPE5NATANT
This is the cell fraction left after the
microsomes have been sedimented by spinning at
100,000 x g for 60 min# This fraction is a
clear red solution#
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(a) The disappearance of 7a-hydroxycholesterol
from incubations v/itb the supernatant fraction
fortified with HAD has only been measured in five
experiments. With this fraction, as with micro¬
somes and supernatant}, the 7o.-hydroxycholesterol
can be estimated directly in the ether:alcohol
cuts from the alumina columns as there seem to be
no interfering substances, as in microsomes. The
disappearance of 7a-hydroxycholesterol was found
to be about 10^ in these experiments.
In experiments using labelled 7a-hyuroxy-
cholesterol the disappearance was confirmed to be
10%
(b) Identification of metabolites
(i) On running the ether:alcohol cuts from the
alumina columns from incubation mixtures of
"boiled'and ""active" supernatant with NAD added it
was seen that in the "active" incubation a u.v.
absorbing substance had been formed. This sub¬
stance had the same characteristics as eholest-4—
en-3-one-7a-ol, i.e., the Hp value in the benzene:
ethyl acetatesacetone thin layer system was 0.66
and it gave an absorption spectrum with a peak at
242 mg. By using labelled substrate it was shown
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that this substance was also radioactive, indicat4
ing that it had been formed from 7a-hydroxycho1es¬
terol, Estimating this product both by radio¬
active measurements and by its absorption at 242
mix, showed a very small amount (2$) had in fact
been formed from 7<x-hyaroxycholesterol*
7-ketoeholesterol was shown to be formed in
incubations with both boiled and active tissue,
and again only 2fo was produced* Incubations
carried out with no added NAD showed that no
cholest-4-en-3-one-7a-ol was formed*
(ii) On running the ether cuts from the alumina
columns obtained from incubations with boiled and
active tissue it was seen that a substance which
gave a blue colour on spraying the plate with
phosphotungstie acid was formed in the incubation
with active tissue. This substance was fairly
non-polar as it was eluted in the ether cut from
alumina and from its mobility on the plate in the
benzene: dioxane (19:1) system, was thought to be
an ester of 7a-hydroxycholestei dl* The Rp values
of some synthetic 7a-hydroxycholosterol esters















graphic system are shov/n in Table 17 and compared
with the Re value of this substance produced in
r
supernatant incubations. The synthetic esters
are eluted from alumina also in the ether cut.
When labelled 7a-hyciroxycholesterol was used
as substrate it was shown that this substance was
also labelled and that about 3£o was formed from
7a-hydroi<ycholesterol in "active" incubations.
(iii) A complete radioactive analysis of the
extracts from incubations was carried out by run¬
ning the three cuts from the alumina columns on
thin layer plates which were segmented and counted.
This showed that no further metabolites were formed
in incubations of 7o-hydroxycholesterol with




This cell fraction is obtained after removal
of nuclei, cell debris etc., by spinning the sup¬
ernatant at 10,000 x g for 15 min. The mitochon¬
dria are always washed with sucrose and re-sedi-
mented*
(a) In this fraction, 7a-hydroxycholesterol
can be estimated directly by earring out a Lif-
schttts test on the contents of the ether:alcohol
cut from the alumina column. In the presence of
NAD it was found that about 15)! of the 7a-hydroxy-
cholesterol disappeared from an "active'' incuba¬
tion. When no NAD was added, however, about 4$
disappearance could be detected.
Using initiated substrate and estimating the
disappearance by radioactive measurements con¬
firmed this value of approximately 15/' disappear¬
ance In the presence of NAD.
(b) Identification of metabolites
(i) Comparing thin layer plates obtained from
incubations with "boiled" and "active"' tissue with
7a-hydroxycholesterol and added NAD showed that in
the "active" incubation a u.v. absorbing substance
Pig. 21
Photographs of fluorescent thin layer plates,
obtained from incubations of 7<x-hydroxycholesterol
with mitochondria and HAD, illuminated by u.v.
light.
1. Boiled mitochondria, and 10 p moles NAD
2. Mitochondria and 10 p moles HAD
3. Mitochondria, 10 p moles NAD and 3 ml. SP
u.v. absorbing substances?
a) nicotinamide




with a mobility identical with that of cholest-4-
en-3-one-7o-ol was formed (see Fig* 21)* The
substance, when eluted from a plate had an absorp-
tion spectrum identical with that of cholest-4-en-
I 5-one-7a-ol (see Fig* 16), and it also gave a pink
colour when sprayed with phosphotungstic acid*
Incubating labelled 7a-hydroxycholesterol with
mitochondria and N/03 gave rise to labelled product,
confirming that it had been formed from the sub¬
strate and measurement of the amount formed both
by radioactive methods and by reading the absorp¬
tion at 242 mp*, indicated that about 6% was
usually formed* This type of estimation was car—
.
ried out twelve times*
Thus it would seem that mitochondria with
added NAD can also produce cho1est-4-en-3-one-7a—
ol from 7a-hydroxycholesterol, although, from the
same weight of liver the enzyme (or enzymes) is
not as active as the enzyme occurring in micro¬
somes* For example, mitochondria equivalent to
1 g* wet weight of liver when incubated with 7a-
hydroxy cholesterol and 10 p. moles of NAD gave 7%
cholest-4-en-S-one-7a-ol whereas microsomes equiv¬
alent to the stone amount of liver, when incubated
with 7ix-hyclroxycholesterol and 10 p. moles of Bid)
gave rise to 25^' cholest-4-en-3-one-7a-ol*
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(il) As can "be seen from the photograph of the
fluorescent thin layer plates obtained from incub¬
ations with boiled and active tissue Fig. 21),
7-ketocholester-ol is formed in both cases. This
must again be produced by autoxidation and is
formed from 70,-hydroxyeholesterol, as it is
labelled after incubations with labelled substrate
7p-hydroxycho1estero1, in very small quantity was
also seen to be formed autoxidatively.
(iii) No other metabolites could be detected in
incubations with 7a-hyclroxycholesterol and mito¬
chondria with NADf either from a complete radio¬
active analysis of the incubation extract, or by
spraying the plates and comparing with those
obtained from "'boiled** control incubations.
(c) Production of cholest-4-en-d-ono-7a-ol
from ^a-hydroxycliol'cs terpl^studiea under
various conditions
(i) Kffect of varying the substrate concentration
on the production of cholest-4-en-3-one-7a-ol
Incubations were set up containing mitochondria
20 p moles NAD and amounts of 7a—hydroxycholesterol
varying from 50 pg. to 450 pg. The cholest-4-en-
3-one-7a-ol formed in each case was isolated from





the thin layer plates obtained from the incubations
and estimated by reading the absorption at 242 mp
The results are shown in Table 18.
TABLE 18.
Substrate conc. Cholest-4-en-3-one-7a-o:





A graph was drawn of substrate concentration
against the amount of cholest-4-en~3-one~7a-ol
formed per hr. (Pig. 22), and this showed that the
amount of cho1est-4-en-3-one-7a-ol increased
slowly with increasing substrate concentration.
A graph of the reciprocal of the substrate concen¬
tration against the reciprocal of the reaction vel
ocity was constructed and found to be a straight
line which cut the horizontal axis at such a point
as to give a value for the reaction of 3.8 x
ICf3 M. This Kffi value is quite different from
that obtained for the microsomal oxidation of
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7a-hydroxycholesterol to choles t-4-en-3-onc~7a-ol
which would indicate that different enzymes are
involved in the two reactions and that the mito¬
chondrial reaction is not due merely to microsomal
contamination.
1
The values calculated for the graph of s
1
against — are given in Table 19.
TABLE 19
pg* substrate added/
6 ml. 50 180 360 450
p moles/ml. substrate
added 0.021 0.075 0.15 0.188
i/(substrate cone.) 47.6 13.3 6.66 5.32
1/v (pg./hr.) 0.143 0.087 0.068 0.063
(ii) Effect of varying the N/J) concentration on
tHe production or choles't-4-en-3-one-7c.-6T
This experiment has been described later in
this section (e, ii) in connection with the effect
of OF on the metabolism of 7a-hydroxycholesterol
in mitochondria. From the tables and graphs given
there (p. 140 ) it can be seen that the amount of
cholest-4-en-5-one-7a-ol formed depends on the
amount of NAD present in the incubation. The
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amount of cholest-4-en~3-one-7a-ol formed increases
up to about 20 p moles and then the curve flattens
off slightly up to 40 jx moles. These results
show, however, that the enzyme is not satiated
at 10 p moles NAD.
(iii) iffeet of cyanide on enzymie activity
Incubations wei'e set up to discover whether
cyanide had any effect on the production of
eholest-4—en—3~one-7a-ol from 7a-hyo.roxycho1es teroX
Labelled 7c-hydroxycholesterol was incubated with
mitochondria and 10 p moles of HAD, and also with
mitochondria, 10 p moles NAD and 10 p. moles of
potassium cyanide.
The cholest-4~en-3-one-7a-ol formed in each
case was marked on the fluorescent thin layer
plates, elated and estimated both by its absorption
at 242 mp. and by radioactive means.






♦ NAD 4100 6%
b) Mitochondria
+ NAD + cyanide 7750 10$
140 pg. substrate added (70,000 c/m)
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These results ere similer to those obtained
with microsomes, and are equally unexpected. It
was thought that cyanide would probably inhibit
the oxidation reaction, but, in fact, the addition
of cyanide increases the percentage conversion of
7a-hydroxycholesterol to cholest-4~en~3-one-7a-ol
from 6% to lOf• This could be explained if the
cyanide was inhibiting other reactions occurring
in the mitochondria which would normally be using
up added HAD*
Prom the NAD concentration variation experi¬
ment (c, ii), it was found that the enzyme was
not saturated at 10 p. moles NAD and therefore the
explanation for the behaviour of cyanide when
10 p. moles NAD are present is probably valid.
(d) The influence of boiled supernatant
fraction (SF) on the metabolismof"
Tci-hydroxycholes terol.
The preparation of this boiled supernatant
fraction (BP) has been described on p. 38 • As
so much importance has been laid on this BP in
cholesterol metabolism (see Introduction, p.. 20 )
when combined 1 ith mitochondrial preparations, it
was thought to be advantageous to study its effect
on the disappearance of 7a-hydroxycholesterol from
incubations with mitochondria and NAD.
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(i) Effect of BP on disappearance of 7a-hydroxy-
"eholesterol
Incubations were carried out in which the
disappearance of the unlabelled substrate was
estimated by the Lifschtttz reaction as has been
described (p. 309 )• Mitochondria, mitochondria
+ 3 ml. SP, and boiled mitochondria + 3 ml. S.F
were compared, all of these containing added NAD.
The disappearance of 7a-hydroxycholesterol from
boiled mitochondria + SP was about 3 — 5% and
from mitochondria, as has been mentioned above
(p» 124) was 15%. However the disappearance from
active mitochondria + SP increased to 30 + mea¬
sured in fifteen experiments. When this increase
was discovered it was thought that SP had indeed
an effect on the metabolism of 7a-hydroxycholes-
terol, but, at this stage of the work, no meta¬
bolites of any of the cell fractions had been ide¬
ntified, and therefore the way in which SP affected
this increase was not known.
In later studies involving radioactive sub¬
strate, in which a complete radioactive analysis
of the extracts from such incubations was mace, no
increase in any of the metabolites formed when SP
was added could account for this increase in the
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disappearance of 7a-hydroxycholesterol* In fact,
although nearly the total number of counts added
to these incubations could be recovered and
accounted for, from boiled mitochondria + SP and
from active mitochondria, only 85% of the added
counts could be recovered from incubations with
active mitochondria + SP* Every vessel, etc*,
used in the whole procedure was checked for radio¬
activity and the tissue residue was extracted for
6 hr* in a Soxhlet apparatus with ethyl acetate,
and even then 10% of the added counts could not be
*
recovered* The only explanation of this phenome¬
non is that 10% of the counts, either still as 7o-
hydroxycholesterol or as products, must be bound
very firmly to the tissue and that SP plays some
part in this binding* This "binding" phenomenon
is not unknown as Szego (1953), incubating Ci4r-
labelled oestrone with rat serum, cotild only
recover the total counts added, by strong acid
hydrolysis of the protein* Szego and Roberts
(1956) showed that addition of rat liver homogenate
to the serum increased the binding end attributed
this effect to an enzymic mechanism in the liver
tissue, capable of promoting the binding of labelled
oestrone, oestradiol and their metabolites to the
rat serum proteins*
1.33.
Thus, as will be seen in the following pages,
the increase in disappearance of 7a-hydroxycholes<
terol when SP is added to mitochondria is not, as
had been previously thought, due to an increase in
the formation of any metabolite of 7a-hydroxy-
cholesterol.
(ii) Effect of SF on the metabolites formed from
frq-hydro^ycholesterol
When mitochondria, fortified with 10 g moles
of NAD are incubated with 7o,-hydroxycholesterol,
about 6y>> cholest-4-en-3-one-7a-ol is formed, as
has been discussed previously (p.125). However,
on adding 3 ml. of SP to mitochondria, 10 y. moles
of NAD and 7a-hydroxycholesterol only about 8% of
the substrate is converted to cholest-4-en-3-one-
7a-ol. (This has been measured in twelve experi¬
ments. )
By viewing the fluorescent plates obtained
from incubations involving mitochondria and NAD,
and mitochondria, NAD, and SP under the u.v. lamp, (Fig.21)
a u.v. absorbing substance was seen to be formed
in the incubation containing SP. This substance
is slightly more polar in the benzene: ethyl acetate:
acetone system than 7a-hydroxycholesterol having
and Ep value of 0.51, whereas 7a-hydroxycholesterol
has an Rp value of 0.35. On spraying the plate





















Wavelength in mp .
Fig. 23
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with phosphotungstic acid, the substance gives a
pink colour. When eluted from the plate and its
u.v. absorption plotted, (Pig. 23), the substance
was found to have a peak at 240 mg., indicating
that it is probably an a p -unsaturated ketone.
On the basis of its mobility and properties it is
suggested that this substance is a hydroxylated
derivative of cholest-4-en-3~one-7a-ol, and that
it is probably the 26-hydroxylated derivative
(Danielsson, 1961 (e)).
It was not possible to separate this u.v.
absorbing substance completely from 7a-hydroxy-
cholesterol in the benzene:ethyl acetate:acetone
system. It is therefore not possible to estimate
it by radioactive measurements. If, however, it
can be assumed that it has the same extinction co¬
efficient as cholest-4-en-3-one-7a-ol, which is
probable because most
molar
have/extinction co-efficients of about 16,000, it
would be possible to estimate it by its absorption
at 240 mpt. Such estimates showed that about 3$
of the u.v. absorbing substance was formed.
B
. 24
Photographs of thin layer plates, obtained from
incubations of mitochondria with 7c-hycroxycholes-
terol, with no NAD added. The plates were sprayed
with phosphotungstic acid and plate A was run in
benzene:ethyl acetate: acetone (10:5:S) while plate
B was run in benzene:ethyl acetate:acetone:ethanol
(10:5:3:2)
Substances present on plates:





When the two incubations described above were
sprayed it was discovered that a further metabo¬
lite was formed in the incubation with added SF,
This substance gave a blue colour when the plate
was sprayed with phosphotungstic acid, which
would indicate that its structure is very similar
to that of 7cx-hydroxyeho1estero1, It is, however
much more polar that 7a-hydroxycholesterol in the
benzene:ethyl acetate:acetone system, and is also
more polar than the u.v. absorbing substance also
formed in this incubation. From a study of its
mobility and properties it is suggested that the
substance is eholest-4~en-30,7<x-26-triol, i.e.,
the 26-hydroxy1ated deriv tive of 7o-hydroxy-
cholesterol (Danielsson, 1961 (e)). This polar
product has the same mobility as the authentic
cholest-5~en-3j3-7G,26~triol (for synthesis, see
Appendix, p, 307 ) in two thin layer systems.
In benzene:ethyl acetate:acetone (10:5:3) both
the product and the authentic substance have an
Ep value of 0,15, and in benzene:ethyl acetate:
acetone:ethanol (10:5:3:2) they have an Rp value
of 0,78 (Fig, 24), Authentic cholest-4-en-3(3,
7a,26-triol also gives a blue colour with phospho¬
tungstic acid, as does the polar product. It
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therefore seems very probable that the polar pro¬
duct is the 26—hydroxylated derivative of 7a-hy¬
droxycholesterol.
Y/hen labelled 7<x~hydroxycholesterol was used
as substrate this metabolite was produced labelled
and usually 3-4$ was formed in incubations with
mitochondria, NAD, and SP. This was measured in
twelve experiments.
On some occasions a further metabolite can be
seen in such incubations in minute quantities.
This substance has a mobility which causes it, in
the bensene:ethyl acetate:acetone system, to run
between the cholest-4-en-30,7a,26-triol and the
cholest~4-ei>"3-one-7a,26-diol. It also gives a
blue colour when sprayed with phosphotungstic
acid, indicating that it has a structure similar
to that of 7c,-hydroxycholesterol.
In any further discussion of the two polar
me tabo1ites cholest-4-en-3-one-7a,26-dio1
and cholest-5-en~3p,7a,26-trlol mentioned above
they v/ill be referred to as "polar u.v. absorbing
substance" and ,rtriol"' respectively.
7-ketocholesterol was formed from 7a-hydroxy-
cholesterol in incubations with mitochondria, NAD
and SP, to the same extent as in incubations with
CHjOH







CHOLEST,4- EN-3-ONE -7»C- OL
EFFECT OF S.F. ON THE METABOLISM OF 7* HYDROXYCHOLESTEROL IN MITOCHONDRIA
Figure 25
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mitochondria and NAD, and as it is formed also in
the boiled control incubation it again must be
produced non-enzynically.
On running the concentrated ether cuts from
the alumina columns from incubations with mito¬
chondria, NAD and SP, the same substance as was
formed in incubations with supernatant fraction
and 7a-hydroxycholesterol was produced, i.e., an
ester of 7a-hydroxycholesterol. This substance
was found to be labelled when labelled 7a-hydroxy-
cholesterol was used, and usually about 3;! was
formed. Very occasionally this ester is produced
when 7a-hydroxycholesterol is incubated with mito¬
chondria and NAD, but it always seems to be formed
when BP is added to the mitochondria.
The diagram (Pig. 25) summarises the metabo¬
lites which are formed enzymically when 7<x-hydroxy-
cholecterol 5s incubated with mitochondria and
mitochondria + SP, NAD having been added to both
these fractions.
Thus, when SP is added to an incubation with
mitochondria and NAD, the amount of cholest-4-en-
3-one-7o:-ol is decreased to less than half that,
which would have been formed if no SP was present.
138
At least two (and probably three) further meta¬
bolites of 7a-hydroxycholesterol are produced by
introducing SF, and as these are probably hydroxy-*
lated derivatives, it may be that SP plays some
part in the complicated mechanism of hydroxy-
lation. 7a-hydroxycholesterol ester may be pro¬
duced on addition of SP because of the consequent
addition of free fatty acids, or perhaps acyl co-
ensyme A esters#
The increase in disappearance of 7a-hydroxy-
cholesterol from incubations on the addition of
SP, as discussed in (d, i) cannot be accounted for
by these differences in the metabolites produced#
On a radioactive analysis, the percentage of 7a-
hydroxycholesterol converted to metabolites in
incubations with mitochondria and NAD and with
mitochondria, NAD and SP, is almost the same#
The amount of cholest-4-en-3-one-7a-ol formed in
the first type of incubation is about 6%, whereas
in the second type of incubation addition of the
amounts of cholest-4-en-3-one-7a-ol,triol and u#v.
absorbing material formed also equals about 6 -
If ester is produced in the latter type of incuba¬
tion it will only account for 2$ of the added 7a-
hyaroxycholesterol#
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Thus the Iff' difference found between the
disappearance of 7a-hydroxycholesterol when incub¬
ated with mitochondria and NAD and with mitochon¬
dria, NAD and SF, cannot be due to an increase in
the formation of any metabolite but must be due
to binding of the 7a-hydroxycholesterol or metabo¬
lites, promoted by SF, to the tissue.
Attempt to discover the mechanism of the
influence exerted by~s¥ 'o"n the metabolism
of ~^a-hydro'xycholesterol' in mitnchonrTria" *
In the previous Section the effect of adding
SF to an incubation containing mitochondria, NAD
and 7d-hydroxy cholesterol has been discussed. It
seems that SF somehow "directs" the metabolism of
7a—hydroxycholesterol so that hydroxylation rather
than oxidation reactions are favoured.
(i) Incubation of 7a-hydroxychoIesterol with mito¬
chondria. ' - no added NAD
Incubations were set up with mitochondria and
7a-hydroxychoIesterol with no additions except
buffer, magnesium sulphate and nicotinamide, i.e.,
no HAD was added at all. When the thin layer
plates obtained from such incubations were examined
under the u.v. lamp, no cholest-4-en-3-one-7a-ol
was detected. 7-ketocholesterol was seen, but no







Photographs of thin layer plates, sprayed with
phosphomolybdic acid.
1. Plate obtained from an incubation of
7a-hydroxycholesterol with mitochondria and NAD,
2. Plate obtained from an incubation of
7a-hydroxycholesterol with mitochondria, with
no NAD added.






the plates were sprayed with phosphotungstic acid*
it was seen that cholest-5-en-3f5,7<x,26-triol had
been formed (Fig. 26). This was labelled when
labelled substrate was used, ahowing that it had
been produced from the substrate.
These results show that if no HAD is added
to incubations with mitochondria and 7a-hydroxy-
cholesterol, hydroxylation of 7a-hydroxycholestercil
occurs and no oxidation reactions take place.
This situation, then, is similar to an extreme
case of adding SF to mitochondria and HAD, when
hydroxylation is favoured in place of oxidation.
It would seem, therefore, that bF is exerting at
least part of its influence by depleting in some
way the added Hid) so that the latter is no longer
available for the oxidation of 7a-hydroxycholest¬
erol to eholest-4—en-3-one~7a-ol» Thus, hydroxy¬
lation becomes the favoured reaction. To test
this hypothesis incubations were carried out in
which mitochondria were incubated with 7a-hydroxy-
choleeterol in the presence of increasing amounts
of HAD
(ii) Incubations of 7o.-hydro;Qrcholesterol with
mitochondria - increasing HA'!) ~concVntration
Six incubations were set up each containing
mitochondria and 7a-hydroxycholesterol (unlabelled]
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and the NAD concentration was varied from zero
to 50 p. moles NAD per 6 ml. of incubation mixture*
Am incubation containing mitochondria, 10 ju, moles
NAD and SF was also included* The thin layer
plates obtained were viewed under the u*v* lamp
and the cholest-4-en-5-one-7o-o1 formed was marked
eluted from the plates and estimated by its
absorption at 242 mg, The plates were then
sprayed* Table 21 shows that the amount of
cholest-4-en-3-one-7a~ol appearing per hr* is
dependent on the NAD concentration. Judging the
amount of triol formed by eye, it can be seen that
as the NAD concentration increases the amount of
triol formed decreases. Thus a considerable
amount of triol was present at 2*5 u moles NAD,
and only a trace at 5 p moles NAD*
This mitochondrial preparation seemed to be
rather inactive at producing cholest-4-en-3-one-
Vci-ol. For example, when 10 g moles NAD was
added only 3 ig. cholest-4—en-3-one-7a-ol was
formed* Usually in such a preparation this
value is about 10 jj,g* However, this preparation
seemed to be very active at producing the triol*
The incubation which contained SF and 10 p moles
NAD produced triol, the polar u.v* absorbing sub¬





























































































The experiment was repeated using labelled
substrate. In this case the cholest-4~en-3-on.e-
7<x—ol formed and the triol formed were estimated
by radioactive means. Prom Table 21 and the
accompanying graph (l ig, 27) it can be seen that
as the NAD concentration increases, the amount of
triol formed decreases and the amount of cholest-
4—en-3-one-7ci-ol formed increases, confirming the
results of the above experiment. The values
in this experiment are more typical than those in
the one described above.
These results, therefore, support the hypo¬
thesis that 8F may act by depleting the added NAD
available for the oxidation reaction. These
results do not explain, however, how or why the
polar u,v, absorbing substance is formed when SP
is added to mitochondria and NAD,
The difference in apparent 30-hydroxy dehy¬
drogenase and isomerase activity in the two exper¬
iments .just described can be explained if the
levels of endogenous NAD in the mitochondria when
prepared were different. If the NAD concentra¬
tion in the mitochondria used in the first expert-*
ment were much lower than normal it follows that
more NAD has to be added to these mitochondria
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than to the "normal" mitochondria in the second
experiment to obtain the same degree of oxidation
of 7a-hydroxycholesterol.
- -
(iii) Incubation of 7a>ho/dreKycholesterol with mito¬
chondria and IfADi Succinate "concentration
varied
If the hypothesis that SP exerts part of its
influence by "inactivating" NAD is correct, then
it is possible that it does so by reducing the
added NAD to NADH. This would agree with the
apparent direction by SP towards hydroxylation
reactions, as the NADH so formed could, be con¬
verted. by a transhydrogenase to NADPH, which
seems to be essential for most hydroxylation
reactions.
Recent work by Chance (1956), Slater and
Htlsmann.(1959) and Snoswell (1962) has aroused
interest in the possibility that dicarboxylic
acids such as succinic acid, may control the ratio
of NAD to NADH in the living mitochondrion. In
fact, they have shown that succinate reduces NAD
to NADH more efficiently than do the conventional
NAD-lihked Krebs cycle acids, such as malate.
This is a different reaction from the normal Krebs
cycle oxidation of succinate to furmirate, which is
FAD-linked.
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It was therefore decided to try adding suc¬
cinate to incubations vdth mitochondria, NAD and
7a-hydroxycholesterol in place of SF, to discover
whether succinate had the same effect as SF.
In a preliminary experiment, incubations were
set up comparing mitochondria + 10 g moles NAD,
mitochondria + 10 g moles NAD + SF, mitochondria
+ 10 g moles NAD + 36 g moles succinate, and
mitochondria with no additions. On examining
the thin layer plates it was seen that:-
(a) mitochondria + NAD produced only cholest-
-4-en-3-one-7a-o1;
(b) mitochondria + NAD + SF produced less
cholest-4-en-3-one-7a-ol, but also
produced triol and polar u.v. absorbing
substance;
(c) mitochondria + NAD + succinate also pro¬
duced less cholest-4-en-5-one~7a-ol but
also produced triol and u.v. absorbing
substance;
(d) mitochondria alone produced only triol
Thus it would seem that succinate can indeed
mimic the effect of SF.
In order to investigate this matter more
closely an experiment was set up using labelled
substrate and incubating it with mitochondria +
10 g moles NAD and varying succinate concentra-
Pig. 28
Photograph of a thin layer plate, sprayed
with phosphotungstic acid. Choiest-5-en-3p ,7a,
26—triol isolated from incrabations of mitochondria
with 7a~hydroxycholerol, 10 ji moles NAD and suc¬
cinate, re-run in benzene:ethyl acetate:acetone.
1. 7.2 p moles succinate
2. 36 p. moles succinate
EFFECT OF ADDING SUCCINATE
TO MITOCHONDRIA+10 JJLMOLES NAD
CHOLEST-5-EN -
3 B, 7^,26 ?—TRIOL
O 20 40 60 SO
MMOLES SUCCINATE ADDED TO
INCUBATION MIXTURE.
EFFECT OF ADDING SF TO MITOCHONDRIA +
IO MMOLES NAD
. CHOLEST— 5—EN -'
3 B, 7at. 26 ?—TRIOL
-jxx.




tion. Using mitochondria from the same prepara¬
tion, incubations were set up with mitochondria +
10 u moles NAD and with varying amounts of SP
added* The cholest-4-en-3-one-7a-ol formed in
each case was estimated by eluting it from the
plates and reading its absorption at 242 mg.»
after which it was also estimated by radioactive
means. The triol formed was also eluted from
the plates, an aliquot part taken for counting,
and the rest re-run on thin layer plates in the
benzene:ethyl acetate:acetone system. The plate©
were sprayed and then photographed in order to
identify the triol, (Fig. 28)
Prom Table 22 and the accompanying graph
(Pig. 29) it can be seen that adding a small
amount of succinate (3.6 g moles) gives a large
degrease in the amount of chol st-4—en-3-one-7a-ol
formed and an increase in the amount of triol
produced. The amount of triol formed increases
slightly after the initial sharp increase as suc¬
cinate concentration increases and the amount of
cholest»4-en-3-one~7a-ol formed decreases slightly.
The curves obtained by plotting increasing
amounts of DP against, in the first instance, the
























































































secondly the amount of triol formed, were of the
same shape as those given "by increasing succinate
concentration.
The polar u.v. absorbing substance was formed
in all incubations containing mitochondria, NAD
and either SP or succinate, but was not formed
in those containing mitochondria and NAD.
These results confirm those found in the pre¬
liminary experiment involving succinate end show
that succinate has the same effect on triol for¬
mation, or direction of the reaction to?;ards
hydroxylation, as SP. This would indicate that
SP is exerting its influence by depleting added
NAD by reduction to NADH, but this does not mean
that SP is necessarily succinate, although succ¬
inate does exist in the supernatant fraction of
rat liver and is thermostable. Experiments
performed later and described on pages 1-59-161
show that SP is probably not succinate.
(iv) Effect of various dicarboxylic acids on the
metabolisRr^oF^afhydr¥xychol'es"terol iff"mito¬
chondria with added NAD
If the hypothesis that succinate and SP direct
the metabolism of 7a-hydroxycholesterol towards
hydroxylation by reducing added NAD to NADH is
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correct, other citric acid cycle intermediates
should have the same effect. For example, fum-
arate should have a similar effect to succinate,
but maleate (the eis-isomer of fumarate) should
not.
(a) An experiment was set up to compare the
effect of adding succinate, fumarate and maleate
to mitochondria and HAD with labelled 7a-hydroxy-
cholesterol as substrate. The c ho lest-4-en-3-
one-7a-ol formed in each case was isolated by
elution from thin layer plates and estimatedby
the absorption at 242 rap. and by radioactive
means. The amount of triol formed in each case
was also determined by radioactive methods, ar
aliquot part being re-run on thin layer plates to





10 p moles NAD
ii.As i + 78 p moles
succinate
ili.As i + 72 p moles
fumarate














(14-0 pg. substrate - 70,000 c/m, added)
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It is thus seen that fumarate has the same effect
as succinate when added to mitochondria + NAD,
i.e., it lowers the amount of cholest-4—en-5-one-
7a-ol formed and gives rise to triol formation.
Fumarate, although not an R/D-linked- substrate, .
must be stimulating the removal of NAD by the
citric acid cycle. Maleate, on the other hand,
has no "succinate-like" activity, which would be
expected as it is not a citric acid cycle inter¬
mediate.
(b) A further experiment was carried out
similar to that above, in order to compare the
effect of adding SF, oxaloacetate and citrate to
mitochondria, NAD, and 7<x-hydroxycholesterol.
An incubation with unwashed mitochondria and NAD
was also included. The experiment was carried







10 p. moles NAD 3570
206011. As i + 3 ml. SF 1400
ifuAs i + 72 (x moles
oxaloscetate 1630 1700
iv.As i + 72 g moles
citrate 1230 3300
v . Unwashed mi to chon-
dria + 10 gmoles NAD 5000
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These results show that both oxaloacetate and
citrate have the same effect on the metabolism
of 7a-hydroxycholesterol in mitochondria as SP
or succinate. In other words, adding citrate
or oxaloacetate gives rise to less cholest-4-en-
3-one-7a-ol than would be formed without these
acids, and also triol and the "u.v. absorbing
material" are formed. Citrate seems to be part¬
icularly active in this respect. Comparing un¬
washed and washed mitochondria with added NAD,
shows that more cholest-4-en-3-one~7a—ol (7%) is
formed in incubations of 7a-hydroxycholesterol
with unwashed mitochondria, than is formed in
washed mitochondria (5; )• This fact is probably
due to less endogenous NAD being present in
washed mitochondria, some having been dialysed
out during the washing procedure.
(c) A further experiment was carried out,
similar to those described above, to compare the
effect of adding SP, succinate, malonate, a-keto-
glutarate and dihyciroxyfumarate to incubations of
7o,-hydroxycholesterol with mitochondria and HAD.
The results are shown in Table 25.
Incubation
i. Mitochondria +
10 p. moi s NAD
lUAs i + 3 ml* SP
iUUAs i + 72 \x moles
succinate
iv.As i + 72 ix moles
malonate
v, As i + 72 p moles
c~ke toglutarate



















These results are atypical, because, in this
experiment, the mitochondria were not washed with
sucrose. Thus, the amount of cholest-4-en-3-one-
7o..-ol formed in mitochondria + NAD is higher than
usual, due to the fact that probably more endo¬
genous NAD was present (see Table 24 ). SP,
however, has its usual activity in lowering the
amount of cholest-4-en-3-one-7a-ol formed, but
very little triol, if any, is produced. The
counting results for the triol formation could
not be confirmed by running an aliquot on thin
layer plates. Succinate and a-ketoglutarate are
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seen to have the same effect as SF. Malonate
and dihydroxyfumarate, however, exert no such
effect and, in fact, give rise to more eholest-4-
en-3-one-7o-ol than mitochondria and HAD.
The results of these three experiments
strengthen the theory that 3F has its effect
partially "by depleting the added HAD. The di-
carhoxylic acids and the tricarboxylic acid,
citrate, having the same effect as SF are all
citric acid cycle intermediates, (i.e. succinate,
fumarate, a-ketoglutarate and oxaloacetate) and
all stimulate the removal of NAD as NADH whereas
the dicarboxylic acids having no effect are
closely related acids, but are not citric acid
cycle intermediates. The fact that malonate and
dihydroxyfumarate actually stimulate the formation
of cholest-4~en-3-one-7a-ol from 7a-hydroxycholes¬
terol can be explained if these acids are inhibit¬
ing the normal functioning of the citric acid
cycle, thus making more NAD "available" for reac-
ti on.
Incubations were carried out in order to
compare the effect of NAD + SF and NADH on the
various reactions involving 7c,-hydroxycholesterol
in mitochondria. It was found that NADH has
1 2
Fig. 30
Photograph of a thin layer plate obtained
from incubations of 7a-hydroxycholesterol with
mitochondria, sprayed with phosphotungstic acid.
1. Mitochondria and 7a-hydroxycholesterol
with no NAD added
2m Mitochondria, 3 ml. SF, and 7a-hydroxy-
cholesterol, with no NAD added.






exactly the same effect as NAD + SF. Ill both
cases, the amount of eholest-4-en~3~one-7a~ol
4-
.
formed was considerably less than that produced
by mitochondria and NAD, and triol and the "t»r,
absorbing material" were also formed.
This evidence is further support for the theory
that SF exerts an effect by reducing NAD to NADili,
(v) Incubations of 7a-hydroxycholesterol with mito¬
chondria wi th "no added "NAD but varying the
amount oir bF added.
It had been noticed in previous experiments
that the amount of triol formed when mitochondria
alone were incubated with 7c~hyaroxycholesterol
was always less than the amount formed when SF
was added to incubations with mitochondria and
NAD (see Fig, 50), It therefore seemed possible
that SF not only reduces the NAD to NADH but also
in some way "stimulates" hydroxylation.
An experiment was therefore carried out in
which mitochondria were incubated with 7a-hydroxy-
cholesterol without any added NAD and with varying
amounts of added SF, Labelled substrate was used.
The triol formed in each case was eluted from the
thin layer plates, an aliquot part taken for
counting and the rest re-run on thin layer plates
5, 000










ml. SF added to incubation mixture
Graph of succinate added plotted against





1, 000 . cholesterol with mitochondria
(no added NAD)
25 50 75




sua sprayed with phosphotungstie acid to identify
the triol#
Prom Table 26 and the accompanying graph
(Fig. 31) it is seen that the amount of triol
formed does in fact increase as the amount of SF
added to the incubation is increased* (As no






Mitochondria + G»5 ml. SF 3700
Mitochondria + 1.5 ml. SF 4500
Mitochondria + 3 ml. SF 4200
(140 pg. substrate (70,000 c/m) added)
This increase in triol formation could be
explained in two ways: either (a) the SF is
"stimulating" hydroxylation or(b) the SF is
reducing any endogenous NAD present.
If, as has been suggested, the reason that
triol is formed is because less cholest-4-en-5-
one-7a-ol is produced, the second explanation is
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not a very likely one. In the last experiment
no cho1est-4-en-3-one-7a-o1 was produced, which
would indicate that the concentration of en&o-
genous NAD is not sufficiently high for the reac¬
tion to occur.
(vi) Incubations of 7a-hydroxycholesterol with
mITochondria with ho "and"varying
the succinate 'con cen trati'on
In section e (v) it was seen that with no
added HAD, SP stimulated in some way the formation
of triol. It was therefore of interest to dis¬
cover whether succinate could replace SP In this
respect as well as in incubations where NAD was
included.
An experiment similar to that discussed in
e (v) was set up, but in this case succinate was
added in varying amounts (zero to 72 \x moles)
instead of SP. Labelled 7a-hydroxycholesterol
was used and the triol formed in each case esti¬
mated by radioactive means. The results are





Mitochondria + 7.2 n moles succinate 2300
Mitochondria + 36 fj. moles succinate 2390
Mitochondria + 72 p moles succinate 2120
157.
These results show that when varying amounts
of succinate are added to mitochondria and 7a-
hydroxycholesterol no increase in the amounts of
triol formed can be detected. Thus succinate,
unlike SF, does not stimulate triol formation,
but only acts by depleting the added HAD.
(vii) Substitution of NADP for HAD in incubations
of 7a-hydroxycholeste~r'ol with mitochondria
Incubations v/ere set up to compare the effect
of N.ADP with that of HAD on the oxidation reaction
occurring in mitochondria when 7a-hyoroxycho1es-
terol is converted to cholest-4-en-3-one-7a-ol
as follows:-
(a) Mitochondria + 10 p moles NAD
(b) Mitochondria + 5 (/ moles HADP
(c) Mitochondria + 10 p moles NADP
(d) Mitochondria + 10 p. moles NADP •+ SF
The thin layer plates obtained from these
incubations were viewed under the u.v. lamp and
the choles t—4—en—5-one—7a-ol which had been
formed was marked, eluted, and estimated in each
case by its absorption at 242 mp. The remaining
part of each plate was sprayed with phosphotung-
stic acid. The results of this experiment are
summarised in tne following Table.
Incubation


























These results shc?»ed that NADP could partialiy
replace NAD as co-factor in the oxidation reac¬
tion, Thus 10 p moles NADP gave only half the
amount of cholest-4-en-3-one-7a-ol given by 10
p moles NAD, The formation of cholest—i-en-5-
one-7a-ol depended on the amount of NADP present;
thus 5 p moles gave less product than 10 p moles,
and at 5 p moles NADP a trace of triol and polar
u,v, absorbing substance could be detected. In
incubations with NADP and GF (as with NAD v 8P)
no cholest-4-en-3-one-7a-o1 was formed, but triol
and u,v, absorbing substance were produced.
It can therefore be concluded that NADP
behaves in the same way as NAD in these reactions
althoiigh it is not so efficient as acting as
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co-factor for the oxidation of 7<x-hydroxycholes-
terol to cholest-4-en-3-one-7a-ol.
(viii) The stability of SF to pH changes
In order to obtain eorae information about the
nature of SP it was decided to treat it with aci
and alkali at 100°C. If SP is a dicarboxylic
acid this treatment should make no difference to
its effect on the metabolism of 7c.~hydroxycholes-*
terol. If, on the other hand, a phosphate ester
or similar substance, such as ATP, is involved,
this treatment would bring about hydrolysis,
especially under alkaline conditions.
SP was treated in three ways:-
(i) Hydrochloric acid was added to the SP
(3 ml.) which was then heated for 5 min. at 100°0.
The SP was then neutralised with alkali (sodium
hydroxide).
(ii) Sodium hydroxide was added to the SP,
which was then heated as in (i). The solution
turned bright yellow. It was then neutralised
by adding hydrochloric acid.
(iii) The amount of sodium chloride formed
by the above treatment was calculated, and this
amount added in the appropriate volume of water
to a further 3 ml. of SP.
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Incubations were set up as follows:-
(a) Mitochondria + NAD + BP,
(b) Mitochondria + NAD,
(c) Mitochondria + NAD + acid-treated BP,
(d) Mitochondria + NAD + alkali-treated BP,
(e) Mitochondria + NAD + sodium chloride-
treated SP
Using labelled substrate, the cholest-4—en-
3-one-7a-ol and the triol produced were estimated
as in previous experiments. The results are





a) NAD 4- BP 920
b) NAD 3430
c) NAD + "acid-SF" 1610
d) NAD + "alkali-BP" 3900







From these results it can be eeenr
(1) that adding sodium chloride has no effect on
the activity of the SP, which reduces the amount
of cholest-4-en~3-one-7a-ol that would have been
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formed if CP had heen absent (see b) and which
gives rise to triol}
(2) that "acid treated" CP does not seem to be
quite as active as untreated SF, although triol
is produced and the amount of cholest-4-en-3-one-
7o-ol is reducedj
(3) that "alkali-treated" SP on the other hand,
seems to be completely laoking in the typical SP
activity.
It would therefore seem that SP cannot be
only succinate, or some citric acid cycle inter¬
mediate, but that its activity may depend on the
presence of a hydrolysable substance such as ATP.
(ix) Incubations with an acetone powder of mito¬
chondria
An acetone powder of mitochondria was prep¬
ared as described on p. 39 # Incubations with
native mitochondria from the same rat were shown
to be quite normal, i.e., when SP was added to
mitochondria and NAD, a small amount of cholest-
4-en-5-one-7a-ol was formed as well as triol and
u.v. absorbing substances.
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Incubations were carried out with acetone
powder, dissolved in buffer, with 7a-hydroxychol-
esterol and NAD and with sibstrate, NAD, and SF.
The cholest-4-en-3-one7a-ol produced in each case
was estimated by radioactive means, and the remain
der of the plates sprayed.
The results are shown in the Table below.
Incubation cholest-4-en—3- Triol u.v





der + NAD 4550
Acetone pow¬
der + NAD + SF 1700
It is thus seen that no hydroxylation appar¬
ently takes place, so that an acetone powder of
mitochondria does not behave like native mito¬
chondria in this respect. However, the addition
of SF does decrease the amount of cholest-4-en-3-
one-7o—ol formed, as it does with native mito¬
chondria. The 3(3-hydroxy dehydrogenase and iso-
merase activity of the mitochondria is not impaired
by the acetone treatment.
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(x) Effect of hydroperoxide of llnoleic acid
It has been mentioned in the Introduction
that hydroxylatiori reactions might involve a
hydroperoxide, as an oxygen donor. It seems
feasible, also, that the hydroperoxide of linoleic
acid might play a role in the hydroxylation of
cholesterol and related sterols. It was there¬
fore decided to find out whether potassium lino-




Two methods are available for the formation
of this substance from methyl linoleate or the
potassium salt of linoleic acid.
(i) The plant enzyme, lipoxidase, very readily
converts potassium (or sodium) linoleate to the
hydroperoxide. 1 ml. of solution of metl^l lino¬
leate was hydrolysed for 1 hr. under nitrogen with
1 ml. alcoholic potassium (or sodium) hydroxide.
The ethanol was removed in vacuo and potassium
hydrogen phosphate was added until the solution
was pH 7.4. The potassium linoleate was used in
this form in some incubations. The solution was
made alkaline, pH 9.0, and was used as a substrate
for the lipoxidase enzyme in buffer. As the
164,
hydroperoxide has an absorption peak at 250 mp,
the formation of this substance could be followed
by allowing the reaction to occur at room tempera-
ture in a cell of the recording spectrophotometer,
(ii) The hydroperoxide of linoleatscan be
produced by the method of Banks, Fazakerley, Keay
and Smith (1959), 1 ml, methyl linoleate was dis¬
solved in petrol ether, and shaken with 8($> meth¬
anol: water j oxygen 95;.':: C0S 5% was bubbled through
the solution for three hours, the peroxide being
extracted into the methanol layer as it was
formed,- The methanol layer was concentrated
until it was a white oil. This oil, when tested
with potassium iodide and acetic acid, liberated
iodine, indicating the presence of the hydropero¬
xide,
a) Incubations were set up to discover whether
potassium linoleate or the hydroperoxide (formed
by the action of lipoxidase) could replace SF in
incubations of 7c-hydroxycholesterol with mitochon¬
dria and 10 p moles HAD, The cholest-4-en-3-one-
7a-ol was isolated in each incubation by elution
from the thin layer plates and estimated by the
absorption at 242 mp, and by radioactive means.
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The triol formed was estimated "by eluting and
counting an aliquot part of the eluate. The
triol was identified by re-running on thin layer
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In incubations d) and f) a polar u.v. absorb¬
ing material was seen to be formed, with a mobility
similar to that of the triol. It was therefore
more polar than the "polar u.v. absorbing material"
suspected to be cholest-4-en-3-one-7a,26-diol.
This material may have given rise to the 1700 c/m
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found in incubation d). By chromatography no
triol was seen to he formed.
As can he seen, the presence of neither lino-
lea te nor the hydroperoxide affects the formation
of cholest-4~en-5-one-7a-ol, whereas SP reduces
the amount formed by half. Also linoleate and
the hydroperoxide cannot give rise to triol. Thus,
neither linoleate or its hydroperoxide can replace
SF.
b) Incubations of 7a-hydroxycholesterol with an
acetone powder of mitochondria, with added NAD,
showed that addition of SP lowered the amount of
cholest-4-en-3-one-7a-ol formed but did not give
rise to triol. This would indicate that either
the hydroxylating system is inactivated by the
acetone treatment or that the acetone has extracted
some material necessary for hydroxylation. An
experiment was carried out to find out if the
hydroperoxide of linoleate, made by the method of
Banks, et al. (1959) eouia give the acetone powder
the power to hydroxyl&te 7a-hydroxycholesterol.
Incubations were set up containing a buffer
solution of an acetone powder of mitochondria
10 p moles NAD and varylhg amounts of hydroperoxide
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where 0.1 ml. of the aqueous solution was theore¬
tically sufficient to provide enough oxygen to
hydroxylate 7a-hydroxycholestero1. (This was
estimated "by titration with potassium iodide and
thiosulphate).
The cholest~4-en~5-orre-7a-ol was isolated and
estimated "by radioactive means. The plates were





10 p. moles NAD)
i)Acetone powder
ii)As i + 0.1 ml.
peroxide
jBi)Ae i + 0.2 ml.
peroxide
iv)As i + 0.5 ml.
peroxide









Thus* the peroxide cannot give an acetone powder
of mitochondria the power to hydroxylate 7a-hydro-
xycholesterol. However* the amount of cholest-4-
en-7o-el formed decreases as the amount of peroxide











MITOCHONDRIA + 10 pmoles NAD 6% -
+ 50 umoles NAD 11% "
MITOCHONDRIA + 10 pmoles NAD
'
+ SF 2% 4%
MITOCHONDRIA + SF - 6%
( NO NAD ADDED)
MITOCHONDRIA + 10 pmoles NAD
+ 10 umoles CYANIDE 10% "
MITOCHONDRIA + 10 pmoles NAD
+ 72 pmoles SUCCINATE " 6%
ACETONE POWDER OF
MITOCHONDRIA + 10 pmoles NAD 7% -
ACETONE POWDER + 10 pmoles NAD
+ SF 2% "
Pig. 32
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that occurring when EP is added# Ac this lower¬
ing of the amount of product formed does not
happen when native mitochondria are used, it is
thought that the pero;:ide must be inhibiting the
acetone powder enzyme# It may be that in native
mitochondria, the hydroperoxide is rapidly metabo¬
lised.
The Table shown in Pig# 32 summarises the
results obtained, from incubations of mitochondria
with 7a-hyciroxycholestemJLstudied under various
conditions#
(xi) Formation of polar u#v# absorbing substance
In many incubations carried out with mito¬
chondria and 7a-hydroxycholesterol under various
conditions it has been noted that the polar u.v#
absorbing substance is only formed in those cases
when triol is also produced, and co-factor is
present# For example, the substance is formed in
the following types of incubations-
(a) Mitochondria + NAD (or NADP) + SF
(1>) Mitochondria + succinate + NAD;
(c) Mitochondria + NADH;
(d) Mitochondria + 6 p. moles HAD (in this
case the HAD concentration was low enou^i
for triol to be produced; see p# 141 ).
Figure 33
PhD Thesis Digitisation Project
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The polar u.v. absorbing substance is not,
however, formed in the following types of incuba¬
tion:-
(a) Mitochondria alone (triol is formed in
this case)
(b) Mitochondria + SP (triol is formed in
this case)
(c) Mitochondria + 10 p moles NAD
This u.v. absorbing substance, if it is
indeed cholest-4-en-5-one~7a,26-diol, could be
formed by two routes
(i) by hydroxylation of cholest-4—en-5-one—
7a-ol (this reaction does occur in mito¬
chondria and will be discussed in the
Section on the metabolism of cholest-4-
en-3-one-7a-ol, p. 196 )
(ii) by oxidation of the triol
The two routes are shown in Pig. 33.
If it were formed by hydroxylation of
cholest-4—en-5-one~7o*o1 it would be expected that
more of it would be produced when more cholest-4—
en—3-Oiie-7a-ol was formed, such as when mitochon¬
dria were incubated with large amounts of NAD (20
- 40 p moles). This, however, is not the case,
as no polar u.v. substance is formed.under these
conditions.
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It would seem that NAD or NADP is also requi¬
red for its production, even if triol is formed,
because mitochondria with no added NAD cannot give
rise to the u.v. absorbing substance, although
capable of producing triol. Thus it is probable
that route (ii) is the correct one, and that the
substance is formed by the oxidation of the triol
for which presumably NAD or NADP is required. In
the cases where SP or succinate are added to mito¬
chondria ♦ NAD and are thought to deplete the NAD
It must be assumed that nevertheless sufficient
is available for the oxidation of the triol to
produce the polar u.v. absorbing substance.
Incubations with cholest-5-en-3ft,7a,26-trlol as
substrate
Pour incubations were set up with authentic
cholest-5-en-3p,7a,26-tricl as substrate (about
20 M-g.) in the following way
a) Mitochondria
t) Mitochondria + 10 jj, moles NAD
c) Microsomes
d) Microsomes + 10 moles NAD
Comparing the fluorescent thin layer plates
obtained from these incubations by viewing them
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tinder the ultra-violet lamp showed that in incuba¬
tion b) a u.v. absorbing substance with the same
■
mobility in the benzene:ethyl acetate:acetone
system (Rp = 0,31) as the u.v, absorbing material
obtained from incubations of 7c—hyeroxycholesterol
with mitochondria, NAD and SP, was formed. No
such substance was seen to be produced in incuba¬
tion a). Therefore, mitochondria, on addition of
NAD, can convert the triol to the "polar u,v, ab¬
sorbing material" and presumably this is an oxida¬
tion., reaction as it does not occur in the absence
Of NAD,
I
These results strengthen the theory described
above, accounting for the formation of the "polar
u.v, absorbing material" on incubation of 7a-
hydroxycholesterol with mitochondria, NAD and SF,
by an oxidation of the triol (see route (l),
Pig, 35) rather than by hycroxylation of cholest-
4-en-3-one-7a-ol, The identify of this "polar
u.v, absorbing material" has been suggested to be
eholest-4-en-3-one-7a,26-diol (p. 134) and the
fact that it is found to be formed both by oxida¬
tion of the rriol and by hydroxylation of cholest-
4-en-5-one~7c-ol (see later, p, 196), greatly
supports this suggestion.
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A comparison of the plates obtained from
incubations c) and d) showed that the u.v, absorb-t¬
ing material was produced from triol in both
cases, although oiiya trace amount was seen in
incubation c) which contained no NAD. Thus
microsomes, particularly on addition of NAD, can
: '
also convert triol to the "polar u.v. absorbing
material". This is not surprising as the micro-
scmeshliave been found to convert 7a-liydroxycho1es-
terol to the oxidised compound, cliolost-4-on-3-one-
7a~ol very efficiently in an analogous reaction
and probably the same enzyme system is involved in
the oxidation of the triol.
5. IDENTIFICATION OF TB3 METABOLITES PRODUCED ON
INCUBATING 7a—HYDROXYCHOLESTBRPL WITH MICRO-
SOKES + SUPBRNAMT AND MICROSOMES + SF
This subject is discussed here instead of
in its more logical place after pj.04 because
firstly the study was conducted after the work on
mitochondria had been carried out, and secondly it
is hoped that the discussion will be clearer if
presented in this order.
Pig, 34
Photography of fluorescent plate, illuminated
by u,v, light# Plate obtained from an incubation
of microsomes + supernatant v/ith 7c,-hydroxy-
cholesterol and NAD
u.v, absorbing substances: —
a) nicotinamide




A. Microsomes 4 supernatant v/lth added NAD
Experiments were performed to compare the
metabolites produced on incubation of 7a-hyaroxy-
cholesterol with microsomes + supernatant and with
boiled microsomes + supernatant. 10 p. moles NAD
was added to each incubation. The steroids were
extracted and separated after incubation in the
usual way, and the thin layer plates obtained were
viewed under the u.v. lamp. As can be seen from
the photograph (Pig. 34), three u.v. absorbing
substances were formed in the active tissue incub¬
ation and only one in the boiled tissue control.
(a) The least polar substance formed in active
tissue has the same Hp value (0.66) as cholest—4—
en-3~one-7a-ol in the benzenes ethyl acetate; ace¬
tone system. It also has an absorption spectrum
identical with that of this substance with a. peak
at 242 mp. Cholest-4-en~3-one-7a-ol is presuma¬
bly produced almost entirely by the microsomes
with only 2f contributed by the supernatant.
(b) A substance with an Rp value of O.So in
the benzene:ethyl acetate; acetone system was pro¬
duced in both "boiled" and "active" incubations.
This substance has properties identical with those
of 7-ketocholesterol, and is presumably formed by
autoxidation.
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(c) The more polar u.v. absorbing substance
, , .... . .
discussed on p. 104 was formed only in the active
tissue incubttion.
In spraying the plates obtained from incuba¬
tions with active and boiled tissue no further
metabolites could be seen. This was confirmed *>3T
carrying out e complete radioactive analysis of
the ether:alcohol cut.
Examination of the thin layer plates obtained,
from the ether cuts from the columns revealed the
formation of a substance less polar than 7a-hydro-
xycholesterol in active incubations. This sub¬
stance was produced in incubations with supernat¬
ant alone and is thought to be an ester of 7a-
hydroxycholes terol.
Thus it seems that microsomes + supernatant
with RAD can give rise to the polar u.v. absorbing
substance from 7a-hydro>.yc.holesterol although
neither microsomes and NAD, or supernatant and NAD
can produce this substance. If the polar u.v.
absorbing substance is the 26—hydroxy derivative
of cholest-4-en-5-one-7a-ol, then active supernat¬
ant must contribute some factor or enzyme for
hydroxylation.
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B. Microsomes + SF, with added NAD
When microsomes were incubated with "boiled,
deproteinised supernatant (i.e., 3F) and NAD, 7a—
hydroxycholesterol was converted to cholest-4-en-
3-one-7a-ol as expected. However, the polar u.v.
absorbing substance was also produced. Thus,
some thermostable factor in the SF somehow "acti¬
vates" the microsomes giving them the power to
hydroxylate.
This situation is similar to that occurring
in mitochondria and it was wondered whether SF
was acting by the same mechanism with microsomes
•»
as in mitochondria, i.e., SF appears to deplete
added NAD.
If this were the case one would expect the
following to occur:-
(a) Microsomes with no added NAD and there¬
fore unable to produce cholest-4—en-3-one-7a-ol
should be able to hydroxylate 7a-hydroxycholesterol
to give triol.
(b) Microsomes incubated with SF and NAD
should give rise to considerably less cholest-4-
en-3-one-7a-ol then microsomes + NAD with no SF
and triol should also be produced.
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(c) Microsomes incubated with varying amounts
of NAD should form, at low concentrations of NAD
the two hydroxylated derivatives which occur in
similar incubations with mitochondria.
(d) Adding succinate to incubations of micro*
somes with added NAD should decrease the amount ofi
cholest-4—en-3-one-7a-ol produced from 7a-hydroxy-
cholesterol and also give rise to the two hydroxy-
l&ted derivatives, as in mitochondria.
Incubations were set up to discover whether
(a) and (b) take place showing that neither of them
occurred. Previous experiments (see pages 111 &117)
also indicated that (c) and (d) do not occur. It
thus appears that microsomes alone cannot hydroxy-
late 7G-hydroxyeholesterol, and that SP, and also
succinate, do not have the same effect as they do
in mitochondria. Thus, the situation is not par¬
allel to that occurring in mitochondria, and SP
does not apparently deplete the added NAD.
C. Microsomes + supernatant with no added h D
Microsomes + supernatant incubated with 7c-
hydroxycholesterol without added NAD gave rise to
no cholest-4-en-C-one-7a-cl, as expected. How¬
ever, contrary to expectation, triol was seen to
be formed. Thus, microsomes with active
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supernatant and no NAD have the power to hydroxy-
late 7o,-hydro:xycholesterol# Incubations set up
with active supernatant with no added NAD have
shown that under these conditions no hydroxylatian
of* 7a-hydroxycholesterol occurs (p#121 )#
D. Microsomes + SF with no added NAD
7a.-hydroxycholesterol, when incubated with
microsomes + SP, was not metabolised at all* No
cholest-4-en-3-one-7a-ol was formed and also no
triol#
Therefore in the formation of triol from 7a-
hydroxycholesterol, a factor in the active super¬
natant fraction is required before microsomes are
capable of hydroxylating 7a-hydroxycholesterol#
This factor is probably ensymic, since on boiling
and deproteinising the supernatant, this activity
is lost#
These results indicate: -
Pirstly, that if a thermostable factor con¬
tained in the supernatant fraction is added to
incubations of 7a-h.ydroxycholesterol with micro¬
somes and NAD, a polar substance is formed# It
is suggested that this might be the 26-hydroxy
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derivative of cholest-4-en-5-one-7ci-ol. This
substance is presumably formed by hydroxylation
of cholest-4-en-3-one-7a-ol, as no triol is
formed (see p. 176 )# This is quite a different
situation to that occurring in mitochondria.
SF does not, apparently, direct the reaction
towards hydroxylation by depleting the added NAD
as it does in mitochondria;
secondly, that the addition of active supernatant
to microsomes with no added NAD enables them to
hydroxylase 7a-hydroxycholesterol to produce
triol, indicating that two enzymes are probably
involved, each inactive when confined to the sep¬
arate cell fractions in which they are found#
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SUIv'tMi-iRY OF SECTION IV
The metabolism of 7a-hyclroxycholesterol was
studied by incubating this substrate, both labelled
with tritium and unlabelled, with the different
cell fractions of rat liver. After incubation,
a lipid extract was made and the constituents were
crudely separated on small alumina columns. The
metabolites were further separated, identified,
and estimated by using thin layer chromatography
on fluorescent thin layer plates.
It was found that:
(1) In the microsomes + supernatant fraction, the
disappearance of 7a-hydroxycholesterol (used as a
measure of its metabolism) was dependent on the
concentration of NAD and also on substrate con¬
centration.
(S) Anactive enzyme (or enzymes) was found to
exist in microsomes which oxidised 7a-hydroxy-
cholesterol to cholest-4-en-3-one-7a,-ol. No
other products were formed in this fraction.
This reaction was studied under various
conditions:-
(i) It v/as found to be dependent on the NAD
concentration, ffljl of 7a-hydroxycholest-
erol being converted into cholest-4-en-3-
one-7a-ol when 10 g moles of NAD were added.
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(ii) The reaction was dependent on substrate
concentration
(iii) Increasing amounts of cyanide gave
increasing amounts of product
(iv) The reaction had an optimal pH between
7.0 and 7.4
(v) Succinate had no effect on the reaction
(vi) An acetone powder of microsomes retained
the enzymic activity.
(3) In the supernatant fraction, 7o-hydroxycholes-
terol was converted into a substance with proper¬
ties and mobility similar to those of an ester of
7a-hydroxycholesterol. A trace of cholest-4-en-
5-one-7cx-ol was produced on adding NAD to the
incubation mixture.
(4) The mitochondrial fraction of rat liver, in
the presence of NAD could convert 7a-hydroxy-
cholesterol into cholest-4-en-3-one-7a-ol.
a) This reaction was studied under various
conditions:
(i) The formation of product was dependent on the
substrate concentration.
(ii) Formation of cholest-4-en-3-one-7a-ol was
dependent on the concentration of NAD added.
(iii) The addition of cyanide increased the amount
of product formed.
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b) The effect of SP on the metabolism of 7a-
hydroxycholesterol in this fraction was studied.
(i) SP added to active mitochondria caused the
substrate or products to be bound firmly to the
tissue making complete recovery impossible. No
such effect was noticed when SP was added to
boiled mitochondria.
(ii) SP added to mitochondria, NAD, and 7a-hydroxy-
cholesterol gave rise to the formation of a small
amount of cholest-4-en-5-one-7c.—o1 and also to two
other more polar metabolites, which, it is sugge¬
sted, might be eholest-4-en-3-one-7a-26-dio1 and
cholest-5-en-3p,7a,26-triol. A substance with
mobility similar to that of an ester of 7a-hydro-
xycholesterol was also formed.
c) An attempt was made to discover the mech-
anims of the influence exerted by SP on the meta¬
bolism of 7a-hydroxycholesterol.
(i) Mitochondria without added NAD were found to
convert 7a-hyciroxycholesterol into the more polar
,,?triol,? compound.
(ii) Increasing the NAD concentration in incuba¬
tions of mitochondria and substrate showed that as
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the NAD concentration increased, the amount of
"triol" formed decreased, and the amount of
choles t-4-en-3-one-7a-ol formed increased.
(iii) The addition of increasing amounts of suc¬
cinate to incubations of mitochondria, NAD, and
substrate showed that succinate had the same
effect as BP, in that as the succinate concentra¬
tion increased the amount of " triol"formed
increased, and the amount of cholest-4-en-3-one-
70,-cl formed decreased.
(iv) Other dicarboxylic acids were inetibated with
mitochondria and NAD to find out if they could
also mimic the effect of SP. Only those dicarho¬
xylic acids which are citric acid cycle inter¬
mediates had the same effect as SP*
Conclusions were dram from these experiments
to explain the effect of SP. It is thought that
SP may exert its effect partially by depleting in
some way the added NAD, probably by converting it
into NADH. NADH was found to have the same effect
as NAD + SF.
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(v) When increasing amounts of SP were added to
mitochondria ?/ithout added NAD, increasing amounts
of "triol" were formed.
(vi) A similar experiment involving increasing the
succinate concentration with mitochondria with no
added NAD showed no such increase in "triol"
formation. It was therefore concluded that SP
may have two roles - depleting the NAD added,
and "stimulating" hydroxylation reactions.
(vii) NADP was found to be able to replace NAD as
co-factor for the oxidation reaction, although it
was not as efficient. SP had the same effect when
NADP was co-factor as when NAD was co-factor.
(viii) When the SP was treated ?/ith acid at 100°,
and with alkali at 100®, and then brought back to
neutrality and used in incubations it was found
that acid-treated SF behaved in the same way as
untreated SP, whereas alkali-treated SP lost its
activity.
(ix) Incubations of 7a-hydroxycholesterol with an
acetone powder of mitochondria showed that, on
addition of NAD, the substrate v/as converted to
185
cholest-4-en-3-one-7a-ol. On addition of 8F to
such an incubation it was seen that no hydroxy-
lation occurred, hut less cholest-4—en-3-one-7a-ol
was produced#
(x) Neither potassium linoleate nor its hydro¬
peroxide could replace SF in incubations with
native mitochondria. Also no hydroxylation of
7a-hyclroxycholesterol was seen to occur on addition
of linoleate hydroperoxide to an acetone powder of
mitochondria#
(xi) It is thought that the polar u.v# absorbing
substance must be formed from the "triol" in
mitochondria by oxidation with NAD as co-factor#
(5) The metabolites produced in incubations of 7a-
hydroxycholesterol with microsomes + supernatant,
or microsomes + SF were discussed#
(A) Microsomes + supernatant with added NAD
gave rise to the formation of cholest-4-en-3-one-
7a-ol and also to the formation of the more polar
u.v. absorbing substance, cholest-4-en-3-one-7a,
26-diol (?)
Approximate amounts of products formed during incubation of






















2. 5% 6% - 1%
Mitochondria + SF
(with added NAD)
2. 5% 2% 4% 1% 1%
Microsomes
(with added NAD)
3% 25% - -
Supernatant 2% 2% " - 3%
Figure 35
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(B) When SP was exchanged for supernatant in
(A) the same result was obtained. Thus, a therm¬
ostable co-factor is present in supernatant which
gives microsomes the power to hydroxylate cholest-
4-en-3-one-7'a-ol •
(C) Microsomes + supernatant with no added
NAD gave rise to the formation of "triol".
to When SP was exchanged for supernatant in
(c) it could not replace it, and no triol was
formed. Thus, a thermolabile co-factor or enzyme
is present in supernatant, giving microsomes the
power to hydroxylate 7a-hydroxycholesterol.
SBCTICW V
METABOLISM OP CH0LEST-4-EN-3-0NE-7a-0L
IE RAT LIVER CELL FRACTIOUS
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METABOLISM OF CHGLEST-4-EN-3-0NE-7a-GL
There Is now much evidence to suggest that
cholest-4-en-3-one-7a-ol is an intermediate in
the breakdown of cholesterol to bile acids.
Danielsson (1961, b) has shown that when the tri¬
tium-labelled compound is administered to rats
with bile fistulas it is converted into bile ecidj^
for the most part into ehenodeoxycholic acid, and
a little into cholic acid. The evidence presen¬
ted here indicates that 7a-hydroxyeholesterol is
converted quite efficiently into cholest-4-en-3-
one-7a-ol in the microsomal fraction of rat liver.
If 7a-hyctroxycholesterol is on the pathway from
cholesterol to bile acids this evidence would
support Danielsson^ observations.
In order to investigate thi point it was
decided to incubate cholest-4-erv-5-one-7a-ol
unlabelled, and labelled with tritium, with the
different fractions of rat liver, the object being
to discover whether the substance was converted
into 3a,7c.-dihydroxyCOprostane which has been
shown by Bergstrbm and Lindstedt (1956) to be an
intermediate in the formation of bile acids.
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Chemical synthesis of cholest-4-en-3-one-7a-ol
Tlie chemical synthesis of cholest-4-en-3-
one-7a-ol is described in the appendix (p. 304 ).
The labelling of the pure compound with tritium
and the subsequent purification of the radio¬
active compound are also outlined there.
Experimental conditions and methods
(a) The incubation mixture used in the
following experiments was the same as that used
in the incubations involving 7a-hydroxycholest¬
erol as substrate, except that no HAD or other
co-factors were added unless otherwise stated.
The incubation mixture was thus as follows:
200 jig. cholest-4-en~3-one-7a-ol (0.5 ji mole)
in 0.1 ml. methanol
1 ml. 0.02 M phosphate buffer, pH 7.4
0.5 ml. 0.2 M nicotinamide (100 ji moles)
0.5 ml. 0.2 M magnesium sulphate (10 ji moles)
3.0 ml. tissue, equivalent to 1 g« wet weight
of liver
(b) The extraction procedure used was that
described on p. 50 and the dry residues were
put on to 2 g. alumina columns in ether.
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(o) .Alumina columns
Two experiments were carried out, firstly to
find out in which cut cholest-4-en-3~one-7G-ol
was eluted from the 2 g. alumina column, and
secondly to check the recovery of known amounts
of cholest-4-en-3-one-7a-ol from these columns.
(i) For the estimation of cholest-4~en-3-one-7a-ol
advantage was taken of its u.v. absorbing proper¬
ties. Ethanolic solutions of the substance can
be read in the u.v. spectrophotometer and from
the optical density readings at 242 mg. and the molar
extinction co-efficient (15,500), the number of
g moles and thus of gg. of ch o 1est-4-en-3-one-7a-
ol in the solution can be calculated.
200 gg. cholest-4-en-3-one-7a-ol was put on
a 2 g. alumina column in 5 ml. of ether. The
column was eluted with a furt er 10 ml. of ether,
then with 30 ml. of ether:alcohol (9:1) in two
separate 15 ml. cuts and lastly with alcohol.
The cuts were taken to dryness, and the residues
run on thin layer flviorescent plates. The
cholest-4-en-5-one-7c-ol was found to be eluted
quantitatively in the ether:alcohol cut, mainly
in the first 15 ml.
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(ii) The recovery of cholest-4-en-3-one-7a-ol
•' * 1 " > * 5
from the alumina columns was tested as follows:-
Amounts of a standard solution varying from
17 jig. to 176 jig. were taken to dryness and put
on to S g. alumina columns in ether. The columns
were eluted with 15 ml. of ether, and 30 ml. of
ether:alcohol (9:1). The ether:alcohol cuts
were taken to dryness and the residues dissolved
(3 ml.)
in ethanol. The ethanolic solutions/were read
at 242 mg. and the number of jig. of the substance
present calculated (see Table 31 ).
(d) Thin layer chromatography
Owing to the presence of nicotinamide in the
ether:alcohol cuts (see p. 52 ) the cholest-4—en-
3-one-7c-ol recovered from an incubation cannot
be estimated directly in the ether:alcohol cut.
The cuts off the alumina columns were therefore
concentrated and run on fluorescent plates.
Because of its u.v. absorbing properties, cholest-
4-en-3-one-7a-ol is easily located on the plates
and can therefore be eluted as described on p. 60
It can then be estimated either by its absorption
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Recovery of- cholest-»4-en-5-onc-7g-ol from thin
layer plates
An experiment was carried out in which
known amounts of labelled cholest-4-en-3-one-7o-6L
from 5 b g. to 190 jag. were spotted on to thin
layer plates which were then run in the benzene:
ethyl acetate: acetone system. The cholest-4-ei>t
3-one-?o-ol was marked and eluted with 10 ml.
of ether:alcohol (1:1). The extracts were taken
to dryness and dissolved in ethanol. The ethan-
olic solutions were read at 242 mg., taken to
dryness and counted. The amounts of cholest-4-
en-5-one-7a-o1 recovered in this way were
plotted again: t the amounts that were put on to
the plates, as seen in Table 32 and Fig. 36.
Using the above methods, cholest-4-en-3-one-
7a-ol, labelled and unlabelled, was incubated
with the different cell fractions of rat liver,
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(i) Labelled cholest-4-en-3-one-?o~ol was
incubated with "boiled" microsomes and "active"
microsomes, the microsomes being prepared as
described on p. 36. • The cholest-4~en~3-one~
?&-ol was recovered from the thin layer plates
and estimated by radioactive means. It was
found that no cholest-4-en-3~one-7a-ol whatever
had disappeared from either the incubation with
active tissue or the boiled tissue control.
(ii) Identification of metabolites
Thin layer plates run on the ether:alcohol
cuts obtained from incubations of cholest-4-en-5-
one-7a-ol with boiled and active microsomes were
viewed under the u.v. lamp and any u.v. absorbing
spots were marked. The plates were then sprayed
firstly with phosphotungstic acid and then with
phosphomolybdic acid.
No further spots could be seen on the plate
obtained from the incubation with active tissue
which did not occur on the plate obtained from
the boiled control incubation. 7a-hydroxychol¬
esterol and 7(3-hydroxycholesterol were seen to be
produced on both plates. When a complete radio
195.
active analysis was carried out on all the cuts
off the alumina columns by segmenting the thin
layer plates run on these cuts, it was found that
all the radioactivity added was recovered as
cholest—4-en-3-cne—7a—ol from "both "boiled" and
"active" incubations. Thus no metabolism of
cholest-d-en-5-one-7a-ol had occurred in the
microsomal fraction. No radioactivity was assoc¬
iated with the 7a- and 7p-hydroxycholesterol
which had been seen to be produced in both types
of incubation, which indicates that these sub¬
stances were produced by the autoxidation of the
cholesterol occurring naturally in the microsomes
and not from the added cholest-4-en-3-one-7a-ol.
This was confirmed by carrying out incubations of
active microsomes with no substrate present and
showing that 7a-hydroxycholesterol and 7g-hydroxy-
cholesterol were formed.
These experiments indicate that cholest-4-e
5-one-7a-ol is not metabolised further in the
microsomal fraction of rat liver.
sn-
Pig, 37
Photograph of a fluorescent plate, illuminated
by u,v, light, Plate obtained from an incubation
of mitochondria with cholest-4-en-3-one-7a-ol
u,v, absorbing substances:-
a} nicotinamide






(i) Cholest-4-en-3-one-7a-ol was incubated
vdth "boiled" and "active" mitochondria, which
were prepared as described on £>.36. The sifostrate
was recovered by elution from the thin layer
plates and estimated. Using unlabelled substrate
and comparing the recovery of substrate from
incubations with boiled and active tissue it was
found that in the active tissue incubation 1C?C of
the cho le s t-4—en-3-one-7c,-o1 had disappeared (i.e.
metabolised). When labelled substrate was used
the disappearance in the active tissue incubation
was found to be 6;,, measured in three separate
experiments#
(ii) Identification of metabolites
Thin layer plates run on the ether:alcohol
cuts obtained from boiled and active tissue incub¬
ations were viev/ed under u.v, light and it was
seen that in the active tissue incubation, but not
in the boiled control, a u.v, absorbing substance
had been formed, (Fig. 37), This substance had
the same Sp value (0.31) in the benzene:ethyl ace¬
tate: acetone system as the "polar u,v, absorbing
material" produced in incubations of 7a-hydroxy-
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cholesterol with, mitochondria + SP + NAD, mito¬
chondria + succinate + NAD, and microsomes + SP +
NAD (see p. 135). The substance, when eluted
from the plate and its absorption spectrum plotted
showed a peak at 242 mp., indicating that it is
probably an a,£ -unsaturated ketone (Fig. 23).
The substance behaves like cholest-4-en-3-one-
when sprayed with phosphotungstie acid, giving a
pink colour. When labelled cholost-4—en-3-one-
7a-ol was used as substrate, this u.v. absorbing
material was found to be labelled, showed that it
was formed from the substrate, about 4% being
formed. ,
From the mobility of this u.v. absorbing
material, and from the fact that it is formed from
cholest-4-en-3-one-7a-ol it is suggested that the
substance is the 26-hydroxylated derivative of the
substrate, i.e., cholest-4-en-5~one-7a,26-diol.
This is the suggested identity of the substance
produced from 7a-hydroxycholesterol, (p. 135 ).
A complete radioactive analysis of the extract
from boiled control and active tissue incubations
showed that no other radioactive products were
formed in the active incubations. This was
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supported by the fact that on spraying the plates
no spots which were not present in the extracts
from the boiled incubations appeared in the extr-
acts from active incubations. Again 7a- and 7p-
■
hydroxycholesterols were formed, but these were
found not to be associated with any radioactivity.
Very smell amounts of 7a-& 7p -hydroxyeho1esterc3s
were formed end these separated completely from
• "
the polar u.v. absorbing material (compare p. 134
dealing with incubations of 7a-hydroxycholesterol).
(iii) The" formation of the polar u.v. absorb¬
ing matefTaT^"tu"SieiS' under various
condl tions
- '.M—■■■
(a) Effect of co-factors on the reaction
In many examples of hydroxylation reactions
it has been found that NADPH is essential as a co-
factor. Incubations were therefore set up to com¬
pare the effect of adding "ADH and NADPH to mitochon¬
dria with cholest-4—en-3-one-7a-ol as substrate.
The fluorescent plates obtained from such incuba¬
tions were viewed under the u.v. lamp and it could
be seen that the same amount of u.v. absorbing pro¬
duct was formed in incubations with mitochondria,
mitochondria + NADH and mitochondria with NADPH.
Thus it would seem that neither NADH or NADPH st
ulate the reaction to give more of the u.v. absorb-
product.
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(b) Effect of adding boiled supernatant (or SF) to
the incubations*
If SF does have some effect on hydroxy1ation,
as has been inferred in the previous Section, then
it should stimulate this reaction in which the
more polar u*v* absorbing substance is formed from
cholest-4-en-3-one-7a-ol*
Two separate experiments were carried out in
which incubations were set up as follows, using
labelled substrate:-
(a) Boiled mitochondria 4 3 ml* SF
(b) Active mitochondria
(c) Active mitochondria + 3 ml* SF
(d) Active mitochondria + 6 ml* SF
The ether:alcohol cut from each incubation
v/as run on a fluorescent thin layer plate, which
was then segmented, and the segments eluted and
counted* The results of the two experiments are
shown in Table 33 • The ether and alcohol cuts
from the columns were also analysed by radio¬
activity measurements and the total counts
recovered from each incubation was found* These
are shown in the Table as percentages of the
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The results indicate that in experiment 1 the
addition of SF makes no difference to the amount
of polar u.v. absorbing substance formed, whereas
in experiment 2 the addition of SH seems to produc
slightly more of the substance. The results
although inconclusive, have some interest. ¥/hen
the total number of counts recovered from the incu¬
bations is calculated, it is found that about 95?v
of the added counts can be recovered from the
incubations with boiled mitochondria + SF, or from
active mitochondria, whereas only about 75% of
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the added counts can he recovered from incubations
involving active mitochondria + SF, This is the
same sort of situation as arose with incubations
of 7a-hydrojsycholesterol with mitochondria and SF,
described on p.131 . It may be, then, that SF
does bind, .in some way , the substrate or products
very firmly to the tissue.
(c) Effect of altering the gas phase in the
Incubation flasks
In many examples of hydroxylation reactions
oxygen has been shown to be a necessary addition.
It was therefore decided to incubate mitochondria
and chclest~4-en~5-one-7a-ol in air, in a mixture
of 95?i oxygen + 5g carbon dioxide, and in nitrogen.
the
Just before the incubat ion,/flasks were placed in
the bath at 37® , after which they were flushed out
for two or three minutes with the gases concerned,
and then stoppered tightly. The flask to be
incubated with air as the gaseous phase was
stoppered as usual.
The polar u.v. absorbing substance produced
was viewed on the fluorescent plates under the u.v.
lamp and it was found that perhaps slightly more
of the product was formed in the oxygen:carbon
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dioxide medium, whereas in the nitrogen medium
about the same amount was formed as in the incubaf
tion carried out in air.
Thus, oxygen may stimulate the reaction, and
the fact that the nitrogen has no effect probably
means that either the system is not anaerobic or
that a bound-form of oxygen is present. Obviously
more rigid anaerobic conditions must be applied#
(d) Disruption of the mitochondria
It was thought to be of interest to discover
whether the reaction occurring in mitochondria anc.
giving rise to the polar u.v. absorbing substance
from cholest-d—en-3-one-7a~ol was sensitive to
disruption of the mitochondria by eonieation.
(i) An experiment was set up to compare the
amount of pol r u.v. absorbing material produced
from cholest-4-en-5-one-7a-ol in native mitochon¬
dria with that produced in mitochondria (from the
same preparation)which had been subjected to sonic
disintegration. It was found that this treatment
made no difference to the activity of the mito¬
chondria, as can be seen from the photographs
(Pig. 58), and also that the addition of NADPH to
either native mitochondria or disrupted mitochon-
I




Photographs of fluorescent plates, illuminated
by u.v. light. Plates obtained from incubations
of mitochondria v/ith cholest-4-en-3-one-7a-ol
1. Native mitochondria
2. Mitochondrial debris, from sonication
3. Supernatant, from mitochondrial debris.
u. v. absorbing sub stances:-
a) nicotinamide
bj "polar u.v. absorbing material"
c< 7-2cetocholesterold) choles t-4-en-3-one-7c-ol
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(The fact that the mitochondria had indeed "been
disrupted after sonication was confirmed by exam¬
ination under the interference microscope).
(ii) A sucrose solution of mitochondria which
had been subjected to sonication was centtifuged
at 10,000 x g for 20 min. in the M.S.E. refriger-
ated centrifuge. The debris was sedimented in
this way and separated from the supernatant
fraction which contained the soluble material from
the broken mitochondria. The debris was suspended
in sucrose solution and incubations were set up to
compare the activity of the mitochondrial debris
with that of the "supernatant". Native mitochon¬
dria from the same preparation were also incubated
with cholest-4-en-3-one-7a-ol.
As can be seen in the photograph (Pig. 38) no
u.v. absorbing product was formed in the incubation
involving the "supernatant" fraction of the dis¬
rupted mitochondria, and the activity for prod¬
ucing this substance was found to be associated
with the mitochondrial debris. The activity in
the debris was not increased by adding the "super¬
natant^ fraction to it.
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These results could, of course, be explained
if the mitochondria had not been broken and were
merely resedimented, but examination under the
microscope showed definitely that the mitochondria
had indeed been disrupted. These experiments
were performed several times with different prep¬
arations of mitochondria.
It would appear, therefore, that firstly,
disrupted mitochondria retain enzymic activity, so
that on incubation with ch.olest-4-en-3-one-7a-ol
the u.v. absorbing material (which, it has been
suggested is cholest-4-en-3-one-7a,26-diol; see
p. 196 9 is produced; and secondly that this enzy-
mic activity is contained in the mitochondrial
debris obtained after disruption.
(iii) Mitochondria were burst by osmotic
means (i.e., on obtaining mitochondria they were
shaken with distilled water and kept in the cold
for 30 min. with frequent shaking) and the debris
separated from the supernatant as before. Incuba¬
tions comparing the activity of the debris obtained
from sonically disrupted mitochondria with that of
the debris from osmotically disrupted mitochondria
were set up. The supernatants were also compared
205,
The mitochondria used were derived from the same
preparation of rat liver.
It was found that the u.v. absorbing subst¬
ance was produced from cholest-4—en-3~one-7o-ol to
the same extent in both the "osmotic" debris and
the "sonic" debris. No activity was seen in
either supernatant.
_
(e") Incubations with an acetone powder of mitochon-
cfrla; f
An acetone powder of mitochondria was prepared
as described on p. 39 • This acetone powder
was able to oxidise 7a-hydroxycholesterol but
unable to hydroxylate it. The po?/der was diss¬
olved in buffer and incubated with cholest-4-en-S-
one-7o-ol, with and without NABPH. On viewing
the fluorescent thin layer plates obtained from
these incubations it was seen that no u.v. absorb¬
ing material was produced in either incubation.
Thus it would seem that acetone treatment of the
mitochondria removes any hydroxylating activity
that native mitochondria eontain.
(f) Effect of the hydroperoxide of llnoleate
As has been discussed previously, it is pos-
sible that the hydroperoxide of linoleic acid may
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play some role in hydroxylating reactions. It
was therefore decided to find out whether the
hydroperoxide has any effect cn the hydroxylation
of cholest-4-en-3-one-7a-ol.
(i) The hydroperoxide of sodium linoleate
was prepared by the action of lipoxidase (p.163 ).
Six incubations were set up to compare the effect
of the hydroperoxide on the hydroxylation of
cholest-4~en-3-one-7a-ol in sonically burst mito¬
chondria, in the debris spun down after sonication
and in the supernatant thus left. Cholest-4-en-
3-one-7a-oi was incubated, then, with -
a) disrupted mitochondria, with and without
hydroperoxide ,
b) the mitochondrial debris, with and without
hydroperoxide, and
c) the supernatant with and without hydro¬
peroxide.
The constituents of the incubation mixtures were
separated as usual and the steroids run on thin
layer plates which were then viewed under the u.v.
light. It could be seen that including the hydro¬
peroxide of linoleate in the incubation mixture
made no difference to the formation of the polar
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u.v. absorbing substance in disrupted mitochondria
or mitochondrial debris. In the supernatant, as
has been shown (p. 203) no hydroxylation of
cholest-4-en-3-one-7c<,-ol takes place and this was
also unaffected by the hydroperoxide.
(ii) The hydroperoxide of linoleate was pre¬
pared according to the method of Banks et al. (1959)
(p. 164 )• The effect of linoleate hydroperoxide
on the hydroxylation of cholest-4-en-3-one-?a-ol
under anaerobic conditions was studied. Two
incubations were set up, containing mitochondrial
debris and substrate. To one incubation was
added the hydroperoxide. Both incubation flasks
were flushed out with nitrogen before being incuba¬
ted. The steroids were extracted and run on
fluorescent thin layer plates which were then
viewed under the u.v. light. It was seen that
the u.v. absorbing product was formed in the incub¬
ation contMning no hydroperoxide but was absent
from the incubation containing the hydroperoxide.
This result could be explained if an oxygen
donor was in fact present in the incubation and
if the linoleate hydroperoxide was inhibiting its
activity. If the conditions were not truly anae¬
robic, however, this result does not coincide with
that in (i).
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C. MICROSOMES + SUPERNATANT (OR SF)
In the last Section, which dealt with the
metabolism of 7o,-hydroxycholesterol, it has been
shown that although microsomes when incubated with
7a-hydroxycholesterol, with and \vithout NAD, do
not contain hydroxylating activity, when active
supernatant or boiled deproteinised supernatant
(SP) is added to the microsomes, hydroxylation can
take place (see p. 176 )•
In this Section it has again been found that
microsomes have 110 hydroxylating power, and it was
therefore thought to be of interest to discover
whether the addition of supernatant or SP might
allow hydroxylation to proceed.
To carry out this investigation incubations
were set up as follows
(a) microsomes + active supernatant;
(b) microsomes + SP
In both cases cholest-4-en-3-one-7a-ol was
added as substrate. On viewing the fluorescent
thin layer plates run on the ethert alcohol cuts
obtained from these incubations it was found that
the u.v. absorbing substance thought to be cholest-
4-ei>»3-one-7a,26-&iol was produced in both cases.
(The activity, however, is not as great as that
occurring in mitochondria).
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These results support the observations repor¬
ted on p. 176 • It seems that a thermostable
factor present in the supernatant fraction of rat
liver is necessary before microsomes* which are
inactive alone, can hydroxylate cho1est-4-en-3-on
7a-ol. This supports the evidence that the polar
u.v. absorbing material obtained in incubations of
microsomes + SP + NAD with 7a-hydroxycholesterol
is formed by hydroxylation of cholest-4-en-3-one-
7a-ol produced first by oxidation of 7a-hyc1roxy-
cholestercl.
Stability of SP to pH change
An experiment was set up to discover whether
the thermostable co-factor was stable to boiling
with acid or alkali. Acid and alkali-treated SF
was prepared as described on p.159 and three
incubations were set up, with cholest-4-en-5-one-
7a-ol as sxibstrate.
a) Microsomes + untreated SF
b) Microsomes + acid-treated SF
c) Microsomes + alkali-treated SF
The thin layer plates obtained from these
incubations were viewed under the u.v. lamp and
it was seen that the polar u.v. absorbing material
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had "been produced in incubations a) and b) only.
Thus, treatment with alkali inactivates the thermo¬
stable co-factor. This is the same situation as
was found to occur when mitochondria were incubated
with NAD, 7a-hydx*oxycholesterol, acid and alkali-
treated SP (p. 160 )•
Replacement of SF with succinate
Two incubations were set up, with cholest-4-
en-&-one-7o-ol as substrate.
a) Microsomes + SP
b) Microsomes + succinate (72 p. moles)
On viewing the thin layer plates obtained
from these incubations it was seen that the polar
u.v. absorbing material had not been produced in
incu ation b). Therefore succinate cannot
replace SP in this system, in its ability to pro¬
mote hydroxylaticn of cholest-4-en-3-one-7a~ol.
The results here agree with those obtained when 7a«-
hydroxycholesterol was incubated with mitochondria
with no added NAD and addition of SP was found to
stimulate hydroxylation of the substrate. Suc¬
cinate could not replace SF in that case either,
(p. 156 ).
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D. SIJP'HRNATAPT FRAC11 ON
(l) Choles t-4-en-5-one~7a~ol was inc-abated
with "boiled" and "active" supernatant« which was
prepared as described on p. 36 • The substrate
was recovered by elation from the fluorescent thin
layer plates Obtained from such incubations and
estimated either by the absorption at 242 mp. or
by radioactive means. Using unlabelled substrate
and comparing the recoveries obtained from boiled
and active tissue ineiibations, it was found that
on incubation with active supernatant 12$ of the
added substrate had disappeared (i.e. had been
metabolised). In the same way it was found on
using labelled choles t-4-en-3-one-?<x-ol that 11;
of it had been metabolised in the active incubation.
(ii) Identification of metabolites
Thin layer plates run on the ether:alcohol
cuts obtained from incubations of unlabelled sub¬
strate with active and boiled supernatents were
viewed under u.v. light. No u.v. absorbing mat¬
erial was found to be present in the active incuba¬
tion. On spraying the plates with phosphotungstic
acid two products, not appearing on the plate
obtained from boiled control incubation, were seen
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to be formed in the active incubation. One of
these products had an Rp value in the benzene: ethyl
acetates acetone system identical with that of 7a-
hydroxyeholesterol (i.e., 0.35). The substance
also gave a blue colour with phosphotungstic acid,
as does 7o,~hydroxychole s tero1. The other product
had an Rp value of 0.43 which is identical with
that given by 3a,7a—dihydroxycoprostone in the
benzene: ethyl acetate:acetone system. The sub¬
stance gave a yellow colour with phosphotungstie
acid, as does authentic dihydroxycoprostane (see
Appendix, p. 311.).
(This yellow colour seems to be fairly
specific, as it is given only by trihydroxyeopro-
stane and dihydroxycoprostane out of the compounds
tested.)
Thin layer plates run on the ether:alcohol
cuts obtained from incubations of labelled sub¬
strate with boiled and active supernatant were seg¬
mented, elated, and counted. ho radioactivity was
, «
associated with any other part of the plate than
that containing the substrate in the boiled control
incubation. In the active tissue incubation, how¬
ever, both the products described above were found
to be labelled. About 4;C of the "7$,-hydroxy-
213.
cholesterol" was formed and about 7/"-' of the
" cLihydroxyeoprc stane" *
In the other cell fractions studied, where
7a- and 7g-hydroxycholesterols were formed, they
were found to he uhhbellecL and were therefore not
formed from cholest-4-en-3-one-7a-ol# It was
therefore thought to be doubtful if the "7a—hydro¬
xycholestero1-1ike" product was indeed 7a-hy roxy—
cholesterol, and on account of this uncertainty
this product will henceforth be referred to as
compound X#
A complete radioactive analysis was carried
out on all the cuts from the columns obtained from
boiled and active tissue incubations, and no furtha:
radioactive products were found in the active
incubations# These observations were confirmed
by spraying the plates with phosphotungstic acid
and with phosphomolyb&ic acid#
Thus it seems that active supernatant can
convert cholest-4-en-G-one-7a-ol into two further





(lii) Purification of supernatant fraction
The reduction of* cholest-4-en-5-one—7a-ol
cculd take place by two routes (see Pig. 59).
Either the double bond at 4,5 could be reduced
first, forming coprostan-C-one-7'a-ol which can be
further reduced at the 5 position to yield 5c:,7a-
dihydroxycoprostane, or the 3~2cetorje could be
attacked first forming choicet-4-en-bet,7a-cliol and
then the double bond could be saturated giving
3af7a-dihyc'roxycoprostane. The coxnplete reduction
is an anaHo gous reaction to the reduction of corti¬
sone to tetrahydr ocor tisone• Tomkins (1956, 1957)
has isolated enzymes from the supernatant fraction
of rat liver which catalyse the irreversible reduc¬
tion of cortisone by NADPH, firstly to the 3-keto-
5$—compound, dihycrocortisone, and then to the 3a,
5j3-coxapound, tetrahydrocortisone. It is thus
possible that these "Tomkins" enzymes might be the
ones found in tii.is study which also occur in the
supernatant fraction. The supernatant fraction of
rat liver was therefore purified by the method due
to Tomkins.
(a) Preparation of an active fraction from supernat¬
ant"
The volume of the supernatant fraction,
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obtained as described on p. 36» was measured and
an equal volume of saturated ammonium sulphate
solution was added to make the final solution 50^
saturated with this substance. This mixture was
stirred in the cold for 80 min. and a white preci¬
pitate was seen to be formed. This precipitate
was removed by centrifugetlon at 10,000 x g for
15 min. in the refrigerated K.S.E centrifuge.
More ammonium sulphate was added to the supernatant
layer until the solution was 70k saturated with
ammonium sulphate. The mixture was stirred and
centrifugefi as before and the precipitate was re-
suspended in about 10 ml. of distilled v/ater. The
solution was dialysed against 8 litres of distilled
water overnight and could then be stored for
several weeks at 0°C. Three fractions could thus
be obtained by this procedure:-
a) the protein precipitating between 0% and
&$> saturation;
b) the protein precipitating between 50k and
70£a saturation; and
c) the supernatant of (b)
216.
Tomkins found his activity in fraction (b).
The activity for reducing cholest-4-en-3-one-7a-ol
was also found to exist in fraction (b) using the
methods described.
(b) Incubation procedure and assay system
Incubations were set up in the usual way
using the following incubation mixture:-
0.5 ml. 0.05 M phosphate buffer, pH 6.4
0.1 ml. 0.0048 M NADP (4 mg./ml. of water)
0.1 ml. 0.035 M sodium glucose-6-phosphate
0.5 ml. glucose-6-phosphate dehydrogenase
(equivalent to 0.5 unit, where 1 unit
reduces 1 g mole NADP) ->
0.1 ml. 0.05 M magnesium sulphate
50 jjg. cholest-4-en-»3-one~7a-ol (in 0.025
ml. methanol)
Enzyme solution.
Incubations were carried out for 1 hr. at
37°C. in air, with shaking. The reactions were
then stopped by adding 10 ml. of methanol and 20 ml.
of chloroform. The mixtures were then centrifuged
and the methanol layers discarded. The chloroform
layers were taken to dryness, the residue dissolved
in ethanol, and the amount of cholest-4-en-3-one-





estimated directly by reading the ethanolic solu¬
tion at 248 mg. No column procedure was necessary
to remove interfering substances. The ethanolic
solution could then be concentrated and run on
fluorescent thin layer plates which could be
sprayed to identify metabolites.
When labelled substrate was used the fluore- I
scent thin layer plates were segmented, and the
segments eluted with ether: alcohol (l:l) and
counted, giving a complete radioactive analysis of
the incubation extract.
An attempt was made to follow the reaction
directly by conducting the incubation in a silica
cell belonging to the u.v. recording spectrophoto¬
meter. It was hoped that by placing the cell in
the spectrophotometer it would be possible to see,
as the reaction proceeded, a decrease in the absor;
tion at 242 mg. as the substrate was metabolised
and a concomitant decrease in absorption at 340 mg,
as the NADPH was used up.
NADPH was therefore generated first by incub-'
ating the constituents of the NADPH generating
system in buffer for 30 min. and stopping the reac¬
tion by boiling. The enzyme and substrate were
then added to the generated NADPH and the solution
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was put into the silica cell of the spectrophoto¬
meter. However, on placing the cell into the
spectrophotometer and reading against a blank
containing NADPH and enzyme, it was found to be
impossible to balance the machine in the 200 —
270 mg, wave-length region because of the amount
of protein present. It was possible, however,
to balance the machine in the 540 mg region and
a slight decrease in absorption at 540 mp. could
be seen with increasing time.
Thus, it seems that it is impossible to
follow the reaction directly with this partially
purified enzyme. Further purification of the
enzyme might make this technique a possible one
to use, as less protein would be required for
activity.
(c) Identification of metabolites
Thin layer plates run on the chloroform
extracts from incubations of cholest-4-en-3-one-
7a-ol with this partially purified enzyme were
viewed under the u.v. light and then sprayed with
phosphotungstic acid, (Fig. 49) Comparison of
an incubation stopped at zero time with one
stopped after 1 hr. showed that the two products
formed by incubations with unpurified supernatant
were produced in the latter (p. 211 )•
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Using labelled substrate and segmenting,
eluting, and counting the thin layer plate showed
that these two products were labelled, and that
no further products were formed. It was found
that about lCf}l of compound X (p, 213 ) and 45% of
the "dihydroxycoprostane" were formed.
It is therefore clear that the ammonium sul¬
phate treatment brought about considerable puri¬
fication of the enzyme,
(i) Identification of compound X
As has been discussed on p, 214 , cholest-4-
'
en-3-one-7a-ol could be reduced in two ways. It
is possible, although not very likely, that the
3-ketoue group could be reduced to yield a 3£-
hydroxyl group rather than a 3a-hydroxyl group, or
that on reduction of the double bond the hydrogen
might occupy the Sa-position, Thus, the reduction












By a study of the mobility of compound X and
of its properties many of these possibilities can
be eliminated. Thus, (c) and (d) can be elimina¬
ted because they would be less polar than the
substrate, and also would not give a blue colour
with phosphotungstic acid. Compounds (e), (f),
(g) and (h) would all be less polar than compound
X and again would not give the blue colour, so
they too can be eliminated. However, compounds
(a) and (b) and also (i) all have properties simi¬
lar to those of compound X.
To discover whether compound X was 7a-hydroxy-
cholesteroi, or either cholest-4-en-3a,7a-diol,
or the Sj'i-epimer, the following experiment was
carried out.
Oxidation of compound X v/ith manganese dioxide
If compound > were 7a~hycroxycholesterol it
would yield 7-ketocholesterol when oxidised with
manganese dioxide. If, on the other hand comp¬
ound X were either cholest-4-en-3c.,7a-diol or the









CHOLEST -4 -EN-3«c,7oC-DIOL. CHOLEST-4-EN-3-ONE-7oC-OL.
PIG. 41
A ^COMPOUND X, PARTIALLY
OXIDISED WITH Mn 03.














DIAGRAM OF THIN LAYER PLATE RUN IN BENZENE".
ETHYLACETATE". ACETONE SYSTEM, IDENTIFYING
OXIDISED COMPOUND X AS CHOLEST -4 - E N -3-ON E - 7cC-OL.
PIG. 42
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A thin layer plate was run on the extract
from an incubation with labelled substrate and,
without spraying, the section-of the plate con¬
taining compound X was eluted with chloroform and
the silicic acid removed by centrifugation. The
chloroform solution was shaken with manganese
dioxide for 6 hr. and then left at room tempera¬
ture for 18 hr. The solution was then filtered,
concentrat ed, and re-run on a fluorescent thin
layer plate. On the same plate was run a stand¬
ard solution containing both cholest-4-en-3-one-
7a-ol and 7-ketocholesterol. It was found that
oxidised compound X was u.v. absorbing and had the
same mobility as cholest-4-en-3-one-7a-ol» The
oxidised compound X was eluted frcim the plate and
found to be labelled. The experiment was repea¬
ted but after oxidation the chloroform solution
was halved. One half of the solution was run on
a fluorescent plate as before and the other half
was mixed with authentic cholest-4-en-0-one-7a-ol
and also run on the plate. The standard solution
was also included on the same plate (see Pig. 42).
On viewing the plate after running it was seen
that oxidised compound X did not separate from
authentic cholest-4-en-3-one-7a-ol, which was found
to be labelled on elution from the plate.
222#
These results show that compound X, on oxida>
tion with manganese dioxide gives rise to cholest-
4-en-5-one-7a-ol and therefore compound X cannot
he 7<u-hydroxycholesterol hut must be either
cholest-4-en-3a,7a-diol or cholest-4-en3p,7a-diol
Re-incubation of compound X with supernatant
enzyme
In order to discover if compound X is an
intermediate between cholest-4-en-3-one-7a-ol and
the compound thought to be 3a,7a-dihydroxycopro-
stane (see p. 219), compound X was isolated from
an incubation with cholest-4—en-3-one-7a-ol and
supernatant enzyme. This isolation was carried
out by eluting compound X from an unsprayed thin
layer plate# Before incubating compound X with
enzyme, a small amount was run on another plate
and sprayed, to ensure that no 3a,7a-&ihydroxy-
coprostane which had also been formed in the firs
incubation had also been eluted# Compound X was
then incubated with supernatant enzyme and NADPH
generator for an hour# The steroids were extra¬
cted as usual and the chloroform extract was con¬
centrated and run on a thin layer plate# On
spraying the plate with phosphotungstic acid and
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phosphomolybdlc acid it could "be seen that a very
small amount of 3a,7a-dihydroxycoprostane had been
formed# On repeating the experiment and re-in¬
cubating compound X without NADPH, it was seen
that no 3a,7a-dihydroxycoprostane was formed#
Thus, it would seem that compound X is an
intermediate between cho1est~4~en-3-one-7a-o1 and
3a,7a-dihydroxycoprostane, althou^i it does not
seem to be very readily converted into the latter
substance# However, this would indicate that
compound X is probably cholest-4—en-3a,7a-diol anc
not the 3p-epimer#
Experiments with authentic cholest-4-en-3a»
ygftrsi — —
(i) Cholest-4—en-5a,7a-diol was prepared by
Mr# Naqul by the method described in the Appendix
p# 305# This substance was incubated with the
supernatant enzyme with and without NADPH# The
steroids were extracted as usual and run on thin
layer plates which were sprayed to identify meta¬
bolites# There appeared to be very little con¬
version of cholest-4-en-3a,7a-diol to dihydroxy-
coprostane in the presence of NADPH# Thus
cholesfc-4—en-3a,7a-diol is not readily converted
this enzyme preparation to dihydroxycoprostane#
a) b)
Pig. 43.
Photographs of thin layer plates, sprayed with
phosphomolybdlc acid.
1. 3ci,7a, dihydroxycoprostane isolated from
an incubation of cholest-4—en-3-one-7a-ol with
supernatant enzyme, mixed with authentic dihydroxy¬
coprostane and re-run in benzene:ethyl acetate:
acetone.
2. a) cholest-4-en-oa,7a-diol isolated as in 3.
b) cholest-4-en-3c,,7a-diol isolated as inl,
mixed with authentic cholest-4-en-3a,
7a-diol and re-run in benzene:ethyl
acetate:acetone.
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(ii) Compound X was isolated from an incubation
as described above (p. 222 ) ®nd re-run on a thin
layer plate together with authentic cholest-4-en-
3a,7a-diol. Compound X did not separate from the
standard in the benzene: ethyl acetate: acetone
system (Fig. 43)« Cholest-4-en-3a,7a-diol does
separate from the 3§-epimer in this sytem, the 3£f
epimer being less polar than the 3a,epimer.
These results show, then, that compound X,
which is formed from cholest-4—en-3-one-7a~ol
v/hen incubated with a partially purified enzyme
from the supernatant fraction of rat liver, is
probably eho1es t-4-en-3a ,7ct-dio1, although there
is a slight possibility that it could be the 3f=—
epimer. Compound X is presumably formed by
reduction of cholest-4-en-3-one-7c,-ol with NaDPH
as co-factor and on incubation with the enzyme
forms 3a,7a-dihydrosycoprostane, although not very
readily. Thus, cholest-4-en-3a,7a-diol is a pos¬
sible intermediate on the pathway from cholesterol
to bile acids.
(ii) Identification of "diliydroxycoprostane"
The other product, less polar than compound X
formed when cholest-4-en-3-on©-7c-ol is incubated
225.
with the purified supernatant enzyme had an R^
value of 0.43 in the benzene:ethyl acetate:acet¬
one system, and 0.06 in the benzene: dioxane
system. These R^ values are identical with those
given by authentic 3a,7a-dihydroxycoprostane in
the above systems. The product gives a yellow
colour with phosphotungstic acid as does 3a,7a-
dihydroxycoprostane, and this yellow colour seems
to be fairly specific.
A thin layer plate obtained from an incubation
of cholest-4—en-3-ono-7a-ol with the enzyme was
not sprayed but the portion containing the product
was scraped off and ©luted. The eluate was taken
to dryness and concentrated sulphuric aeid v/as
added to the residue. A yello?/ colour was seen
to develop and after one hr. the u.v. absorption
spectrum of the solution was plotted. The spec¬
trum was found to be similar to that given
by an authentic sample of 3a,7a-&ihydroxyeopro-
stane, i.e. a peak at 312 np. was obtained. This
reaction is not very sensitive, about 25 fig. of
dihydroxycoprostane being required to give an
optical density of 0.1 at 312 np. A tracing of
the two spectra is given in Pig. 44.
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The product v/as isolated as above from an
incubation with labelled cholest-4~en-3-one-7a-ol
and mixed with genuine 3a,7a-dihydroxycoprostane.
The mixture was run in three different solvent
systems on thin layer plates, viz., benzene:ethyl
acetate (2:1), benzene:dioxane (19:1), and ben¬
zene: ethyl acetate:acetone (10:5:3). On spray¬
ing the plates it was seen that the product had
not separated from 3a,7a-dihydroxycoprostane in
any of the systems (see Pig. 43). Similar plates
were run, but not sprayed. These were segmented,
eluted and counted, and it v/as found that the
radioactivity was concentrated on the plate in
the section where the dihydroxyeoprostane should
be located.
The product was isolated from several incuba¬
tions as above, and the infra-red spectrum of the
product was plotted. This was compared with the
infra-red spectrum of authentic dihyoroxycopros-
tane. The spectrum of the product showed a peak
in the hydroxyl region, and was similar to the
spectrum of the pure substance. There was not
really enough of the product to attempt to plot
the infra-red spec turn and the region from about
10 - 15 microns wave-length, which is different
PERCENTAGE
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Graph of enzyme concentration against substrate metabolised
Figure 45
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for every compound Cfinger-print region") did not
show up any characteristic peaks.
The cumulative evidence produced here indic¬
ates that one of the products obtained by incuba¬
ting choicet-4-en-3-one-7a-ol with a partially
purified enzyme from the supernatant fraction of
rat liver is 5a#7a-dihydroxyeoprostsne» which has
been shown by iiergstrom and I-indstedt (1956) to
be converted to bile acids in the fistula rat.
(c) Metabolism of choice t-4-en-5-one-7ci-ol
51^^IeS^iirTHel"Jpu>ifTed"su^rnatant "
fraction under various conditons
(i) Variation in enzyme concentration
Four incubations were set up, each containing
the same amount of NADPH generating system and
substrate (40 pg.) (see incubation mixture, p. 186
but each containing a different amount of enzyme,
varying from 0.1 ml. to 0.5 ml. enzyme. The
steroids were extracted from the incubation mix¬
ture as described (p. 50) and the residues from
the chloroform extractions were read in ethanol
at 242 mp. The amount of substrate disappearing
in each case could then be calculated, and is
given in Table 34 • A graph was drawn of amount
of enzyme added against amount of substrate
228.
disappearing, and showed that as the enzyme con¬
centration increased the amount of substrate
which disappeared also increased (Fig# 45)#
TABLE 54
ml. enzyme Substrate recovered
optical density pg. SubstratemcuDcXion Qt 24g ^ disappearing
a) 0.1 0.500 35.7 4.3
b) 0.2 0.400 29 11
c) 0.3 0.355 25.3 14.7
d) 0.5 0.280 20 20
40 gg. substrate added to each incubation
(equivalent to an optical density of 0.57)
After reading the ethanolic solutions at
242 mg. the solutions were concentrated and run
on thin layer plates, which were then sprayed
with phosphotungstic acid# It was found that as
the enzyme concentration increased, the amounts
of both products also increased.
(ii) Variation in substrate concentration
In the following experiments, labelled
cholest-4-en-3-one-7a-ol was used as the substrate
in incubations with the enzyme. A measure of the
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K = 9 x 10"5M
m
Dihydroxycoproctane
K = 1. 1 x 10" M
m
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—— (where S is substrate concentration in pmoles/ml,
Figure 46(a)
The initial substrate concentration is corrected in
this figure, for the amount of substrate disappearing,
using a factor / 1 \
M—)
f , where f is the fraction
of the initial substrate disappearing (Fisher, R. B. and
Parsons, D. S. , J. Physiol., 119 , 210 (1953)).
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metabolism of the substrate was obtained by-
isolating and counting the two products, cholest-
4-en-3a,7a-diol and 3a,7a-dihy&roxycoprostane
formed#
Incubations were set up containing IhtDPH-gen¬
erating system, 1 ml* enzyme solution and amounts
of labelled substrate varying from 10 fig. to 2oQ
gg. After incubation, the two labelled products
were Isolated from thin layer plates by elution
and were estimated by radioactive methods. The
results are shown in Table 35 . Graphs of sub¬
strate concentration against (a) the amount of
dihydroxyeoprostane formed per hr. (in c/m) and.
(b) the amount of eholcs t-4~on-5a,7a—dio1 formed
per hr. (in c/m) were drawn, (Fig. 46).
The results show that the amounts of both
products formed increase with increasing substrate
concentration sharply up to about 50 gg. substrate.
Further increase in substrate concentration does
not give rise to such a sharp increase in the
amount of products formed, the curve being thus
typical of an enzymic reaction. A graph was con-*
structed of the reciprocal of the substrate con¬
centration against the reciprocal of the reaction













































































































hr.) for each product and both plates were found
to be straight lines. From the intercepts on
the horizontal axis the K„, values for each reac-
tion could be calculated (Fig. 46).
(iii) Co-factor requirements
(a) Incubations with 1 ml. enzyme and 50 gg.
unlabelled substrate were set up to compare the
effect of adding no co-enzyme, NaDPH or NADH on
the formation of the two products. Thin layer
plates obtained from such incubations were sprayed
firstly with phosphotungstic acid and then with
phosphomolybdic acid.
No products at all could be detected when
either NAEK (equivalent to the amount of NADPH
v/hlch is generated by the glucose-6-phosphate
system normally used) or no co-enzyme was added
to the incubation. The two products, cholest-
4—en-3c,7c-dio1 and dihyaroxycoprostane v/ere,
however, seen to be formed when NADPH (in the
form of the generating system) was added.
These results show that the reduction of
cholest-4-en-3-one-7a-ol requires NADPH as co¬
enzyme, and that the NADPH cannot be replaced by
NADH.
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(b) Variation in HADFH concentration
In order to know the exact amount of N.ADPH
added to the incubation mixtures, the NADPH was
generated before adding to the mixtures, instead
of allowing it to be produced in the incubating
mixtures themselves.
A mixture containing:-
0.2 ml. KADPH (0.0048 M)
0.2 ml. glucose-6-phosphate (0.035 M)
0.8 ml. magnesium sulphate (0.05 M)
0.1 ml. glucose-6-phonpha to dehydrogenase
(equivalent to 1 unit, where 1 unit
reduces 1 p. mole NADP)
2.3 ml. phosphate buffer, pll 6.4
was incubated for 30 min. at 37°• The absorption
spectrum of the solution was then plotted, and
from the optical density reading at 340 mg. it waS
calculated that 0.85 ^ mole of 1TADPH had been
formed in 3 ml. This solution was boiled to stop
any reaction and was then used to add known amounts
of NADPH to the incubation mixtures.
Incubations were set up, each containing the
same amount of labelled substrate and enzyme (l ml. )
but each ith a different amount of NADPH, varying
from zero to 0.5 g moles. The thin layer plates
obtained from these incubations were segmented and
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elnted and the amounts of both products formed
and the amount of substrate disappearing were
estimated by radioactive means. The results ere
given in Table 36 .
Graphs were drawn of NADFH concentration
against (a) amount of substrate disappearing in
2 hr., (b) the amount of dihydroxycoprostane in
2 hr. and (c) the amount of choles t—4-en-3c,,7c.—
diol formed in 2 hr. It can be seen from these
graphs (Pig. 47) that the amount of substrate dis¬
appearing with concomitant rise in products formed
increases as TT/.DPH concentration increases, sharply
up to about 0.1 p. mole FAJDPH. Concentrations of
,.12.1+ ml.
HADPH greater than 0.1 g mole/gave no further
increase in products formed or substrate disapp¬
earing. Thus the enzyme would appear to be satu-
2.1+ ml.
rated at about 0,1 ji mole HADPF/ It would seem,
therefore, that the formation of both cholest-4-
en-3at7a-diol end cliby roxycoprostane from
cholest-4—en—5-one-7a-ol is dependent on the NADPI [
concentration in the medium.
(c) Cholest-4—en-S-one studied as a possible
inhibitor
As cholest-4-en-3-one is such a toxic sub¬




























































Graphs of substrate concentration plotted against
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(Steinberg and Frederickson, 1956; Tomkins,
Nichols, Chapman, Hotta and ChaiEoff, 1957) it
was wondered whether, in fact, the cholest-4-en-
3-one is inhibiting one of the reactions on the
pathway of the breakdown of cholesterol to bile
acids. The reduction of cholest-4—en-3-one-7a-
ol might be the reaction inhibited, as the struc¬
ture of cholest-4-en-3-one is so similar to that
of cholest-4-en-5-one-7a-ol.
The possible inhibitory effect of eholest-4-
en-3-one was tested by setting up incubations con¬
taining a fixed amount (50 jig.) with varying
amounts of cholest-4-en-3-one-7a-ol. The two
reduction products of the substrate were isolated
from thin layer plates and estimated by radio¬
active means. These incubation results were
compared with results obtained from incubations
with varying amounts of substrate but containing
no inhibitor. These results are shown in Table 37
Graphs were drawn of substrate concentration
against (a) the amount of dihyciroxycoprostane
formed and (b) the amount of cbolest-4-en-3a,7a-
diol. These graphs were compared with the cor¬





















































































































































It can be seen that adding cholest-4-en-3-one
to incubations with cholest-4-en-3-one-7a-ol
gives rise to less dihyaroxycoprostane than is
formed without inhibitor. However, inhibitor
does not seen to affect the formation of cholest-
4-en-3<x,7a-diol, Plotting the reciprocal of the
substrate concentration against the reciprocal of
the reaction velocity shows that the inhibitory
action of cholest-4-en-3-one on the formation of
non-
dihydroxycoprostane is of a/competitive nature,
as the K value of the inhibited reaction is the
m
same as that of the uninhibited reaction (Fig, 48
The fact that the formation of cholest-4-en-
3a,7a-diol is unaffected by inhibitor, whereas
the formation of dihydroxycoprostane is affected
is not in accord with the theory that cholest-4-
en-3-one-7a-ol is reduced firstly to cholest-4-
en-3a,7a-dio} which is further reduced to dihydro¬
xycoprostane, One explanation of these results
is that dihydroxycoprostane may be formed by
another route from cholest-4-en-3-one-7c-ol in
this enzyme preparation (see p, 214 )•
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(d) Activity of enzyme towards several
A4r~3»ke tones
As this partially purified enzyme is presuma¬
bly the same preparation as that described by
Tomkins, (1956, 1957) and should therefore be
capable of reducing cortisone, it was decided to
test the specificity of the preparation by incuba¬
ting several ^4-3-ketones with it.
Solutions containing approximately 50 jj,g. in









Incubations were set up containing NADPH-gen¬
erator, 1 ml. enzyme and 50 gg. of each substrate.
Two incubations v?ere set up for each substrate,
one of which was stopped at zero time to act as a
control, while the other was allowed to incubate
for 2 hr. The incubations were extracted as usual
and the residues from the extractions were
I
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dissolved in ethanol and their absorption spectra
plotted. The absorption spectra of standard sol¬
utions of each steroid were also plotted.
The ethanolic solutions were then concentrated
and run on thin layer plates which were sprayed
to identify products* and photographed. The
number of p moles of each steroid metabolised are
shown in Table 38 and it can be seen, firstly tha^
the enzyme is very active towards C8i-steroids,
such as androst-4-en:3:17-dione; secondly that
cholest-4-en-3-one, used in the inhibitor studies
is also metabolised very slightly but that
cholest-4-en-3-one-7a-ol is more readily reduced.
Other experiments comparing the reductive activity
of the enzyme towards cholest-4-en-3-one and
eholest-4—en-3-one-7a-ol showed that the former
substrate was not metabolised at all. The fact
that cholest-4-en-3-one may be a substrate for
this enzyme preparation complicates the conclusions
that can be drawn from inhibitor studies.
Metabolism of coprostan-3-one-7a-ol
There are tv/o possible routes for the forma¬
tion of 3a,7a-dihyc'roxycoprostane from cholest-4-
en-3-one-7a-.ol, as has been discussed on p. 214
















































































as eholeet-4-en-3a,7o-diol and 3a,7a,-dihydroxy-
coprostane were obtained as reduction products of
eholest-4-en-3-one-7a-ol by the supernatant
enzyme, the route for the formation of dihydroxy-
coprostane must lie via cholest-4-en3a,7a-aiol.
However, the facts that (a) authentic cholest-4-
en-3a,7&-dlol was not readily converted into
dihydroxycoprostane by this enzyme, and (b) the
inhibition studies using eholest-4-en-3-one
indicated that only the formation of dihydroxy-
coprostane was affected by inhibitor, are not in
accord with this theory. Thus, it seemed advant*-
ageous to discover whether coprostan-3-one-7o-o1
was a substrate for this enzyme and could be con¬
verted into dlhydroxycoprostane.
(The synthesis of coproston-3-one-7a-ol is
described in the Appendix, p. 206 )•
Incubations of coprostan-3-one-7a-ol with
supernatant enzyme
(a) Incubations were set up containing NADPH-
generating system and enzyme to compare cholest-
4-en-o-one-7<x-ol, copro s tan-3-one-7a-ol and
cholest-4-en-3a,7a-diol as substrates for the
enzyme. After incubation the steroids were
4
Pig. 49
Photographs of thin layer plates obtained from
incubations with supernatant enzyme. Plates
sprayed with phosphomolybdic acid.
1. Cholest-4-en-3-on-7G-ol as substrate
2. Coprostan-3-one-7a-ol as substrate
3. As 2
4. Standard 5a .7a-dihy tiroxycopros tone
5. Product isolated from an incubation of
enzyme with coprostan-3-one-7a~ol, mixed
with standard 5c.,7a-dihyclroxycoprostane
6. Product obtained from coprostan-3-one-7a-ol




incubation product of copros tan-3«-one-7a-0L.
coprostan-3-one-7a-ol
1 2 3 4
Pig, 49 (a)
Photographs of thin layer plates obtained from
incubations of varying amounts of coprostan-3-one-
7a-ol with supernatant enzyme and NADPH. Also
included is a plate obtained from an incubation of
cholest-4-en-3-one-7a-ol with the enzyme
1, 16 pig. coprostan-3-one-7a~ol as substrate
2, 84 pig, coprcstan-5-one-7a~ol
3, 40 ptg# coprostan-3-one-7a-ol
4, 42# 5 ptg, cho1est-4-en-3-one-7a-ol







extracted and the extracts run on thin layer
plates which were then sprayed to show up the
.
products. From the photograph (Fig. 49) it can
he seen that coprostan-3-one-7a-ol, in the pres¬
ence of enzyme and HADPH is very readily converted
indeed into a substance with the same mobility as
Sa#7a-dihyr3roxycoprostane. Indeed, by eye, it
would appear that more than half of the added
coprostan-3-one-7a-ol had been converted into
dihydroxycoprostane. A control incubation
stopped at zero time gave no such substance when
extracted and run on thin layer chromatography*
Cholest-4-en-3a,7a-diol was seen to give rise to
a trace amount of dihyroxycoprostane.
Jour incubations were set up, one of which
contained 45 pg. of cholest-4-en-3-one-7o-ol and
the other three containing varying amounts of
coprostan-5-one-7a-ol (16, 24 and 40 pg). The
incubations were otherwise identical and were
treated in exactly the same manner. The lipid
extracts were run on thin layer plates which were
then sprayed to develop the products. The plates
were photographed (Fig.49 a) and it can be seen
that as the amount of coprostan-3-one-7a-ol as sub¬
strate increases, the amount of dihyd.roxycoprostane
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formed increased# It can also be seen that
40 |o.g, coprostan-3-one-7a-ol gives rise to more
dihydroxycoprostane than does 45 gg. cholest-4-
en-3-one-7a-ol•
(b) Identification of the product as 3a,7a-
dihycl.roxycopro stane
On spraying the thin layer plate obtained from
an incubation of supernatant enzyme, NADPH and
coprostan-3-one-7a-ol the only product seen had a
mobility identical with that of authentic 5a,7a-
dihydroxycoprostone in the benzene:ethyl acetate:
acetone system, i.e., 0.45 (see Pig. 49 ). The
product gave a yellow colour when sprayed with
phosphotungstic acid as does 3a,7a-dihydro:xy-
coprostane. The product was eluted from an
unsprayed plate, and the eluate taken to dryness.
Concentrated sulphuric acid was added to the resi¬
due and the absorption spectrum of the yellow sol¬
ution was plotted after one hour. The spectrum
showed a peak at 312 mg. similar to that given
by 3a,7a-dihydroxycoprostane (Pig. 50)
The product of the reaction was eluted from
an unsprayed plate, as above, and half of it was
re-run on a similar plate mixed with authentic
,
dihyoroxycoprostane. The other half was also run
Sulphuric acid spectra of authentic dihydroxycoprostane and product obtained




on the plate but not mixed with the pure 3a,7a-
dihydroxycoprostane. In the benzene: ethyl acet¬
ate: acetone system the incubation product did not
separate from the genuine compound# (Fig. 49).
This substantive evidence shows that when
coprostan-3-one-7a-ol is incubated with this
partially purified supernatant enzyme it is very
readily converted into 3a,7a-dihydroxyeoprostane.
(c) Co-factor requirements
(i) Incubations were set up to compare the effect
of adding (a) NADPH-generating system, (b) NADH
(equivalent to the amount of NADPH formed), and
(c) no co-enzyme, on the formation of dihydroxy-
coproctane from coprostan-3-one-^a-ol.
Thin layer plates were run on the lipid
extracts from such incubations and were sprayed
firstly with phosphotungstic acid and then with
phosphomolybdic acid. It was seen that dihydro-
xycoprostane was formed when either NADPH-genera-
ting system or NADH were added. No product could
be detected when no co-enzyme was present#
Thus, the enzyme system which converts copro-
stan-3-one-7a-ol to dihydroxycoprostane is not
specific for NADPH but functions equally well
when NADH is added as co-factor.
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(ii) An attempt was made to measure the amount
of product formed when coprostan-3-one-7a-ol
was incubated with varying amounts of NADPH from
zero to 0.4 |i moles, prepared as described on
p. 233 • The product formed in each case was
eluted from the unsprayed thin layer plate on
which it was run, and to the residue, concentra¬
ted sulphuric acid was added. After one hour
the solutions were read at 312 mp and the number
of pg« of dihydroxycoprostane formed was calcula¬
ted from a calibration curve constructed by
reading known amounts of dihydroxycoprostane in
sulphuric acid at 312 mp., However, this reaction
is not a very sensitive one, and is not very
accurate for quantities of dihydroxycoprostane
less than about 50 pg. It was therefore impos¬
sible to draw any graph from the results. How*
ever, it was seen that there was no peak at 312
mpt. when 0 p, moles of NADPH were present, whereas
at 0.25 p. moles NADPH about 25 pg. of dihydroxy¬
coprostane was formed.
(d) Conclusion
It has been found in the above experiments
that coprostan-3-one-7a-ol in the presence of
either NADPH or NADH and. enzyme is converted very
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readily into 3a,7a-dihydroxycoprostane. This
evidence, then, would indicate that two routes
do exist for the formation of aihydroxycoprostane
by reduction of cholest-4-en-3-one-7a-ol (see
Fig. 39). As coprostan-3-one-7a-ol is so readily
reduced to dihydroxycoprostane it presumably does
not accumulate when eholest-4-en-3-one-7a-ol is
incubated with the enzyme, and can therefore never
be isolated from an incubation mixture.
On the other hand, as cholest-4-en-3a,7a-diol
is not readily converted to dihydroxycoprostane,
it does accumulate and can be isolated from the
incubation mixture.
?.Jhen eholest-4-en~3-one-7a-ol is incubated
with enzyme and no co-factor, or with FADH, it
has been shown that no products accumulate. It
has also been shown that the reduction of copros-
tan-3-one-7a-ol recjuires either NADH or NADPH.
This evidence suggest that the reactions reducing
(a) cholest-4-en-3-on-7a-ol to cholest-4-en~3a,7a«*
diol, and (b) cholest-4-en-3-one-7a-ol to
coprostan-3-one-7a-ol are both NADPH dependent.
The evidence obtained from the inhibitor
studies indicates that cholest-4-en-5-one must
inhibit, or be a substrate for the enzyme system
which converts cholest-4-en-3-one-7aol to copros-
tan-3-one-7a-o1•
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SUMMARY OP SECTION V
The metabolism of cholest-4-en-3-one~7a-o1
was studied by incubating this substance, labelled
or unlabelled, with the various cell fractions of
rat liver. The methods employed lipid extraction,
crude chromatography columns and the identifica¬
tion and estimation of metabolites using thin
layer chromatography.
The results showed:-
(A) No metabolism of cholest-4-en-3-one-7a-ol
occurred in the microsomal fraction.
(B) In mitochondria the more polar u.v. absorbing
product was obtained. This hydroxylation reac¬
tion was studied under various conditions and it
was found that:
a) the reaction was not stimulated by either
NADPH or NADH;
SP (boiled supernatant) slightly stimulated
the reaction;
c) Oxygen, as the gas phase, also slightly
stimulatedthe formation of the product;
d) disruption of the mitochondria either son-
ically or osmotically did not destroy the
enzymic activity, which was found to lie
in the debris sedimented after disruption
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€i) an acetone powder of mitochondria was
inactive
f) addition of the hydroperoxide of linoleate
to mitochondria had no effecc on the
hydroxy!ation of cho1es t-4-en-3-one-7ci-o1
except under anaerobic conditions when the
hydroxperoxide inhibited the hybroxylation
reaction
(C) If either active supernatant fraction or SP
were added to microsomes, the polar u.v. spot
was produced from chole st-4-en-3-one-7a-ol •
Thus a thermostable co-factor found in the super¬
natant fraction gives microsomes the power to
hydroxylate. The co-factor was inactivated by
treatment with alkali at 100°•
(D) The supernatant fraction was partially puri¬
fied by an ammonium sulphate precipitation
according to Tornkins.
1« (i) The substrate was found to be reduced
to both cholest-4-en-3a»7a-&iol and
3a,7a-dihydroxyeoprostane
(il) The production of both those substance





(iii) The production of dihyclroxycoprostane
was partially inhibited by the pres¬
ence of cholest-4-en-3-one whereas
the production of cholest-4-en-3a,7a-
diol was not
(iv) Chclest-4-on-3a,7a-diol was found to
be not readily converted into
dihydroxycopro st fine
(v) The enzyme system was not a specific
one, as many 3-Ice tones especially
Csi steroids were readily reduced by
it*
This partially purified supernatant
fraction was able to convert coprostan-
3-one-7a-ol very readily to dihy&roxy-
coprostane with either TTADPH or NADH as
co-factor, thus suggesting two possible
routes for the formation of dihyclroxy-




IN RAT LIVES CELL FRACTIONS
252.
METABOLISE' OF 5a ,7c,-DIHYDROXYCOPROBTANE
IN RAT LIVER CELL FRACTIONS
It has "been shown in this work, that
cholest-4-en-3-one-7c-ol can be converted effic¬
iently in the supernatant fraction of rat liver
to 5a,7a-dihyciroxycoprostane, which has been
shown by Bergstrom and Lindstedt (1956) to be con¬
verted in the bile-fistula rat to both chenodeoxy-
cholic acid and cholic acid. It would therefore
be of interest to discover whether dihydroxy-
coprostane can be hydroxylated at position 12 to
give 3<x,7a,12a-trihydroxycoprostane. The mech¬
anism of 12-hydroxylation may be even more compli*
cated than other hydroxylations and the reaction
may not be easily reproduced in vitro, as there
has not been any evidence produced by workers in
this field for the formation of 12-hydroxylated
metabolites. Some very preliminary experiments
were carried out using dihydroxycoprostane as a
substrate and incubating it with the different
cell fractions of rat liver.
(a) 3a,7c,-dihydroxycoprostane was incubated
with the three cell fractions of rat liver, mito¬
chondria, microsomes and supernatant. Buffer,
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pH 7.4, magnesium sulphate and nicotinamide were
the only additions to the incubations. The
incubation mixtures were extracted and columned
as in the described method and the concentrated
ether:alcohol cuts from the columns were run on
fluorescent thin layer plates. The plates were
examined under u.v. light and then sprayed with
phosphotungstic acid. No u.v. absorbing products
were seen to be formed in the incubations of any
cell fraction. On spraying the plates, however,
a more polar substance than dihydroxycoprostane
was seen to be formed in the mitochondrial incuba+-
tion only. Trihydroxycoprostane run as a stand¬
ard in the same solvent system had a mobility
similar to this substance. The substance gave a
yellow colour with phoophotungstic acid, as does
dihydroxycoprostane itself, and also trihydroxy¬
coprostane.
(b) Two incubations were set up, containing
dihydroxycoprostane as substrate. One of these
contained boiled mitochondria and the other con¬
tained active mitochondria. The incubations were
treated as usual and the section of the thin layer
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plate obtained from the incubation with active
tissue which should contain the polar substance
seen to be formed in the first experiment, was
scraped off, eluted with ether:alcohol and re-run
on a thin layer plate alongside standard tri-
hydroxycoprostane. The rest of the first plate
was sprayed with phosphotungstic acid and it was
seen that no polar substance with the same mobil¬
ity as the substance formed in the active incuba¬
tion, was produced in the boiled tissue incubation.
On spraying the second plate, which was also run
in the benzene:ethyl acetone:acetone system, the
polar substance produced in the active incubation
was found to be slightly less polar than 3a,7a,-
lSa-trihyclroxycoprostane. This would indicate
that the substance is probably 26-hydroxylated
derivative cf 3a,7a-dihydroxycoprostane as the
addition of a 12-hydroxyl group would make a sub¬
stance more polar than the addition of a 26-hydro-*
xyl group.
Active mitochondria can therefore convert
3a,7a-dihydroxycoprostane to a more polar sub¬





A brief summary of the progress achieved in
this study is given in the following paragraph: -
a) A method has been developed whereby small
amounts of the possible intermediates in choles¬
terol breakdown, can be incubated with rat liver
cell fractions.
b) A study of the initial hydroxylation of
cholesterol has been undertaken.
c) The study of the met. bolism of 7a-hydroxy«
cholesterol in the different cell fractions of
rat liver and combinations of cell fractions has
led to sane interesting discoveries.
d) It has been established that the possible
intermediate in cholesterol breakdown, cholest-4-
en-3-one-7a-ol, is metabolised efficiently in rat
liver to 3a,7a-dihydroxycoprostane, a knowninter-
mediate. Cholest-4-en-5-ono-7a-ol is also con¬
verted to a more polar compound, possibly the
26-hydroxylated derivative.
d) Preliminary experiments show that 3a,7a-
dihydroxycoprostone is converted to a more polar
compound also.
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The method of extraction and purification of
metabolites that has been developed in this work
has the advantage that man# incubations can be
carried out on the cell fractions from any one
rat liver. This means that not only can small
amounts of substrate be used, but also each rat
acts as its own control. This is important as
there is no doubt that there is variation from
one rat liver to another. This may depend on
the age of the animal but could also depend on
the levels of co-enzymes occurring in each prep¬
aration. Several examples have been cited in
the text, especially where mitochondrial prepara¬
tions are concerned when it has been suggested
that certain results are unusual because of a low
or high level of NAD in the preparation (see pages
141 and 152 )• A further advantage of being
able to carry out several incubations on the cell
fractions from one rat liver, is that an effect,
such as substrate concentration variation or co¬
enzyme concentration variation, can be studied,
although the cell fractions have not been further
purified.
257.
The development of thin layer chromatography
and very especially the development in this study
of the fluorescent thin layer plates has proved
to be of importance in this method. The method,
however, does have the disadvantage that subst¬
ances must be eluted from the plate before estim¬
ation and a column method of separation of metab¬
olites giving a direct estimation of substances,
could, perhaps, be more convenient. However,
it is likely that no simple and quick column
method could give such complete separation of com¬
pounds as thin layer chromatography, and probably
only on reverse phase columns such as used by
Danielsson (1958) could such separation be
achieved. The reverse phase system of columning
is slow and also susceptible to temperature change
Danielsson used mg. amounts of substances and it
might be difficult to adopt this reverse phase
system to a micro-scale. The reverse-phase
system then is not suited to the rapid separation
of the many metabolites obtained from incubations
some of which are only present in amounts of 5 pg.
or less. An advantage of thin layer chromato¬
graphy over such a column system is that it gives
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not only a method of separation but also a direct
way of identifying metabolites at one and the
same time.
With the method, that has been developed,
no attempt has been made to detect the formation
of acidic metabolites such as chenodeoxycholic
acid and cholic acid or the corresponding copros-
tanic acids. However, with modifications in the
extraction procedure, the columning and the
solvent systems used for thin layer chromatography
the method could easily be adapted to study this
aspect.
Thus, it seems that this method allows the
study of the metabolism of possible intermediates
in cholesterol breakdown in rat liver incubations
with the minimum time taken for results to be
obtained. Metabolites can be identified, and
estimated even when only 2?., of the substrate has
been converted to a product.
Some preliminary experiments have been
carried out to try to discover how and where the
initial hydroxylation of cholesterol takes place.
Using cholesterol as a substrate presents
the problem of autoxidatlon, as has been pointed
out, and the experiment performed incubating
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labelled cholesterol with the different cell
fractions of rat liver failed to give much useful
information, partly because of this. In this
experiment the results obtained by Danielsson
(i960) were not confirmed. This is probably
because he used mouse mitochondria and mitochon¬
dria plus SP, with additions such as NAD, AMP,
etc. and also used SP only as a control to indi¬
cate the degree of autoxidation. The cholestero
used in the experiment performed in Section IJI,
Y/as probably not sufficiently radioactive, v/hich
meant that small changes were very difficult to
identify. Thus, if small amounts of metabolites
had been formed, their presence might have been
overlooked. Thus, it seems that about the only
information to be gained from the experiment is
that autoxidation is particularly marked in the
microsomal fraction. An interesting point is
that in the active mitochondrial incubation, the
radioactivity recovered from the 7a-hydroxycholes-
terol segment was actually less than that obtained
from the corresponding segment of the boiled mito¬
chondria incubation. It might be possible, then
that as the 7a-hydroxycholesterol was formed from
cholesterol, it was converted to a more polar
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product such as cholest-5-en-3p,7c,,26-triol.
This hydroxylation reaction has "been found to
occur in mitochondria (see Section IV, p. 139)
with no additions. The radioactivity recovered
in the origin sequent of the active mitochondrial
incubation, where the triol would run was higher
than that obtained from the boiled inclination,
which would agree with this theory.
In an attempt to discover the mechanism of
the initial hydroxylation at the 7a-position, the
7<x-hydroperoxide of cholesterol was used as a sub¬
strate. It is possible that in the formation of
7a-hydroxycholesterol, a hydroperoxide is formed
as an intermediate ?/hich is then reduced by some
agent such as NADPH. Chanically, it is readily
reduced to 7a-hydroxycholesterol by lithium alum¬
inium hydride. However, the study of the metabo¬
lism of this substance is made very difficult by
its instability, even to incubation at 37° with
buffer, when both 7c,-hydroxycholesterol and 7-lceto-
cholesterol are produced, the latter probably by
dehydration. Adding the reducing co-enzyme NADPH
to the buffer incubation gave no increase in the
amount of 7c,-hydroxycholesterol formed. Thus,NADPH
cannot reduce the substrate in buffer solution onlj*
On adding an acetone powder of mitochondria,
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however, about double the amount of 7<x-hydroxy~
cholesterol was formed. Addition of NADPH
to the acetone powder made no increase in the
amount formed. It may be, then, that possibly
ensymic activity does exist in mitochondria which
will catalyse the reduction of the 7a-hydropero-
xlde but the reduction could just as easily be
brought about by a reducing agent such as gluta¬
thione present in the acetone powder. On com¬
paring the activities of boiled and active mito¬
chondrial powder it was shown that in the active
incubation more 7o~hydroxy cholesterol was pro¬
duced than in the boiled incubation, indicating
that some ensymic activity does exist. Any
attempt to study the metabolism of the 7c-hydro¬
peroxide in native tissue cell fractions will be
made very difficult by the instability of the
compound and adequate controls will have to be
induced in any series of incubations.
It would be of interest to discover whether
labelled 7a-hydroperoxide would be convex1 ted to
bile acids in the bile-fistua rat.
The study of the metabolism of cholesterol
by rat macrophages raised some interesting points.
This tissue preparation was found to be clean ro
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?/ork with, no column procedure was required to
purify the constituents of the lipid extracts and
also autoxidation was at a minimum although after
long periods of incubation, it became more notic¬
eable. It was found in the experiments carried
out, however, that in any series of incubations
stopped at different tin® intervals, no increase
in products could be seen with increase in time.
In fact, it seemed that either the incubation
was Inactive in metabolising cholesterol or was
very active. This is probably due to the con¬
dition of the cells. Sometimes for unknown
reasons, the macrophages do not grow satisfactorily
and tend to slough off the surface of the "baby
bottle". Thus, variations in results are
probably due to this.
When an incub; tion was active, however, it
seemed to produce fairly readily, 7a-hydroxy-
cholesterol and more polar substances from choles¬
terol or its esters. In one experiment bile
acids have been identified as products. This
result does not agree with the findings of Day,
(1961) who showed that no oxidation of the side-
chain of cholesterol was brought about by rabbit
macrophages. However, he was using cholesterol
263.
as a substrate and in the experiments conducted
in this study a mixture of cholesterol and
cholesterol esters as they occur in serum was
employed. This would imply that cholesterol
esters may be the starting compounds for the bre¬
akdown of cholesterol to bile acids. The possib¬
ility that the bile acids found in the incubation
described in Section III p. 95 may have been
present in the serum must not be overlooked
however. AJ.so Day used rabbit macrophages,
whereas in this work rat macrophages were employed.
It is interesting to note that a substance v/ith
chromatographic properties identical to 7a-hydro-
xycholesterol was present in minute quantity in
the rat serum. This substance was found to be
non-radioa c tive.
This type of experimental approach shows
great promise in the study of cholesterol break¬
down and it would be of interest to discover
whether 7a-hydroxycholesterol and cholest-4-en-3-
one-7a-ol and other possible breakdown intermed¬
iates of cholesterol can be metabolised by these
cells. In the case of substrates, other than
cholesterol, they would have to be added to the
incubation in some medium other than serum, such
264.
as methanol or albumin suspension. Check experi¬
ments would then have to be performed to find out
if methanol had any adverse effect on the growth
of the macrophages.
The study of the metabolism of 7a-hydroxy-
cholesterol in the different cell fractions of
rat liver and combinations of cell fractions has
brought to light some interesting points.
As has been discussed in the Introduction#
it certainly seems that rat liver and mouse liver
can convert 7a-hydroxycholesterol to the less
polar, oxidised substance, cholest-4-en-3-one-7a-
ol, presumably being the intermediate formed
during the epimerisation of the sp-hy&roxyl group
and the satxiration of the double bond. However,
there seems to be some doubt as to where in the
cell this conversion is carried out. Yamasaki
et al. (1959) have found activity for producing
an a,£-unsaturated ketone from 7a-hydroxycholes-
terol in what they call "the supernatant fraction"
of rat liver whereas Danielsson (1961 b) finds
the formation of cholest-4-en-3-one-7a~ol to take
place in the mitochondria of mouse liver to which
SF has been added. The results obtained in this
work, however, do not agree with either of these
findings.
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In this work, then, two enzyme systems, both
presumably containing 3p-hydroxy dehydrogenase and
isomerase activities have been found, both of
which can convert 7a-hydroxycholesterol to
cholest-4-en-3-one-7a-ol. One of these enzymes
is located in the mitochondria find is dependent
on either NAD or NADP as electron acceptor.
This may be the enzyme which gives the activity
described by Danielsson (1961 b) in mouse mito¬
chondria. The other enzyme found in this work,
is considerably more efficient at converting 7a-
hydroxycholesterol to the oxidised compound than
is the mitochondrial enzyme. In fact, for the
same weight of liver and the same amount of co¬
enzyme, the microsomal enzyme is nearly four
times as active as the mitochondrial enzyme.
This microsomal enzyme may be the enzyme described
by Yamasaki et al. (1959) as producing an c&^-un¬
saturated ketone from 7ci-hydroxycholesterol, as
Yamasaki prepared the "supernatant fraction" by
spinning the homogenate free from nuclei and cell
debris, at 80,000 x g for 30 min. It is doubtful
if this procedure would completely sediment the
microsomes so that Yamasaki*s "supernatant frac¬
tion" might contain some microsomes. In this
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work, only 2fo of the substrate was ever found to
be converted to cholest-4-en-3-one-7a-ol in the
100,000 x g supernatant, and this may be due to
unsedimented microsomes.
It was thought that perhaps the two oxidative
enzymes discovered in this work might be one and
the same and that the mitochondrial activity was
merely due to microsomal contamination. There
are in fact several similarities between the two
'
v
activities. Firstly, both are dependent on NAD
as electron acceptor, which can be replaced in
both mitochondrial and microsomal systems by
NADP. Secondly# the effect of cyanide on these
enzymes is very similar. In both cases, contrary
to expectation, adding cyanide increased the
amount of cholest-4~en~8-one-7a-ol formed from
7a-hydroxycholesterol. This is thou^t to be
due to the cyanide, inhibiting other NAD-recjuiring
reactions occurring in the two cell fractions,
and thus making more NAD available for the oxida¬
tion of 7o**hydroxycholesterol.
However, even although the two oxidative
enzymes are similar in these two ways, the follow¬
ing points would seem to disprove the suggestion
that only one enzyme systems exists. Firstly,
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on varying the substrate concentration added to
incubations with mitochondria and with microsomes
the same amount of co-enzyme being added to each
series of incubations, it was found that the
curves obtained on plotting substrate concentra¬
tion against reaction velocity, (i.e. amount of
product formed/hr.) were different in shape,
(see pages 114 &127). Thus, the K values for
both enzymes were significantly different i.e.
for microsomal enzyme is 3.13 x and K value
m
for mitochondrial enzyme is 3.8 x 10*"* M.
Secondly, the effect of succinate on the two
enzymes is quite different. Adding succinate to
the microsomes has no effect on the oxidative
activity whereas on addition to mitochondria it
has a profound effect. In mitochondria adding
succinate gives rise to hardly any cholest-4-en-
3-one~7a-ol and in some cases the formation of
product is completely inhibited. This is thought
to be due to the fact that succinate is reducing
all the added HAD to NADH in mitochondria, under
the influence of succinic oxidase (Chance, 1956).
It may be that no such activity for reducing NAD
to NADH with the fid of succinate occurs in micro-
respiratory
somes but/activity is certainly present in this
cell fraction (Ernster, 1958; Perm and Mackler,
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1958)•
Thirdly, the effect of SP on the two enzymes
is different. In mitochondria, as will he
discussed in detail, it has the effect of reduc¬
ing the amount of product formed hy the enzyme
by more than half, two more polar products "being
simultaneously formed. In microsomes, the addi¬
tion of SP gives rise to a slight reduction of
the cholest-4—en-3—one—7a—ol formed, and the
formation of one more polar product.
Thus two enzymes do exist which will oxidise
7a-hydroxyeholestero1 to cholest-4~en-3-one-7a-ol
and probably the most important one is to be
found in the microsomal fraction of rat liver.
In this study it has been found that SP
plays a part in certain hydroxylation reactions
occurring in the breakdown of cholesterol. The
role of SP was hitherto, unknown although it was
found to be necessary for the oxidation of the
side-chain of cholesterol.
The effect that SP seems to have on the
binding of substrates to tissue is interesting
but may not be of any significance. It was
shown that 100>5 recovery of labelled 7a-hyciroxy-
cholesterol could be obtained from an incubation
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with boiled mitochondria and SF, whereas only
about 85/' could be achieved if active mitochondria
and SF were involved (i.e. 85% of the added
counts, some of which were associated with the
products of the reaction). A similar state of
affairs was found to exist when labelled chclest-
4-en~5-one-7a-ol was used as a substrate. This
effect may only be coincidental and not important
in the metabolism of either of these substances.
SF was found, however, to have a profound
effect on the metabolism of 7a-hydroxycholesterol
in the mitochondrial fraction of- rat liver. If
mitochondria are incubated with 7<x~hyclroxyeho1es-
terol and HAD, about 6% of the substrate is con¬
verted into the oxidation product, cholest-4-en-
5-one-7u-ol. If, however, SF is added to such
an incubation mixture, the amount of cholest-4-en-
3-one-7ct-ol formed is reduced to about 2% and at
least two other more polar metabolites are prod¬
uced. The percentages of these polar products
which are thought to be hydroxylated derivatives
add up to about 4%, the amount by which the oxida¬
tion product is reduced. Therefore it appears
that SF "directs"' the metabolism of 7a-hydroxy-
cholesterol away from an oxidation reaction and
towards hydroxylation reactions.
270
In the absence of HAD or SF, mitochondria
are capable of converting 7a-hydroxycholesterol
to one of the more polar products, cholest-5-en-
2£,7a,26-triol. Therefore if this substance is
produced on incubation of 7a-hydroxycholescerol
with mitochondria, and also with mitochondria,
SF and NAD, SF must act by cancelling out the
effect of the HAD. An experiment in which mito¬
chondria were incubated with varying concentra¬
tions of HAD supported this idea, because it was
found that as the NAD concentx'ation increased,
the amount of cholest—4-en-5-on©-7a~ol formed
increased and the amount of triol formed decrea¬
sed. An incubation containing a low concentra¬
tion of HAD was therefore equivalent to an ineuba*.
tion containing a higher concentration of NAD and
SF. If this is the case, then, that SF acts
partially be eliminating the effect of NAD, the
question to be answered is, how does it have this
effect? It seems that SF must either inactivate
the NAD in some way, or cause its removal by met¬
abolising it. The latter explanation seems the
most likely.
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Considerable interest has been aroused
recently by the possibility that diearboxylic
acids, in partictilar, succinate, may control the
ratio of N/DrNADH in the mitochondria (Chance,
19561 Snoswell, 1962) by reducing HAD to NADH#
Alien succinate was incubated with mitochondria,
NAD and 70,-hydroxyeholcsterol in place of SP, it
was found to have the same activity as SP, giving
a lower conversion of substrate to cholest-4-en-
3~one-7a-ol and giving rise to the two hydroxy-
lated metabolites# In this case, one can be con¬
fident that succinate is acting in this way by
reducing the added NAD to NADU and thus limiting
the formation of the oxidation product of the
substrate* Other dicarboxylic acids such as
fumarate, oxaloacetate, 0,-ketoglutaratf, which
would also stimulate the removal of NAD, were found
to mimic the effect of SP. Dicarboxylic acids,
which would not, however, cause the removal of
FAD, such as maleste, malonate and dihydroxyfuma-
rate were founa to have no SP-like activity
when incubated with mitochondria and NAD and
actually gave use to slightly more of the oxidation
product of 7a~hydroxycholesterol than mitochondria
with only NAB added# This might be due to these
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substances inhibiting the normal NAD-requiring
reactions occurring in mitochondria, and thus
making more NAD available for the oxidation of
the sxibstrate. Citrate, the tricarboxylic acid
was found to be as active as succinate in its
effect on the metabolism of 7a-hydroxycholesterol
in mitochondria, Chance (1956) found that suc¬
cinate reduces NAD to NADH more efficiently thati
the conventional NAD-linked intermediates in the
citric acid cycle. In this case, then, it is
probable that when succinate is added to an
incubation it is acting merely as a citric acid
intermediate stimulating the removal of NAD by
stimulating the citric acid cycle, and is not
taking part in the reaction described by Chance
where succinate directly reduces NAD to NADH.
The theory that SF has part of its effect by
reducing the added NAD is thus strengthened by
these findings and also by the fact that incuba¬
ting NADH with mitochondria and substrate gives
the seme result as incubating mitochondria with
SF and NAD. It is not unlikely, then, that SF
contains a substance with similar properties to
succinate or fumarate. It seems however, that
this property of SF of removing added NAD is only
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one part of its activity# If mitochondria are
incubated with 7a-hydroxycholesterol and various
amounts of SF, then the amount of triol formed
increases as SF increases# Thus, SF may also
actually stimulate the process of hydroxylation,
as well as depleting NAD. This "stimulation" of
hydroxylation reactions by SF is also seen to
occur when cholest-4-en-3-one-7a-ol is incubated
with mitochondria. This "stimulation" might be
explained if SF was merely reducing any endogenous




NADH + NADP > NADPH + NAD
NADPH, normally required for hydroxylation reac¬
tions, would then stimulate the hydroxylation rea¬
ction. If this was the case, one would expect
succinate to have the same effect. It was found
however, that incubating 7a-hydroxycholesterol
with mitochondria and varying amounts of succinate
gave no increase in the amount of triol formed.
Also adding NADPH to incubations of mitochondria
with cholest-4-en-3-one-7a-ol gave no increase in
the amount of the hydroxylated derivative formed,
whereas SF did give increased formation. It
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would seem, then, that SP does not stimulate
hydroxylation by this means and this also shows
that SF has two types of activityj firstly, it
has the power to remove NAD, and this activity
may be quite coincidental, and secondly, it has
the power to stimulate hydroxylation reactions.
In the microsomal fraction of rat liver also
it was found that SP plays a part in hydroxylation
reactions. Microsomes, with no additions, unlike
mitochondria, are incapable of hydroxylating
either 7a-hyclroxycholesterol or cholest-4-en-3-one-
7a-ol. If on incubation is carried out with
microsomes, NAD and 7a-hyo.roxycholesterol the
oxidation product, cholest-4-en-3-one-7a-ol is
formed, very efficiently. On addition of SP (or
active supernatant) to such an incubation the
more polar u.v. absorbing compound, the hyclroxy-
lated derivative of cholest-4-»en-3-one-7a»ol is
formed, together with slightly less of the latter
stib stance. This means that SP is causing the
microsomes to hyclroxylate this substance. This
fact is confirmed by adding SP to an incubation
involving microsomes and cholest-4-en-5-one-70,-ol
as substrate, anddiowing that hydroxylation occurs.
This does not happen, as has been pointed out, in
MICROSOMALHYDROXYLATIONREACTIONS Pig.52(a)
275.
incubations with microsomes and substrate alone.
These reactions are summarised in Pig. 52 (a).
This situation, then, is rather similar
to that occurring in the mitochondrial fraction,
in that SF, apparently stimulates hydroxylation.
In the microsomal fraction, however, SF cannot
presumably be acting by removing added NAD. In
incubations of microsomes NAD, 7a-hydroxyhholest¬
erol and 3F, the hydroxylated substance formed is
a derivative of the oxidation product, and not,
as occurs in mitochondria a derivative of 7a-
hydroxycholesterol itself. Therefore, the oxida¬
tion product must be formed first, and then hydro-
xylated and no depletion of NAD can take place.
This latter theory is strengthened by the
fact that adding succinate to microsomes, NAD and
7a-hyclroxycholesterol in place of SF, has no
effect at all. No hydroxylated derivative is
formed and the amount of cholest-4-en-3-one-7a-ol
formed is not significantly reduced. It may be
that no mechanism, such as that occuring in mito¬
chondria for reducing NAD with succinate or SF,
exists in microsomes. Succinate cannot, then,
replace SF in this microsomal hydroxylation mech¬
anism. Also it has been found that adding NADH,
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to microsomes with eholest-4-en-3-one-7a-ol as
substrate does not have the same effect as adding
SF, In other words, NADH cannot replace the
activity of SF in giving microsomes the power to
hydroxylate. Again this is a different situation
from that existing in mitochondria where NADH can
replace NAD + SF.
The evidence summarised here, emphasises
the fact that SF has two types of activity. In
the mitochondrial fraction, firstly, SF can
deplete added NAD probably by reduction to NADH,
and secondly the SF stimulates hydroxylatlon.
In microsomes the latter type of activity only is
found to exist. SF is found, in this case, to
be required before hydroxylation occurs, micro¬
somes with no additions being unable to carry out
hydroxylation. The activity of SF to reduce NAD
in mitochondria may be quite unimportant but as
this effect complicates the situation occurring
in mitochondria, the activity of SF to promote
hydroxylation might be better studied in micro¬
somes.
A very preliminary experiment designed to
obtain some knowledge as to nature of SF, showed
that the activity of SF in mitochondrial incuba¬
tions with 7a-hydroxycholesterol and NAD, was
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resistant to treatment with boiling acid, but on
treatment with boiling alkali, its activity was
completely lost. This means that SP is probably
not succinate or any other citric acid interned-
iate, which have been shown to have the same
effect as SP in depleting NAD, but not in stimul¬
ating hydroxylation, as these substances should
withstand such treatment. SP might possibly be
a phosphate ester, such as ATP or some similar
substance, which wotild be hydrolysed by alkali
under these conditions but not by acid. A
similar situation was also found to occur when
acid and alkali-treated SP were incubated with
.
microsomes and cholest-4-en-3-one-7o-ol, "acid-SP"
retaining its ability to promote hydroxylation,
and "alkali-SF" being inactive. In this case,
no complications due to NAD depletion are^involved.
The fact that inactive (alkali-treated) SP
is bright yellow in colour, might be a clue to the
■
nature of SP. The co-factor required in the
hydroxylation of phenylalanine to tyrosine has
been found by Kaufman (1962) to contain a pteridine
moiety, and many pteridine derivatives are yellow
in colour. Kaufman's co-factor was rendered
inactive by treatment with alkali at 100°, with
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the formation of a fluorescent compound, hut was
not, however, stable to freezing# Thus it is
unlikely that SP is the s eme substance as Kauf¬
man's co-factor#
It has been found, in this work the
hydroxylation of cholest-4-en-3-one-7<x-ol still
occurs in mitochondria under anaerobic conditions*
Initially, this was thought to be due to incom¬
plete anaerobiosls, but another explanation would
be that a bound form of oxygen, such as a peroxide
exists in native mitochondria which could play a
part in the hydroxylation of the steroid# Under
anaerobic conditions linoleate hydroperoxide
actually inhibits hydroxylation, but there is a
possibility that SP itself could be a similar
form of activated oxygen and that, because of this
it has the ability to stimulate hydroxylation
reactions. However, any attempt to replace SP
by the hydroperoxide of linoleate has been unsuc¬
cessful# An experiment set up comparing incuba¬
tions of mitochondria and 7a-hyeroxycholesterol
and mitochondria, SP and 7a-hydroxycholesterol
both under anaerobic conditions, might give results
which would clarify the situation. If, under
anaerobic conditions, hydroxylation of 7a-hydroxy-i
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cholesterol could not occur, then the addition of
SP to such a situation might cause hydroxylation.
to occur. This would Indicate that SF could, in
fact, provide the oxygen required in the reaction.
It is possible that the same mechanism for
the hydroxylation of all steroids, exists. NADFH
has been shown to be absolutely necessary in many
instances where purer enzyme preparations have
been studied and it is to be expected that this
requirement will in due course be noted for all
hydroxylations. The 11-p—hydroxylase enzyme has
had the most extensive study of all the steroid
hydroxylases and Tomkins et al. (1958) found that
the "co-hydroxylaseTT factor required in the reaction
could not be replaced by any of the following sub¬
stances; ascorbic acid, glutathione, nicotinamide
fumarate, citrate, NADPH, hydrogen peroxide, folic
acid or Kaxifman^s phenylalanine-hydroxylating co-
factor. It v/ould be of interest, then to dis¬
cover whether any of these substances could
replace SP in its activity to stimulate hydroxy-
letion of cholesterol derivatives.
Metal ions have also been shown in many
cases to be necessary for steroid hydroxylations
and their participation is assumed to be in the
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activation of oxygen. The addition of the
chelating agent EDTA to the system in microsomes
which with SF, hyclroxylates cholest-4-en-3-one-7a«-
ol might show an inhibition of the reaction which
would indicate that SF was contributing a metal
ion.
However, in order to study the nature of SF
with any success, a hydroxylating system must be
found with a fast assay procedure. As has been
pointed out the amount of triol or polar u.v.
absorbing material obtained either with mitochon¬
dria or microsomes is very small indeed and also
the ensyrne system in mitochondria is not very
stable. This is seen by its inactivation on
treatment with acetone and therefore an attempt
to purify the enzyme system to give a faster assay
procedure, might inactivate the system entirely.
If the amount of' hydroxylated derivative
formed could be increased in some way, probably
the best system in which to study the effect of
SF on hydroxylation would be the microsomal
system, where the polar u.v. absorbing material
is produced from cho1est-4-en-3-one-7a-ol on
addition of SF. The amount of hydroxylated deri¬
vative might be increased by using a much longer
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incubation time or by the addition of other co-
factors such as ATP. The fact that both product
and substrate in this reaction are both u.v.
absorbing means that a method dependent on the
fluorescent thin layer plate technique is very
suitable. If cholest-4:6-dien-3—one could be
used as a substrate, then both substrate and the
hydroxylated product would have an absorption
peak in the u.v. range at 282 mp. with an extinc¬
tion co-efficient of about 28,000. This means
that small amounts of product would be more easily
identified and estimated than the corresponding
amount of "polar u.v. absorbing material" with an
extinction co-efficient of 16,000.
The SP used in all these experiments has been
prepared exactly as described in the original
paper by Anflnsen and Horning (1953). Whether,
in fact, the stimulatory effect of SP on hydrosy-
lation reactions, found in this work, is the same
effect that has been studied on the oxidation of
cholesterol to C03 is not known. Hydroxylation
of the side chain presumably occurs before the
side-chain is split off and so the effect of SP,
seen in stimulating side-chain removal may well be
a reflection of its effect on stimulating hydroxy-
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lation reactions. It would be of great interest
to discover whether SP only stimulates hydroxy-
lotion of the side-chain at position 26 or whether
it also stimulates 12a— or 7a—hydroxylation.
Two pathways must exist for the separate formation
of cholie acid and chenodeoxycholic acid from
cholesterol. This is so because substances such
as 26-hydroxycholesterol or cholest-5-en-3p ,7a,26**
triol give rise only to chenodeoxycholic acid in
the bile-fistula rat, indicating that 12a-hydroxy-
lation cannot take place after modification of the
si^e-chain. Chenodeoxycholic acid itself cannot
be transformed into cholic acid. This means that
if SF stimulates hydroxylation at position 26, as
has been shown here, it has a key role in direct¬
ing the metabolism of cholesterol so that either
chenodeoxycholic acid or cholic acid is formed.
The formation of the 26-hydroxylated deriva¬
tives of the two compounds, 7o—hydroxycholesterol
-
and cholest-4-en-3-one-7a-ol appears to be a com¬
plicated procedure. In this work, the most
easily studied and most efficient reactions have
been those of oxidation and reduction. Veiy small
amounts of these hydroxylated derivatives have
ever been produced and the enzyme system is
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sensitive to acetone treatment. However, if
26-hydroxylation of these compounds is a necessary
step in the pathway to chenodeoxycholic acid,
then one might expect these enzymes to be less
active as usually 20£u of the bile acids produced
from cholesterol is chenodeoxycholic acid whereas
80/i is cholic acid.
In mitochondria, to which NAD is not added,
7<x-hydroxycholesterol is cohverted to cholest-5-
en-3$,7a,26-triol and this is the only product
formed. Adding SF to mitochondria stimulates
the formation of this substance. In microsomes,
however, no triol is formed from 7a-hydroxy-
eholesterol unless active supernatant fraction is
added. SP cannot replace the active supernatant
in this mspect and it would therefore seem that
some thermolabile factor, such as an enzyme
existing in the supernatant fraction is required
by the microsomes before hydroxylation can occur.
Supernatant alone cannot hydroxylate 7a-hydroxy-
cholesterol either. Thus, two enzymes are prob¬
ably required for hydroxylation.
The polar u.v. absorbing substance, thought
to be cholest-4-en-3-one-7a,26-diol is formed
when mitochondria are incubated with cholest-4-en-
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3-one-7a-ol. This reaction has been studied
under various conditions and it is interesting to
discover that the enzyme (or enzymes) responsible
for the reaction are located in the mitochondrial
debris which might mean that hydroxylation occurs
in the wall of the mitochondrion. It is not
really surprising that the addition of NADPII does
not stimulate the reaction in such a crude prepar¬
ation, as 50%' of the cell NADP is found in the
mitochon dria.
The polar u.v. absorbing substance is also
seen to be produced under various conditions when
7a-hydroxycholesterol is used as substrate in
mitochondria. This formation is discussed on
p. 168 and the conclusion reached is that it must
be formed by oxidation of the triol, rather than
by hydroxylation of cholest-4-en-3-one-7a-ol, which
is perhaps contrary to expectation considering
that cholest-4-en-3-one-7a.-ol can be converted to
the u.v. absorbing substance by mitochondria.
This theory was confirmed by incubating triol with
mitochondria and NAD and finding that the polar
u.v. absorbing substance was formed.
In the microsomal fraction it has been found
that no conversion of cholest-4-en-3-one-7o-ol to
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the polar u3v. absorbing substance occurs unless
SP is added to the incubation.Using 7a-hydroxy-
cholesterol as substrate, the only product formed
on incubations with microsomes and NAD is cholest-
4-en-3-one-7a-ol. Addition of active supernatant
or SP, however, then gives rise to the polar u.v.
absorbing substance, together with cholest-4-en-
3-one-7a-ol. In this case, then, the polar uiv.
absorbing substance must be formed by hydroxyl-
ation of cholest-4—en-3-one-7a-ol and not by
oxidation of the triol as no triol is formed under
these conditions.
It has been found that 7a-hydroxycholesterol
can be esterified in the supernatant fraction of
rat liver. Deykin and Goodman (1962 a) have
found that ohly hydrolysis of cholesterol esters
occurs in this fraction whereas esterification
takes placd in the microsomal or mitochondrial
fraction on the addition of co-enzyme A and ATPt
(Deykin and Goodman, 1962 b). Some esterification
of 7a-hydroxycholesterol has also been found, in
this work to occur in the mitochondrial fraction
particularly on the addition of SP. Predricksonj
(1956) investigating the products formed from C1"4-
labelled cholesterol in the mouse mitochondria
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system of Anfinsen and Horning (1953) which
includes 8F, found that 3/S of the products formed
could be attributed to cholesterol esters. Thus
there is an esterifying system present in mouse
mitochondria and probably such a system exists in
rat mitochondria also. In the studies in this
work on the metabolism of C14f-labellefi cholesterol
however, no esterification was seen to take place
in any of the rat liver cell fractions.
It is not know whether esterification of 7a-
hydroxycholesterol is a significant reaction or
whether 7a-hydroxycholesterol is merely acting as
a substrate for the enzymes which normally esteri-
fy cholesterol. The latter may be the case in
the mitochondrial system, but as hydrolysis of
cholesterol esters normally occurs in the super¬
natant fraction the esterification of 7a-hy<3roxy-
cholesterol noted here may be of some importance.
Mawer (1962) isolated 7a-hydroxycholesterol
esters from various sources including rat serum^
skin and liver and human serum from patients
fed safflower seed oil. It is not knownwhether
the 7a-hydroxycholesterol esters found by Mawer,
are formed by hydroxylation of cholesterol It 7a-
position, followed by esterification or by
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esterification of the cholesterol initially and
then hydroxylation, A few experiments carried
■
out in this study incubating 7a-hydroxycholestero].
laurate with the cell fractions of rat liver
showed that hydrolysis of the ester to 7a-hydroxy~
cholesterol occurred readily. This would seem
to imply that if 7a-hydroxycholesterol esters are
formed in vivo, that they are probably produced
by hydroxylatlon of cholesterol esters.
However, if 7a-hyclroxycholesterol esters are
formed normally from cholesterol esters a possible
explanation can be given for their production from
7a-hyc:roxyeholesterol when it is incubated with
the supernatant fraction of rat liver. It may be
than an ester grouping is necessary to protect
the Sp-hydroxyl group, while reactions at other
positions in the steroid are occuning.
It has been established, in this study, that
cholest-4-en-3-one-7a~ol to which 7a-hydroxy-
cholesterol is readily converted in microsomes,
is metabolised in rat liver to 3a,7a-dihycroxy-
coprostane. Both cho1est-4-en-3-one-7a-o1 and
3a,7a~<lihydroxycoprostane have been shown to be
converted to bile acids in the bile fistula rat
(Danielsson, 1961 a; Bergstrom and Lindstedt,1956)
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and are therefore probably intermediates in the
breakdown of cholesterol to bile acids* The
work present here further strengthens this
evidence.
The reduction of cholest-4-en-3-one-7a-ol is
found to take place in a purified preparation of
the supernatant fraction of rat liver* This
preparation, used by Tomkins (1956, 1957) has
been shown to be non-specific, in that it will
readily reduce Cai steroids such as progesterone
and cortisone, but it shows little or no activity
in reducing cholest-4-en-3-one• On further puri¬
fication of this fraction Tomkins found that,
contrary to his expectation of finding one non¬
specific reductase several specific reductases
do exist in the supernatant fraction. Possibly
on further purification of the "supernatant Enzyme"
a specific reductase for cholest-4-en-3~one-7a-ol
might be found*
Tomkins (1956, 1957) found that this purified
supernatant fraction (the protein precipitating
between 50% and 70^ saturation with ammonium
sulphate) converted cortisone firstly to dihy-
diocortisone and then to tetrahydrocortisone
(see diagram,6)* Thus it would be expected that
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cholest-4-en-3-one-7a—ol would be converted to
coprostanr-3-one~7crJ--ol and then further to 3a,7a-
dihydroxycoprostane. Danielsson (1961 c) has in
fact suggested that eoprostan-3~one-7a-ol is an
intermediate in cholesterol metabolism as it is
converted to both chenodeoxycholic acid and cholic
acid in the bile-fistula rat.
However, on incubation of cholest-4—en-3-on-
7a-ol with this fraction two products were
isolated, one of which was 3a,7a-fiihydroxycopro-
stane and the other was cholest-4-en-3a,7a-aiol.
Initially on the basis of this evidence it was
I
thought that cholest-4-en-3-one-7a-ol was reduced
at the 3-keto group first, leaving the double-
bond intact, and then dihydroxycoprostane was
produced by reduction of the double-bond. How—
ever, studies on the incubation of cholest-4-en-
3a,7a-diol with this fraction did not seem to
' *
V
support this theory, as it was found to be con¬
verted only in very-small amounts to dihycroxy-
coprostane. Also inhibitor studies with
cholest-4-en-3-one, showed that dihydroxycoprost¬
ane production was inhibited whereas no effect
could be seen on the production of cholest-4-en-
3a,7a-diol.
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The work carried out using coprostan-3-one-
7a-ol as substrate for this supernatant enzyme,
however, clarified the situation. This substance
was found to be converted very readily to 3a,7a-
dlhydroxycoprostane and therefore it seems that
two series of reactions occur when cholest-4-en-
3-one-7a-ol is incubated with this fraction.
Firstly, cholest-4~en-3-one-7a-ol is converted to
coprostan-3-one-7a-ol with NADPH as co-faetor
(NADH cannot replace NADFH as the production of
dihydroxycoprostane does not occur when NADH is
used). As coprostan-3-one-7a-ol is converted so
readily to dihydroxycoprostane, it does not accum-
ulate and cannot therefore be isolated from an
incubation. The reduction of the 3-keto group
of coprostan-3-one-7o-o1 requires either NADPH or
NADH as co-factor. Secondly, cholest-4—en-3-one4
7c^-ol can be reduced at the 3-keto group first to
'
yield cholest-4-en-3a#7a-diol, the reaction being
specific for NADPH as co-factor. This substance,
as it is not converted easily to 3a,7a-dihydroxy¬
coprostane, accumulates in an incubation and can
be isolated. Cholest-d-en-3-one, presumably
inhibits only the enzyme involved in the reduction
of cholest-4-en-3-one-7a-ol to coprostan-3-one-7a-ol.
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Reduction of the 3-keto group to a 3a-hydro-
xyl group, before reduction of the double-bond,
does not apparently occur v/hen Cai steroids, such
as cortisone are used as substrates. However,
Ringold, Ramaehanaran and Porchielli (1962) have
noted that at pH 5.8, rat liver supernatant, in
the presence of NADPH can convert certain halo-
genated A*-g-keto steroids (Oa-fluoro, 6f3-fluoro,
6a-fluoro and 4-chloro) to the corresponding
allyl alcohols, the 3<x~epimer being the predomin¬
ant product# Testosterone and androsterone,
however, ?/ere not reduced in this way# Also
cholest-4-en-3c,7a-diol has never been suggested
to be an intermediate in cholesterol breakdown to
bile acids# However, this substance could be an
intermediate in the formation of bile acids con¬
taining a hydrogen atom in the 5a-position (i.e*
allo-bile acids) to which more importance has
been given recently, as new? methods for their
separation from the "normal" bile acids (5(3) have
been developed. It would be of interest there¬
fore to study the metabolism of this substance
both in vitro and in vivo in the bile fistula rat#
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Preliminary experiments have shown that
3a,7a-dihydroxycoprostane is converted to a more
polar product in the mitochondrial fraction of
rat liver. This product is thought to he the
26-hydroxylated derivative and not 3a,7a,12a-
trihydroxycoprostane which was slightly more
polar than the incubation product. This is in
accord with the studies of Berseus and Danielsson
(1963) who found that dihycroxyccprostane was
26-hydroxylated in mouse mitochondria and that
the product, coprostan-3a»7a,26-triol was con¬
verted to chenodeoxycholic acid in the bile-fist¬
ula rat.
-
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12a-hydroxylation would seem to be a very
difficult reaction to reproduce in an in vitro
system and no 12a-hydroxy derivatives have been
reported to be produced in vitro studies. How¬
ever, a more detailed study of the metabolism of
dihydroxycoprostane and the effect of SP, might
yield information on this important reaction.
Dihydroxycoprostane, as it can be converted to
either chenodeoxycholic acid or cholic acid
(Bergstrom and Lind.stedt, 1956) then, may lie
at the division in the pathway, one branch of which




Fig. 52 summarises the reactions which have
been shown to occur as a results of this work and
the cell fractions in which they proceed.
The sequence of events in the breakdown of
cholesterol could be visualised as taking place
in an orderly fashion without the steroid having
to be transported from one part of the cell to
another. It is not knownwhere in the cell 7a-
hydroxylation of cholesterol occurs, but it has
been shown here that the most efficient conversion
of 7a-hydroxych.olesterol to cho1est-4-en-3-one-7a-
ol takes place in the microsomal fraction.
Hydroxylation at position 26 of either 7a—hydroxy-
cholesterol or cholest-4-en-3-one-7a-ol takes
place in the mitochondria, but in the latter case
the activity h;: s been shown to lie in the mito¬
chondrial debris. Thus it is possible for the
steroid to be positioned in the cell sap so that
hydroxylations (at position 26) can take place
at one end of the molecule by enzymes in the
mitochondrial wall whereas dehydrogenation and
isomerisation could take place to form cholest-
4-en-3-one-7a-ol at the other end of the molecule
by enzymes in the microsomes. Hydroxylation at
the 26-position has also been shown to be
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catalysed by microsomal enzymes on the addition
of a co-factor from the supernatant. This
hydroxylating system may be more important than
that located in the mitochondria in which case
all the reactions discussed can occur if the
steroid is positioned in the supernatant (or cell
sap) and alongside the endoplasmic-reticulum.
Reduction of cholest-4-en-3-one-7a-ol could then
also take place as the enzymes catalysing these
reactions are found in the supernatant. The
cleavage of the side-chain of cholesterol to give
CO3 takes place in the mitochondria, together with
a co-factor (SF) from the supernatant (Whitehouse
et al. 1961). This reaction is not affected by
sonication of the mitochondria and thus may also
occur in the mitochondrial wall.
In liver there exists a large cholesterol
pool, about 15 mg. in a 200 g. rat. Quantitat¬
ively, the most important route of breakdown of
cholesterol is to the bile acids in liver, about
5 mg. being formed per day in a 200 g. rat. The
steps in this breakdown presumably occur in a
smooth and organised fashion as no intermediates
on the pathway have ever been found to accumulate
in rat liver, except 7a-hydroxycholesterol wrhich
Fie#
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has been isolated together with the other auto-
oxidation products, 7-ketocholesterol, 7p-hydro-
xycholesterol and their dehydration products.
These autoxidation products have probably been
formed during the extraction and isolation proc¬
edure. Therefore, if there are apparently no
slow reactions in the pathway it is puzzling to
find in this study that the reactions proceed in
different cell fractions of rat liver. In the
preceeding paragraph an attempt has been made to
explain this, but it must be emphasised that
in vitro studies are difficult to interpret.
In vivo studies on bile-fistxila rats designed to
Identify intermediates have also provided useful
information on cholesterol metabolism but it must
be remembered that in these bile-fistula rats
cholesterol breackdown is abnormally rapid.
Ho ever, taking the results of in vivo and
in vitro studies together, a picture of the steps
involved in cholesterol breakdown can be built
up (Pig. 55).
From the in vitro work done in this study,
it seems that oxidation and reduction reactions
proceed very efficiently on the addition of the
appropriate co-factors, whereas hydroxylation does
not proceed so easily. This could be interpreted.
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in several ways# For instance, it could mean
that the affinities of the oxidation and reduc¬
tion enzymes for the appropriate substrates are
greater than those of the hydroxylation enzymes#
Alternatively oxidation and reduction may be less
complicated reactions than hydroxylation and
therefore would be more easily reproduced in vitro
Again, the hydroxylating system, in vivo might
be more efficient than oxidation and reduction,
but being a complicated system (for which there
is evidence) the procedure used in in vitro
studies would very likely inactivate part of the
system so that hyciroxylation appears to be an
inefficient reaction*
None of the enzymes involved in the break¬
down of cholesterol have ever been purified and
characterised, although the reductase system in
the supernatant has been partially purified in
this study* This means that, firstly no mech¬
anism for hydroxylation, for example, can be
suggested in such a crude system, although it can
be said that 26-hydroxylation takes place in mito-j
chondria or microsomes and that a co-factor found
in the supernatant fraction is involved. Seconder
the specificity of an enzyme system towards
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several substrates is difficult to test. Thirdly
any reaction studied is complicated by other
reactions occurring simultaneously and possibly
interfering. This is illustrated by the situa¬
tion in mitochondrial incubations where the Hid)
level is so important in deciding whether oxida¬
tion or hydroxylation of 7a-hydroxycholesterol
will occur. It is impossible to tell what the
level of NAD will be in the living rat and there-
fore it is not knownwhich of the two reactions,
oxidation or hydroxylation will normally be
oc curring.
One hormonal effect on cholesterol breakdown
has been studied and this is the influence of
thyroxine. Eriksson (1957) in a study on the
biliary excretion of both cholic and chenodeoxy-
cholic acid in en-, hyper- and hypothryoid bile
fistula rats, found a decreased secretion of
cholate in both hypo- and hyperthyroid rats.
Also a substantial increase in the amount of
chenodeoxycholate formed in hyperthyroid rats
was seen and the chenodeoxycholate excreted in
hypothryoid rats was less than that in euthyroid
rats. These results point to the possibility of
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a direct inhibitory effect of thyroxine on the
12a-hycLroxydase or of a stimulatory effect on
side-chain oxidation. However, no hormonal
effects on any single reaction in cholesterol
breakdown, have been studied in vitro. As 12a-
hydroxylation has not been, demonstrated in vitro
it may be a very complicated reaction, perhaps
influenced by many co-factors, among which might
be thyroxine.
Cholesterol, 7a-hydroxycholesterol, cholest-
4-en-5-one—7a-o1 and dihytroxycoprostane have all
been shown to be hydroxyleted in the 26-position,
the 26-hydroxylr ted derivatives then forming only
chenodeoxycholic acid in the bile-fistula rat.
It is therefore impossible to say whether the 26—
hydroxylase system is very non-specific or whether
a separate ensyme does exist for each of these
substrates. If the former instance is the case,
then the substrate which in vivo is 26—hydroxy-
lated is unknown and will remain unknown until
the enzyme system is purified. On the other hand
if each substrate is 26-hydroxylated in vivo a
series of oxidation and reduction enzymes must
exist which will transform the 3p-hydroxy1 group
to a 3a-hydroxyl group with the 26-hydroxylated
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derivatives as substrates. It may be, of course,
that the oxidation and reduction enzymes studied
in this work catalyse the oxidation and reduction
of the 26-hydroxy derivatives more efficiently
than the compounds studied# Again this possibi¬
lity cannot be tested until purified ens;me
preparations are obtained. Also, for the same
resons, it is impossible to say which substrate
is 12c-hyc roxylated in vivo.
This work has shown that in the breakdown
of cholesterol to bile acids certain definite
variations in metabolic routes exist. Further
studies employing purified cell fractions and
better methods of sterol assay may throw light
on the relative quantitative importance of these
routes. The involvement of the co-enzymes, HAD
and NADP, in the various stages of breakdown of
cholesterol, suggests the possibility of control
of the various pathways by the transhydrogenase
system which in turn may possibly be a site of
action of certain hormones. This work illustrates
that the mechanism of hydroxylation is complex
and perhaps many enzymes and co-factors may take
part in this process. A new co-factor involved
in hydroxylation reactions remains to be identified.
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Some suggestions for further work:
a) As growing rat macrophages have been shown to
metabolise cholesterol or its esters, it would be
advantageous to study the metabolism of ?a-hyclro-
xycholesterol raid other intermediates in bile acid
formation in this type of tissue preparation.
to) As cholesterol is so prone to autoxidation and
the study of its metabolism in vitro therefore
made difficult more information on cholesterol
breakdown might be gained by carrying out a study
on the metabolism of cholesterol esters, which arc
not readily autoxidised. Also it is possible
that cholesterol has to be esterified before
breakdown can occur.
c) An attempt to identify the co-factor SF, which
seems to play a part in hydroxylation reactions
would he of great interest, and might lead to an
insight into the mechanism of hydroxylation.
However, a hydroxylating system which could he
studied by a fast assay procedure is required
before much progress can be made in identifying SF.
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d) A study of the effect of anaerobic conditions
on hydroxylation reactions and the effect of SP
under such conditions might yield information on
the nature of SP, and indicate Y/hether it might
be a bound form of oxygen.
e) The chemical syntheses of 13-hydroxylated
derivatives of cholesterol could be undertaken
and their breakdown or formation studied in the
cell fractions of rat liver, it would be of
interest to discover v/hether SP has a role also
in ISo-hydroxylation.
f) A detailed study of the esterification of 7o»
hydroxycholesterol and the significance of this







This substance was synthesised from cholesterol
acetate, which was reacted with N-bromosuccinimide to
form the 7-brorao-compound. This was converted to
7 **-hydroxycholesterol by the method of Heribest and
Jones (1948) using sodium formate and formic acid. A
mixture of 7 and 7 ft -hy&roxycholesterol was obtained
on hydrolysis and the isomers were separated by column
chromatography on silicic acid. The mixture was added
to the column in 70 % chloroform : 3Of petrol ether and
the oolumn was eluted with increasing amounts of
chloroform in petrol ether and 7 ok -hydroxyeholesterol
was elutod with lOOf chloroform. The purified
substance ran as one spot in several thin layer
chromatography systems (see page 312 ), spraying blue
with phosphotungstic acid.
Melting point = 183 - 184°C.
^"Published melting point = 104°C.,
Barr, Heilbron, Parry and Spring (1936)J
50 rag of the pure 7 (X-hydroxycholesterol was
then labelled with tritium using the Wilzbach method
(ULlzbach, 1957). This method depends on the exchange
1
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of tritium atoms with hydrogen atoms in the substance
to be labelled. The apparatus consists of a conical
flask containing the steroid, spread over as large a
surface area as possible in the bottom of the flask, and
connected by glass tubing to an unbroken tritium
ampoule. The whole system is arranged so that it can be
evacuated. After evacuation, the ampoule of tritium
gas was broken from the outside by using a ball-bearing
inside and a magnet outside. The apparatus was left
under vacuum for about three days, during which the
tritium exchanged with the hydrogen atoms of the
steroid molecules. The steroid was removed from the
apparatus, the labile tritium removed, and,as many
polar degradation products were formed during the
labelling procedure, the 7 -hydroxycholesterol
was re-purified by column chromatography on silicic
acid. The purity of the compound was checked by
running on a thin layer plate, segmenting the plate
and counting each segment. The radioactivity was
found to be associated only with the 7 r-<-hydroxycholest¬
erol. The specific activity of the pure compound was
found to be 500,000 c/m/mg. (Melting point = 183° C.)
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2. Chol93t-4.-en-3-one-7 ^-ol.
The substance was synthesised by Mr. Naqui.
Cholesterol was oxidised with benzoquinone to yield
cholest-4:6-dien-3-one, whioh was further converted to
cholest-4-en-6 ,7 <* -epoxide by treatment with
monoperphthalic acid. The epoxide was reduced with
lithium aluminium hydride producing cholest-4-en-3o<,7°*-
diol, which, on oxidation with manganese dioxide, gave
cholest-4-en-3-one-7^ -ol.
Melting point = 183 -184°C. ^Inblished melting point
= 183 - 18k°0. Danielsson (l96l b )J
Optical rotation = -670
Wavelength of maximum absorption » 2U2 mt
e2l£* 15»5°°
Carbon 80.92f Theory 80.If
hydrogen 11.20f Theoiy 11.Of
This substance was also tritiated by the Wilzbaoh
method, and re-purified by column chromatography. Its
purity was checked by running a thin layer plate in the
same way as for 7 oC-hydroxycholesterol. The specific
activity of the pure compound was found to be
500,860 c/m/mg.
It was found that leaving substances to exchange
with tritium for periods of more than a week led to the
production of so many degradation products that it was
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quite impossible to purify the original steroid. Thus,
substrates were left for only about three days, when they
were found to have a sufficiently high specific activity,
and could be readily purified.
3. Cholest,-5-en-3 >-ol-7£ -hydroperoxide. (Prepared by
r
Mr.Maqui)
Cholesterol was subjected to photo-oxygenation in
pyridine solution with haeaatoporphyrin as catalyst
(Schenk, G-ollnick and Neumuller, 1957)* to yield
cholest-6-en-3 J-ol-5 -hydroperoxide. This substance
was rearranged in chloroform solution to give
cholast-5-en-3/?-ol-7 > -hydroperoxide.
Melting point = 147°C.
Optical rotation = -137°•
Carbon J 77.23% Theory : 77.45#
Hydrogen : 10.76?' Theory : 11.08;
4. Chole3t-4-en-3 d. .7-X -diol. (Prepared by Mr. Naqui)
Cholesterol was oxidised with bensoquinone to yield
cholest-4:6-dien-3-one, which was further converted to
chol8st-4-en-6 d7 -d -epoxide by treatment with
monoperphthalic acid. On reduction with lithium aluminium
hydride, cholest-4-en-3 d,7* -diol was produced.
Salting point = 98°C. Optioal rotation = -135°
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Carbon : 79. &$> Theory : 80.53%
Hydrogen : 11,51% Theory : 11.44%
5. Coprostan-3gf .7 X -diol. (3 X.7 ^-dihydroxycoprostene)
(Prepared by Mr.'Iaqui)
(a) Chilesterol was converted to cholest-4-sn~6 -
epoxide as above, which was then reduced at room temper¬
ature with hydrogen gas and 10% palladium on charcoal as
catalyst to yield coprostan-3~one-7 X -ol. This was
further reduced with lithium aluminium hydride to
yield both coprostan-3'X >7<X -diol and the corresponding
3 fs -epimer. The 3 /3 -epimer was removed by precipitation
with digitonin, leaving coprostan-3 X,7 X -diol.
Melting point = 84 - 86°C. (Published melting point
= 34 - 86°C., Bergstrom and Krabisch, 1957).
(b) Coprostan-3X,7X -diol was also prepared by the
author by electrolytic condensation of chenodeoxycholic
acid with isovaleric acid.
Meliirg point = 80 - 82°C.
6. Copro3tan-3-one-7 x -ol. (Pre ared by Mr.daqui)
This was prepared by two methods; firstly as
described in 5(a)» end secondly by reduotion of
choiest-4-en-3-one-7 X-ol with hydrogen and platinum
at -27°C.
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Melting point = 121°C. (published melting point
= 121 C., Yamasaki, Kawahara and
Shinizu, 1959)
Carbon : 80.8^' Theory : 80.67$
hydrogen : 11.37/* Theory : 11.Uh$-
7. Cholest-5-en-3 3*7^ ,26-triol. (Prepared by Mr.Maqui)
This was prepared from the plant sterol kryptogenin,
which, after a Cleraraenson reduction, yielded two products,
cholast-5-en-3 ,4,26-diol (26-hydroxycholesterol), and
cholest-5-Qn-l6-one-3^,26-diol. The mixture was reduced
giving only 26-hydroxyoholesterol, which was then subjected
to a photo-oxygenation reaction in pyridine with
haematoporphyrin as catalyst, giving
chol9st-5-en-3 ^,26-diol-7-y -hydroperoxide. This was























































3. Kazuno and Mori (1954)
4. Scheer, Thompson and Mosettig (1956)
5. Mandell (1956)
6. Fieser, Fieser and Chakravarti (1949)




LIFSCHIT? C QLOUR RBAGTIOtt
The reagent consists of a solution of 1 g ferric
chloride in 900 ml glacial acetic acid and 100 ml
concentrated sulphuric acid, as described by Bergstrom
and .'/intersteiner (1942), l^Lth 7•hydroxyeholssterol
and some other substances (see Table 39 ), a blue
colour with a maximum absorption between 610 and 640 rau/
/
is obtained. A solution of the substance to be
estimated is dissolved in 1,5 oil dry chloroform and
5 ml of the reagent are added. 'The blue ehromogen
is read at 610 ny^ after 10 minutes against a reagant
blank. The relation between light absorption and
concentration is linear from 20 to 150 for
7 ot-hydroxycholesterol, although at greater concentrations
relatively more colour is produced (see calibration
curve, figure 51)• Thus, estimations of material are
always calculated to come within the above range.
Bergstrom and wintersteiner (1942) suggested
that a 2:4:6-triene or oholest-4:6-dien-3-ol may be
the ultimate precursor of the blue pigment. Allylic
shifts, suoh as from a cholest-5-on-3:7-diol to a
cholest-S-en-3:5»diol and. subsequent dehydration could
easily occur in strong acid.
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TABLB 59














Cholesterol esters - pink
Cholest-4-en-3-one - -
Cholest-5-en-3-one - pink
Choles tan-3-one - -
Coprostan-3-one - -
Cholest-5-en-7-one - mm
Cholestan-3 .3-ol - pink on
prolonged
heating
Coprostan-3 3-ol mm pink on
prolonged
heating
Cholestan-3 -ol pink on
prolonged
heating
Coprostan-3 -ol * pink on
prolonged
heating
Cholest-5-en-3 3 -7^-diol ♦ blue, very
readily
Cholest-5-sn-3 3 tld -diol esters ♦ blue, very
readily
Cholest—3-en—3 3 »7/9 —diol ♦ blue, readily
Cholest-4-en-3-one«7<a-o1 - pink













Chole3t-4«-en-3 ./.,7^-diol ♦ blue
Cholest~4-«n-3 ji ,7^-diol blue
Cholest-5J7-di®!*-3 /! ~ol + bluish-purple
Cholest-3:5-dieiW-on© - pink
Cholest-4:6-dian-3-one * m
Coprostan-3^ ,7V-diol ** yellow, on
prolonged
heating
Coprostan-3 ^<»7^ ,12^-triol m yellow, on
prolonged
heating
Copros tan-3-one-7 -ol - -
Gholest-5-en-3 p,26-diol m pink


























































































































In the above Table
p*t * phosphotungstic acldj p'm » phosphoraolybdic aoidj
u.v. m absorbs when viewed in u.v. light.
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Detection of steroids on chromatoplates
using a non-destructive method
The excellent resolution and rapid development times of thin-layer chromatography
make this technique a very useful tool in the steroid held. As many sterols and steroids
have characteristic absorption bands in the ultraviolet e.g. cortisone, progesterone,
cholestenone etc., advantage may be taken of this fact to develop a method whereby
these substances can be detected, and recovered quantitatively from a thin-layer plate
without the use of a destructive spraying reagent. This is of importance in steroid
studies in vitro where the material has to be quantitatively eluted, chemically de¬
termined and also assayed for radioactivity.
Thin-layer chromatography was carried out in the usual way except that quartz
plates were used instead of glass plates. The plates were viewed with a mercury lamp
(maximum emission 254 m/x) and ultraviolet-absorbing substances appeared as dark
spots. However, the silicic acid layer itself absorbed (or scattered) the incident light
and so the contrast between spots and background was not very great. This meant
that the method had a low order of sensitivity.
Sease1 incorporated an inorganic phosphor into silicic acid and used the mixture
in a quartz column. By viewing the column under ultraviolet light he observed the
presence of ultraviolet-absorbing bands. Kirchner2 adapted this method to thin-
laver chromatography of terpenes using glass plates for the chromatography.
This method was modified to permit its use in the detection of steroids as follows.
Various inorganic phosphors which fluoresce green under the mercury ultraviolet
lamp were mixed with Silica (Tel G (Merck) and used for thin-layer chromatography
of steroids on glass plates. The silicic acid layer was exposed to an ultraviolet source
and the chromatoplate examined from the "glass side". Absorbent substances having
maximum absorption between 240 and 280 m/x show up as dark spots which can be
marked on the glass side, eluted and either estimated spectrophotometrically and/or
assayed for radioactivity. Since the wavelength of the emission from the phosphor
varies with the wavelength of the ultraviolet light used to illuminate the plates the
background colour changes with some phosphors from bluish green at 200 m/x to
green at 240 m/x and to red at 300 m/x.
This method is particularly applicable to the study of intermediary metabolism
of adrenal steroids and oestrogens and also to the study of the breakdown of chole¬
sterol to bile acids where several of the expected intermediates are ultraviolet ab¬
sorbing. For example, using this thin-layer technique coupled to a preliminary column
method it can be shown that incubation of 7a-hydroxvcholesterol with certain cell
fractions of rat liver gives rise to cholest-4-en-3-one-7a-ol (cf. Yamasaki3; Daniels-
son4) with maximum absorption at 242 m/x, while incubation of cholest~4-en-3-one-
7a-ol produces a more polar ultraviolet-absorbing substance (maximum absorption
at 240 m/x) which is possibly cholest-4-en-3-one-7a-26(?)-diol. Using this method,
incubations can be carried out with very small amounts, in some cases less than 25 /xg
of substrate either unlabelled or labelled with tritium and the products of the reac¬
tion detected and quantitatively estimated. These substrates and products cannot
be separated as quickly or in such small amounts using conventional column methods.
The method can be made more specific by varying the wavelength of the ultra¬
violet light used to illuminate the plate. High-intensity ultraviolet sources and gratings
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are required for this purpose because the energy of the monochromatic light emerging
must be considerable to illuminate effectively even small plates.
Using a hydrogen lamp, substances which maximally absorption at 207 m/i such
as cholesterol and 7<x-hydroxycholesterol, can easily be detected. Thus by using a
series of interference filters in the range 200-300 mp. with a hydrogen source, this
method not only shows the position of a substance on the plate but indicates its
ultraviolet-absorbing properties and thus gives information on its possible molecular
structure.
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